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1. INTRODUCTION 
 
 
 
 
“ Dans la vie, rien n'est à craindre, tout est à comprendre”a 
Marie Curie 
 
 
 
 
 
 
 
 
 
 
                                                             
a “ In life, nothing has to be feared, everything has to be understood” Marie Curie 
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1.1 The concept of Symmetry 
“Naturalis potestas ita architectata est”b                               
Marcus Vitruvius Pollio 
Ad pulchritudinem tria requiruntur... 
...et debita proportio sive consonantia” 
Thomas Aquinasc 
 
The term ‘symmetry’ derives from the Greek word ‘συμμετρεῖν’ (symmetreίn) which is 
the sum of ‘σύν’ (‘syn’, meaning ‘with’) and μέτρον (‘metron’, meaning ‘measure’). 
Moreover this word was frequently invoked in ancient greek texts that dealt with the 
beauty and the good and originally meant a relation of commensurability.  However its 
meaning has changed during the centuries. Its subsequent Latin transliteration, 
symmetria was adopted by Vitruvius in the influential theory of architecture (Vitruvius 
praecepta symmetriarum, in De Architectura), in which he wrote about symmetry as the 
proportion of the body and the buildings. In book III he wrote: ‘Symmetry is a proper 
agreement among the members of the work itself, and relation between the different 
parts and the whole general scheme, in accordance with a certain part selected as 
standard.’ And then: ‘in perfect buildings the different members must be in 
exact symmetrical relations to the whole general scheme’. In fact here Vitruvius meant 
proportion, assigning to this characteristic charm and harmony; moreover he did not 
even call attention to the correspondence of the limbs, thus he was far away from the 
concept of relationship between mirror images. Saint Thomas Aquinas in the Summa 
Theologiae, stated the correlation between beauty and “consonantia”, meaning 
proportion as well. 
Throughout some centuries symmetry kept this meaning until the 1436, when the Italian 
artist Alberti in his De picture wrote about symmetry of a human body, clearly 
differentiating it from proportion. At that time the concept was still not clear and 
explicit.  
In fact during the Renaissance a transformation occurred and this concept finally 
changed: in the 1794 the mathematician Legendre adopted the term symmetry without 
                                                             
b “The architect was the power of Nature”Marcus Vitruvius Pollio, De Architectura 
c St. Thomas Aquinas,  Summa Theologiae 
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the aesthetic sense, thus bestowing the scientific community and effectively introducing 
the modern meaning of symmetry. Indeed this was a revolution.d 
1.2 Chirality 
“All the rigid regularities are inherently revolting 
to the taste, because their observation do not offer 
lasting pleasures” 
“I shall call a body which is exactly equal and 
similar to another, but which cannot be enclosed in 
the same limits as that other, its incongruent 
counterpart” 
Immanuel Kant 
 
The observation of symmetry and asymmetry in bodies and in general in the whole 
universe is an ancient matter, even though it has not been rationalized for a long time. In 
the 18th century Kant was the first philosopher to find something interesting in mirror 
images of asymmetric objects and he called them ‘incongruent counterparts’, taking 
advantage of some examples related to human bodies, as the right and left hands. In 
discordance to the classical concept of beauty, he attributed to ‘rigid regularities’  a 
feeling of boredom and a sense of ugliness.e The matter of this dissertation is related to 
those that Kant called incongruent counterparts, that in chemistry are the enantiomers of 
a molecule, the left-handed and the right-handed; the easiest way to understand this 
concept is comparing our hands, as Kant mentioned in his pioneering considerations, 
that are mirror images but not superimposable, like the enantiomers (Figure 1).  
                                                             
d Goldstein, B., From Summetria to Symmetry: the making of a Revolutionary  Concept, Springer, 2008; 
Heilbronner, E. Reflections on symmetry: In Chemistry and elsewhere, Wiley, 1993. 
e Hall, B., The Arguments of Kant's Critique of Pure Reason, Lexington Books, 2010. 
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Figure 1: right and left hands compared 
to two enantiomers 
 
In fact this feature is observed in molecules having a specific property, chirality. The 
word, firstly introduced in 1904, derives from Greek ‘χειρ’ (‘kheir’, meaning ‘hand’). A 
chiral molecule is not superimposable on its mirror image. The discovery of chirality 
happened in 1815, with the observation of Jean Baptiste Biot that some molecules could 
rotate the polarized light plane.1  
The occurrence of only one enantiomer of a molecule in nature is connected to the 
evidence that enantiomers have different biological activity and in general that they 
have a different behaviour in a chiral environment, despite they have the same 
physical/chemical properties. Thus enzymes, receptors and biologically occurring chiral 
molecules behave in a different way towards the left-handed or the right-handed 
enantiomer of a chemical or drug. For instance some different fragrances are isomers of 
the same molecule, for example (S)-limonene (1) smells like pine, instead (R)-limonene 
(2) smells like lemon (Figure 2). One can distinguish the two fragrances because of our 
nasal receptors, made of chiral molecules able to recognise the difference between the 
two enantiomers.  
Figure 2: limonene enantiomers and respective different 
fragrances: pine and lemon. 
(R)
2
(S)
1  
Other examples are molecules used by insects as sexual attractors, pheromones, as well 
as most of the commercialized drugs. Biochemical processes are strongly affected by 
stereochemical differences, because of the chirality of the involved molecules. A tragic 
example is Talidomide, a sedative drug which was broadly prescribed to pregnant 
women to avoid nausea because it did not cause dependence (Figure 3); unfortunately 
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one of the two enantiomers was responsible for foetus deformities as teratogen agent. 
Moreover, in this particular case, an additional problem is in vivo racemization of (R)-
Thalidomide into the (S)-Thalidomide; so even if the drug had been commercialized as 
a single enantiomer, it would have been risky because of racemisation process. 
In the light of these considerations, it appears undeniable the importance of producing 
only one enantiomer of a given molecule, as pure as possible and in large scale. 1    
Figure 3: Thalidomide, the two enantiomers 
 
1.3 Formation of chiral compounds 
“ On ne fait jamais attention à ce qui a été fait ; on 
ne voit que ce qui reste à faire ”f 
Marie Curie 
1.3.1 The three approachesAs just depicted, it is very important for both academic and 
industrial purposes to get important synthetic target molecules as single enantiomer or 
enantioenriched mixture, in the easiest and cheapest way. This goal can be achieved 
choosing among three different approaches:1 
1) Chiral pool: use of enantiopure starting material provided by nature 
2) Resolution: separation of enantiomers by chemical or physical means 
3) Enantioselective synthesis: preparation from nonchiral precursors using chiral 
reagents or catalysts 
Each of the above mentioned strategies presents pros and cons, depending on the 
purpose, and choosing a suitable method is often not easy; several aspects should be 
taken into account, for example reagent costs and hazards, scale, waste generation, 
number of steps.2  
                                                             
f “We never look at what has been done; we just look at what has to be done” Marie Curie 
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1.3.2 Chiral pool 
The chiral pool strategy is the synthesis of a chiral compound starting from naturally 
occurring molecules then modifying the structure in chemical steps towards the target 
molecule; throughout the steps, the stereocentres required for the target molecule will 
generally not be involved and indeed racemisation has to be avoided.1 Noteworthy 
examples of such compounds are amino acids, alkaloids, terpenes, and carbohydrates 
such as compounds displayed in Figure 4; definitely, these building blocks should be 
cheap and readily available in high enantiomeric purity to be useful to the purpose. In 
fact chemists usually opt for this method only if the objective molecule contains a 
structural chiral scaffold, which is easily obtainable from a commercially available 
natural product, whose synthesis would be difficult or too expensive.  
Figure 4: examples of naturally occurring chiral compounds.
 
One example of convenient chiral pool approach is the Holton first total synthesis of 
paclitaxel (10), the anti-cancer agent known as Taxol; Holton’s group achieved this 
important molecule in twenty steps, starting from the commercially available natural 
product patchoulene oxide (9, Scheme 1).3 The depicted synthesis is in fact easier 
and cheaper than other ones which take advantage of other approaches.4 
Scheme 1: Holton’s synthesis of Taxol starts from patchoulene oxide 
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Unfortunately, even though in many cases chiral pool strategy can be suitable, nature 
does not provide such a broad scope of easily accessible chiral scaffolds, therefore 
alternative approaches to asymmetric synthesis are quite often preferred.4  
1.3.3 Chiral resolution 
Resolution, namely the separation of the two enantiomer, has been widely used in 
industry as well as in academia since it displays great advantages; acceding directly to 
the racemate is very often much cheaper, rather than trying to get an asymmetric 
induction. In many industrial protocols this is still the elected technique, despite there 
being the half yield disadvantage; sometimes the by-products can be reconverted into 
the desired optically active product, increasing even more the advantages of this 
method, which in the last decades has been very often criticized because of the above 
mentioned disadvantage and considered “not elegant”.5 
The three main types of resolutions are: (a) classical resolution, (b) chiral 
chromatography, (c) kinetic resolution.  
(a)    The classical resolution is the so-called indirect approach and implies the 
derivatization with an optically active compound to give diastereoisomers which may be 
easily separated either by normal chromatography or via other techniques and then re-
converted into the desired product. The applicability of this methods depends on (i) the 
energy difference between the two diastereomers, (ii) the availability of optically pure 
chiral derivatizing reagents (CDR), (iii) the presence on the substrate molecule of 
moieties that could be covalently derivatized or that could make a diastereomeric salt 
with the CDR that could be crystallized.6 
Scheme 2: classical approach to resolution, diastereoisomers formation with an optically 
pure chiral derivatizing agent (CDR) 
 
A modern example of this evergreen approach is the industrial preparation of 
Duloxetine, a serotonin-norepinephrine reuptake inhibitor, which is used to cure major 
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depressive disorders and many other deseases.7 As depicted in Scheme 3, the racemic 
alcohol is dissolved in toluene and methanol in the presence of (S)-mandelic acid; the 
optically active mandelic acid forms a diastereomeric salt with one of the two 
enantiomers of the alcohol. The salt, which is unsoluble and precipitate, is filtered and 
treated with sodium hydroxide easily affording the (S)-enantiomer of the desired 
product. The pros of this technique, called RRR (resolution racemisation recycle) results 
in limited wastes because the unreacted (R)-enantiomer, still in solution, treated with 
HCl epimerizes and is recycled back.8 
Scheme 3: a) optical resolution of Duloxetine via diastereomeric derivatization with (S)-mandelic acid; b) 
the (R) enantiomer is epimerized and recycled back. 
 
(b)    The second type of resolution, well known as direct approach, take advantage of 
Chiral Chromatography techniques. This is a variant of column chromatography, in 
which generally the stationary phase is chiral and has different affinity with the two 
enantiomers, which therefore are recovered at the end of the column at different times. 
An advantage of this direct method is that the synthesis of diastereomers is not 
required.9 Several different chiral stationary phases have been developed over the years, 
many of them based on oligosaccharides such as cellulose or cyclodextrin scaffold. For 
instance a number of non-steroidal anti-inflammatory drugs and barbiturates, such as 
hexobarbital (14), have been effectively separated by cyclodextrines linked via an 
octamethylene spacer to a dimethylpolysiloxane (Scheme 4).10 The main disadvantage 
of this approach is the high cost of the preparative chiral columns. 
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Scheme 4: cyclodextrine chiral phase Chirasil-Dex was used to separate hexobarbital enantiomers
 
(c)     Kinetic Resolution performs an important role. This method involves a chiral 
catalyst or reagent to promote selective reaction of one enantiomer over the other giving 
a mixture of enantioenriched starting material and product. The desired component is 
then isolated (Scheme 5). The theoretical yields for such resolutions are usually 50%; if 
the undesired material can be racemized, those yields can be brought to very high values 
and this is the case of dynamic kinetic resolution (DKR).2  
Scheme 5: Catalytic Kinetic Resolution 
 
The first example of chemical kinetic resolution (KR) was presented by Marckwald and 
McKenzie in 1899, when they found the esterification of (R)-mandelic acid (15) with 
(S)-menthol (16) to be faster than the reaction of the (S)-enantiomer (Scheme 6).11 
Kinetic resolution can be conducted with the use of chemical reagents and catalysts or 
taking advantage of enzyme catalysis. A noteworthy example of enzymatic KR is the 
Degussa’s methodology for preparing natural and unnatural amino acids employing 
acylases: they synthesized the racemic mixtures of N-acetyl amino acids by Strecker 
synthesis and used acylases to obtain enantiomerically pure L-amino acids (Scheme 
7).12  
Thus kinetic resolution, especially DKR, can be very practical and many companies 
have opted for this convenient methodology. Indeed, there are some conditions that 
must be met, in order to consider the KR approach: 
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i. racemate is cheap 
ii. catalyst is very selective at low loading 
iii. catalyst is cheap and recoverable 
iv. the resolved starting material and product are easily separable 
v. ideally both starting material and product are valuable 
Scheme 6: (R)-mandelic acid resolution by (S)-menthol 
 
OH
HO
O
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Scheme 7: Examples of natural and unnatural amino acids resolved by Degussa’s enzymatic KR 
 
1.3.4 Enantioselective synthesis 
The third way to achieve chiral compounds is traditionally called “asymmetric synthesis” 
(IUPAC, 1996)13 and can be described as “a chemical reaction (or reaction sequence) in 
INTRODUCTION 
 
16 
 
which one or more new elements of chirality are formed in a substrate molecule and 
which produces the stereoisomeric (enantiomeric or diastereoisomeric) products in 
unequal amounts. In fact, enantioselective synthesis is probably the most fascinating 
and intriguing approach to optically pure molecules that a chemist could think about. 
The first definition of asymmetric synthesis was given by Marckwald in 1904: 
“Asymmetrische Synthesen sind solche, welche aus symmetrisch konstituirten 
Verbidungen unter intermediärer Benutzung optisch aktiver Stoffe, aber unter 
Vermeidung jedes analytischen Vorganges, optisch aktive Substanzen erzeugen”g  
 
This definition specifies that asymmetric synthesis allows chemists to avoid any 
analytical separation technique to have enantiopure products. Indeed, high levels of 
asymmetry can be reached by the use of a chiral reagent or catalyst; these compounds 
have the power to induce asymmetry in a chemical transformation by interacting with 
other nonchiral reagents.14 Concisely, the known methods for asymmetric synthesis can 
be conveniently divided into four major classes, depending on how the influence of the 
chiral group is exerted, as follows:1 
I. First generation or substrate-controlled method                                        
Reaction is driven intramolecularly by a stereogenic centre already present in the 
chiral substrate. 
II. Second generation or auxiliary-controlled methods 
The difference with the first generation is that the chiral auxiliary, that initially 
binds the substrate, is removed after it has served its purpose. 
III. Third generation or reagent controlled methods 
The chiral reagent does not bind the substrate therefore does not need to be 
removed. 
IV. Fourth generation or catalyst-controlled methods 
The final refinement is to use a chiral catalyst to direct the conversion of an 
achiral molecule directly to a chiral product with an achiral reagent. 
Among the four strategies towards enantioselective synthesis, the first three require 
stoichiometric amounts of an enantiomerically pure compound, the fourth one instead 
                                                             
g “Asymmetric synthesis are those that produce optically active substances from symmetrically 
constituted compoundswith the intermediate use of optically active materials, but with the avoidance of 
any separations.” Marckwald 
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takes advantage of a catalyst, which is thus used in lower quantities, an can sometimes 
be recovered as well. There are some criteria to judge an asymmetric synthesis and to 
choose one of the possible methods:15 
a. the high stereoselectivity; 
b. if a chiral catalyst is employed, low catalyst loadings are preferable, and the 
catalyst must be easily separable from the product; 
c. if a chiral auxiliary is used, it should be both removable without compromising 
the newly formed stereocenter and recoverable in good yield without 
racemisation; 
d. the chiral auxiliary or catalyst should be readily and inexpensively available, 
preferably as both enantiomer. 
1.3.5 Asymmetric catalysis 
As just depicted, the fourth generation method for asymmetric synthesis presents some 
advantages: the catalyst is used at low loading, the choice of the starting material is far 
wider, since it need no longer to come from the chiral pool, and there is no need to 
dedicate two extra steps to the installation and removal of chiral auxiliary. For these 
reasons the chiral catalyst approach has been extensively exploited in the last decades. 
For asymmetric catalysis the three eligible methods are transition-metals complex 
catalysis, enzymatic catalysis and organocatalysis; those strategies are complementary 
to each other, nevertheless, the chemistry community, for many years, has believed that 
only the first two types of catalysts could be efficient and selective. In fact in the last 
decades enantioselective synthesis by metal-catalysis has been broadly explored; a 
noteworthy example of highly efficient asymmetric synthesis is the rhodium-catalyzed 
asymmetric enyne cycloisomerization of terminal alkynes towards the formal total 
synthesis of (−)-platensimycin (30), presented by Nicolau in 2009 (Scheme 8).16  
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Scheme 8: enantioselective formal synthesis of (S)-plantensimycin via Rhodium catalysis 
 
Although the use of metal catalysts brings many advantages, it represents a polluting, 
expensive catalytic methodology, with respect for instance to enzymatic processes. 
Due to the enormous progresses in the field of enzyme discovery and enzyme 
engineering, in the recent years numerous examples of organic synthesis with enzymes 
have been developed. Enzymes represent a useful and cheap way to obtain different 
reactions and each class of enzymes can cover a broad range of chemical 
transformations. A significant example are the hydrolases, which are probably the most 
popular and frequently used enzymes; among them, representative examples are 
proteases, lipases, and esterases; typical transformations catalyzed by hydrolases 
include hydrolysis of esters and amides, and Scheme 9 give an overview of reactions 
scope.17 
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Scheme 9: examples of reactions catalyzed by hydrolases  
 
The use of enzymes presents some disadvantages, as limited stability of enzymes under 
organic reaction conditions and low efficiency when using wild-type strains. 
Organocatalysis, the third and more recently developed approach to asymmetric 
catalysis, can overcome those problems together with the costs and environmental 
issues that are intrinsic of organometallic catalysis.18 
1.5 Enantioselective Organocatalysis 
 
“..What's in a name? that which we call a rose 
By any other name would smell as sweet..” 
William Shakespeare, “Romeo and Juliet” 
1.5.1 A new concept 
The term “organocatalysis” has been introduced in the scientific community in 2000 by 
D. MacMillan,19 one of the pioneers of this field. It means: the use of small organic 
molecules to catalyse organic transformations, even though some recent examples of 
organocatalysis combined with metal catalysis have been included in the 
organocatalysis branch as well.20 During the last decades, organocatalysis has been 
included among the most important and successful concepts in asymmetric catalysis and 
it has been used for the enantioselective construction of C-C, C-N, C-O, C-S, C-P, and 
C-halide bonds. Furthermore, this new branch experienced a fast rise in the first eight 
years from its advent with more than 2000 manuscripts published in the field, in which 
more than 150 discrete reactions are reported. In one of his masterpieces, MacMillan 
proposed that this big power of attraction could be attributed to the name: he suggested 
INTRODUCTION 
 
20 
 
that  the term Organocatalysis provided a strong identity and helped to unify the field. 
Indeed this fast rise could be possible thanks to some pioneering studies concerning 
non-metal catalysis and to the previously highlighted importance of asymmetric 
synthesis of valuable molecules.  
1.5.2 The history of Organocatalysis 
The history of organocatalysis has the special characteristic of being started more than a 
hundred years ago and actually being ignored as such an important field until the year 
2000. In fact in 1912 Bredig and Fiske reported that cinchona alkaloid promoted the 
addition of hydrogen cyanide to benzaldehyde with low enantioselectivity21 and in 1960 
Pracejus found a cinchona alkaloid catalyzed asymmetric addition of methanol to 
ketenes.22 Afterwards, in 1971, Hajos’s and Wiechert’s groups reported independently 
the (S)-proline catalysed asymmetric aldol reaction, without a satisfying mechanistic 
study and without recognising the important novelty (Scheme 10).23  
Scheme 10: Hajos reaction catalyzed by (S)-proline 
 
Only in 2000, B. List reported an asymmetric (S)-proline (37) catalysed aldol reaction 
between acetone and some aldehydes, leading to the corresponding aldols with very 
high enantiomeric excesses and high yields. The hypothesised mechanism involves the 
formation of the enamine between (S)-proline and acetone, a stronger nucleophile than 
the corresponding enol; (S)-proline is able to increase the HOMO energy and thus the 
reactivity of the nucleophile.18 Moreover in the reaction intermediate, the catalyst 
interacts with the aldehyde through the protonation of the carbonyl (Scheme 11). In the 
same year, D. MacMillan presented a direct Diels-Alder reaction catalysed by a new 
chiral imidazolidinone catalyst (43); in his paper he verified that his catalyst could 
direct the addition of a diene to enals, by lowering the energy of the LUMO, thus 
activating the electrophile towards the nucleophilic addition (Scheme 12).19a 
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Scheme 11: direct aldol reaction catalysed by (S)-proline 
 
Scheme 12:direct Diels-Alder reaction catalysed by MacMillan imidazolidinone 
 
These recently developed organocatalytic reactions paved the way to many groups that 
started to work in the same field, thus developing many different catalysts types and 
contributing to the growth of organocatalysis scope.19b, 24  
1.5.3 Covalent or Noncovalent Organocatalysis 
Among the various organocatalytic methodologies there are different types of activation 
and two main areas can be identified on the mechanistic basis: (i) “covalent 
organocatalysis” and (ii) “noncovalent organocatalysis”. In the former case, within the 
catalytic cycle, the catalyst covalently binds the substrate, in the latter case only 
noncovalent interactions, such as hydrogen bonding or the formation of ion pairs, 
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activate the molecule towards the asymmetric transformation. Typical examples of 
covalent organocatalysis are proline-catalyzed aldol reactions which proceed via 
enamine intermediates (see Scheme 11).18 However, noncovalent organocatalysis has 
recently been explored by many research groups and a vigorous development in this 
area has been achieved as well.24-25  
1.5.4 Noncovalent organocatalysis 
Noncovalent organocatalysis is often attributed mainly to either hydrogen bond network 
or ion pairs formation. As recently elucidated by E. N. Jacobsen, many different kinds 
of interactions are often cooperating within the reaction mechanism in order to lead to 
high enantioselectivities.26 The known noncovalent interactions scope includes  charge-
charge, charge-dipole, dipole-dipole, charge-induced dipole, dipole-induced dipole 
forces, steric repulsion and H-bond  (Figure 5). 
Figure 5: noncovalent interactions 
 
Indeed noncovalent interactions are weaker and less directional with respect to covalent 
bonding; thus in order to get the same results in terms of stereoselectivity, more than 
one interaction is requested in order to have an effective spatial constraints. In fact, 
catalysts for this type of activation bear few H-bond donor or acceptors or acid/basic 
sites, capable of generating multiple, but in concert operating, weak interactions. Many 
catalysts are also called “bifunctional” as they bear more than one function. Noteworthy 
examples of bifunctional noncovalent organocatalysts are the Soós thiourea (47) and 
diphenyl prolinol (48), depicted in Figure 6. Both of these catalysts bear a pseudo-Lewis 
acids function and a Brønsted base function.27 The different functions work in concert 
within many reaction mechanisms, activating both electrophile and nucleophile.28 
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Figure 6: examples of bifunctional – noncovalent organocatalysts 
 
 
Among the different kinds of noncovalent asymmetric catalysis, H-bonding and 
Brønsted acid catalysis are so far the most investigated. 
1.5.5 Hydrogen bonding organocatalysis 
Hydrogen bond organocatalysis clearly relies on H-bond interactions, even though other 
secondary interactions usually cooperate with them. For instance, milestones such as 
Jacobsen’s29 and Schreiner’s thioureas (52, 53, Scheme 13b),27 clearly resemble the 
enzymatic pocket of serine proteases in the activation of the amide carbonyl towards the 
serine nucleophilic attack. Within what is called the “oxyanion hole”, the amide 
carbonyl is coordinated and activated by two NH groups so favouring the serine 
nucleophilic attack with the formation of a tetrahedral intermediate stabilized by H-
bonding in the oxyanion hole (Scheme 13a).30 
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Scheme 13: a) oxyanion hole in serine protease activating a carbonyl; b) hydrogen bonding 
organocatalysts activating a carbonyl 
 
A variety of electrophiles can be activated towards nucleophilic asymmetric addition 
with the same action mode and a series of reactions have so far been investigated.31 
Moreover, H-bonding catalysts can promote enantioselective reactions by stabilizing 
anionic fragments, as in Claisen rearrangement,32 by binding an anion, as in Pictet-
Spengler cyclization33 and hydrocyanation of imines (Scheme 14).34 
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Scheme 14: examples of reactions catalyzed by H-bonding catalysts 
Regarding the classification of hydrogen-bonding catalysts within the Lewis/Brønsted 
acid/base catalysis branches, the Shreiner’s group carried out some studies concerning 
thioureas have been conducted, by the use of NMR, IR and computational techniques, 
as well as some reactivity comparisons between well-known Lewis acids (aluminium 
trichloride, titanium tetrachloride).  These studies proved that there are many 
similarities between Lewis acids and hydrogen bonding additives; this is the reason why 
some hydrogen bonding catalysts can be classified as Lewis acids.27 
1.5.6 Brønsted acids organocatalysis 
Substrate activation by Brønsted acids (BA) is related to, but different from, hydrogen 
bonding catalysis, since in the former case, proton transfer from the catalyst to the 
substrate occurs. The terms “specific Brønsted acid catalysis” and “general Brønsted 
acid catalysis” are used, depending on whether proton transfer occurs to the substrate in 
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its ground state or in the transition state. In specific Brønsted acid catalysis, the 
electrophilic substrate is reversibly protonated in a pre-equilibrium step, prior to the 
nucleophile attack (II, Scheme 15), instead in general acid catalysis the proton is 
(partially or fully) transferred in the transition state of the rate-determining step (I, 
Scheme 15). In transition state I the hydrogen on the acidic centre interacts with the 
substrate via hydrogen bond, instead in transition state II the substrate is protonated. 
This activation mode is related to H-bonding, since clearly the formation of a hydrogen 
bond precedes proton transfer;25 moreover some recent studies by Rueping’s group 
suggested that in some cases the activation mode is in between the two mentioned 
ones.35 
Scheme 15: transition states in general acid 
catalysis (I) and in specific acid catalysis (II) 
 
Chiral BA catalysis has had a breakthrough in 2004, when Terada and Akiyama 
independently presented an enantioselective Mannich-type reaction catalyzed by new 
metal-free phosphoric acid, BINOL-derived compounds (Scheme 16).36 These 
pioneering studies already showed how powerful could be the use of BA catalysis for 
asymmetric synthesis; in fact the BINOL derived catalysts were designed in order to get 
an environment both sterically demanding, to achieve good enantioselectivity, and 
moderately acid, to protonate the imine’s nitrogen. 
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Scheme 16: Enantioselective Mannich-Type reaction presented by Akiyama’s group in 2004 
         
While the first studies did not elucidate the specific mechanistic pathway (even though 
suggesting the protonation of the imide by the phosphoric acidic site), later on, the BA 
catalytic activity came up. First of all in the activation of a compound, i.e. carbonylic 
derivative, towards chemical transformations, for example a carbonylic compound, BA 
differ in the catalytic centre from the well known Lewis Acids (LA): LA). Indeed, in 
BA the centre is a proton instead of a metal or metalloid and this is actually the simplest 
centre an organic chemist could think about (Scheme 17). Furthermore, proton has only 
one valence orbital and the interactions number is limited with respect to LA catalysts. 
As a consequence, the sterically hindering groups of the BA catalyst scaffold should be 
bulkier.37 
Scheme 17: Lewis Acid (LA) vs Brønsted Acid (BA) catalysts 
 
Moreover, BA are bifuctional catalysts, since they bear an acidic site and a basic site 
(Figure 7); thanks to these characteristics in the last ten years many different types of 
chiral phosphoric acids have been synthesized and used as catalysts in a broad scope of 
enantioselective reactions. For instance, the bulky (S)-TRIP, developed by List’s group, 
can efficiently catalyze enantioselective transacetalizations,38 Povarov reactions,39 O-
alkylations,40 Pictet-Spengler reactions,41 and many other transformations (Figure 7).  
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Figure 7: chiral BINOL-derived phosphoric acids, particularly (S)-TRIP 
 
This dissertation is mainly focused on H-bonding and Brønsted acids organocatalysis 
and in the next chapters some successful applications of these activation modes will be 
presented. 
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The importance of organocatalysis in the asymmetric synthesis panorama has been 
previously described. Moreover, in the light of the interesting perspectives in the field 
of noncovalent organocatalysis and of the importance of optically pure compounds  as 
intermediates and building blocks in fine organic synthesis, this PhD work has been 
centred on applications of noncovalent organocatalysis to the synthesis of 
enantiomerically enriched valuable molecules. In particular, among the different aspects 
of noncovalent organocatalysis, bifunctional hydrogen bonding catalysis and Brønsted 
acids catalysis have been exploited. Within these field, two different kinds of 
approaches towards optically pure molecules have been investigated, namely 
asymmetric catalysis and kinetic resolution, which have already been depicted in 
Chapter 1. 
Thus, the results and discussions of this thesis are divided into two sections and reported 
in two different Chapters. 
The first part, reported in Chapter 3, deals with H-bonding bifunctional organocatalysis 
applied to the enantioselective epoxidation of electron deficient olefins, in particular -
ylidenoxindoles 67 (Scheme 18). The goal was developing an efficient, cheap and easy 
asymmetric synthesis of epoxides 68 bearing a quaternary stereocenter. This subject has 
been studied under the supervision of Prof. Maria Antonietta Loreto (University “La 
Sapienza”, Rome). 
Scheme 18: organocatalytic epoxidation of -ylidenoxindoles  
 
The second part of this dissertation, reported in Chapter 4,  is about Brønsted acids (BA) 
organocatalysis employed for a kinetic resolution of racemic 1,2-diols 69 bearing a 
quaternary stereocenter, via asymmetric acetalization (Scheme 19). In particular the 
purpose was developing a new methodology that could lead to both enantiomerically 
enriched products 69 and acetal 70. Moreover, the applicability and the scope of the 
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reaction have been investigated, during an internship in Prof. Dr. Benjamin List’s 
laboratories (Max-Planck-Institut für Kohlenforschung, Mülheim an der Ruhr). 
Scheme 19: organocatalytic kinetic resolution of 1,2-diols 
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3.1 Organocatalysis for the epoxidation of electron-deficient olefins 
Chiral epoxides are among the most valuable intermediates and building blocks in fine 
organic synthesis. The oxirane ring easily undergoes to a number of stereoselective 
chemical transformations that directly led to more elaborate enantiopure compounds 
which are precursors of natural products or biologically active molecules.42 In Scheme 
20 a few examples are presented: a well-known epoxide, such as the antibiotic 
Fosfonomycin 71, and some epoxide-derived molecules, such as the side chain of the 
famous anticancer agent TaxolTM 72 and a Leukotriene precursor 73.43 
Scheme 20: examples of epoxides-derived compounds 
 
For the aforementioned reasons, asymmetric synthesis of epoxides is a hunted goal for 
organic chemists and the enantioselective epoxidation of olefins represents a powerful 
strategy for the synthesis of enantiomerically enriched epoxides. 
Katsuki and Sharpless paved the way to the epoxide asymmetric synthesis, introducing 
a practical method for the enantioselective epoxidation of non-activated olefins, though 
limited to allylic alcohols (75). The Ti(iPrO)4.(R,R)-DETh catalyzed epoxidation, brings 
to the oxidized products in high yields and high enantioselectivities for a very broad 
scope of such kind of compounds (Scheme 21); these appealing features have made 
Sharpless epoxidation one of the most exploited asymmetric transformations.44  
Scheme 21: the first practical asymmetric epoxidation 
 
Many efforts have been made in this field, to afford catalytic asymmetric epoxidation of 
unfunctionalized olefins. In 1990 Katsuki et al. and Jacobsen et al. independently 
                                                             
h Diethyl tartrate (DET) 
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reported enantioselective epoxidation using chiral Mn(salen) complexes (77 and 78) as 
catalysts (Scheme 22). Complex 78 is the first example of the C2-symmetric salen 
catalyst consisting of two chiral subunits. This strategy has achieved wide scope of 
catalytic performance, as well as high enantioselectivity (up to 95% ee).45 Afterwards, 
with some new complexes, the same research groups were able to reach excellent results 
(90->99% ee) by introducing some new salen-complexes;46 moreover, Berkessel et al. 
have recently developed an efficient epoxidation taking advantage of a similar catalyst 
type.47 
Scheme 22: Mn(salen) complexes used as initial chiral 
catalysts for enantioselective epoxidation reactions 
 
Apart from the well established metal-catalysis, some other methods have been 
disclosed for the enantioselective epoxidation which take advantage of the cheaper and 
environmentally friendly organocatalysis. The oxidant for such reactions may be either 
electrophilic or nucleophilic, although electrophilic oxidants are often not sufficiently 
efficient for a broad scope epoxidation of olefins. In particular, they are not strong 
enough to oxidize electron-deficient olefins. A noteworthy example of efficient 
organocatalytic enantioselective electrophilic epoxidation was presented by Shi in 2002; 
this methodology takes advantage of the action of Oxone®, which converts a chiral 
sugar-derived ketone (79) into the oxirane electrophilic reative species (82). The 
reaction leads to a relatively broad scope of epoxides with interesting ees (up to 99%) 
(Scheme 23), but is still strictly substrate-dependent, even though represents the only 
example of organocatalytic epoxidation of α,β-unsaturated esters (80).48 Nevertheless, 
the reaction mixture results to be quite complex as well the reaction pathway which 
easily gives undesired byproducts. 
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Scheme 23: Shi epoxidation 
 
In fact, despite the usefulness of  , -epoxycarbonyl compounds and of epoxides 
bearing electron withdrawing group (EWG), no system for the asymmetric epoxidation 
of electron-deficient olefins has achieved widespread popularity among synthetic 
organic chemists.49 Only over the last few years systems which allow the epoxidation of 
alkenes bearing an electron withdrawing group (EWG) and a number of methodologies 
involving different types of catalyst-reagent combination have been established.50 
Most of the reported methods are essentially asymmetric modification of the Weitz-
Sheffer reaction51 in which one of the oxygen atoms in the nucleophilic oxidant is 
transferred to the  , -unsaturated precursor (83) through the  -peroxyenolate 
intermediate (84) formation (Scheme 24). 
Scheme 24: Weitz-Sheffer epoxidation 
 
Based on this model, some peptide-catalyzed organocatalytic approaches have been 
developed during the last few years; among them, the Juliá-Colonna epoxidation,52 
whose mechanism has been studied by Berkessel et al,53 requires poly-amino acids to 
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activate enones towards nucleophilic attack of hydrogen peroxide via H-bonds. 
Berkessel et al. furthermore showed that, for aminoacidic poli-Leucyne TentaGeli-
bound catalysts, high enantioselectivities (> 95% ee) can be achieved with just five L-
Leu residues (Scheme 25). 
Scheme 25: Berkessel epoxidation of enones 
 
Among organocatalytic approaches to Weitz-Sheffer-type epoxidation of enones, a 
noteworthy method is a phase transfer catalytic reaction (PTC), which take advantage of 
Cinchona alkaloids derivatives (88) or quaternary ammonium salts (89) (Scheme 26); to 
this purpose t-butyl hydroperoxide (TBHP), hydrogen peroxide or NaOCl are used as 
oxidants.54 Although the scope of the substrates is narrow, this method has been 
successfully employed for the epoxidation of calchone (90), since good 
enantioselectivities are achieved (96% ee). 
                                                             
i Poli-Leucyne catalyst is bound to a poliethylen glicol – polistirene resin, Tentagel S-NH2 
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Scheme 26: PTC in the epoxidation of enones 
 
In this context, the List group recently developed an interesting asymmetric variant of 
the Weitz-Sheffer reaction; the use of bifunctional Cinchona alkaloid derivative 92 as 
catalysts and hydrogen peroxide as oxidant, allowed them to obtain the oxidation of 
varius cyclic and non-cyclic enones with excellent enantioselectivities (up to 98% ee) 
(Scheme 27).55 
Scheme 27: List enones epoxidation 
 
For the enantioselective epoxidation of   and  -branched enals, Hayashi’s and 
Jørgensen’s groups independently disclosed the dreadful potential of α,α-diaryl prolinol 
silyl ethers (97 and 98) catalysis (Scheme 28), obtaining the desired epoxide in high 
enantioselectivities (up to 98% ee) and excellent yields (up to 90%).56 
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Scheme 28: catalytic enantioselective epoxidation of enals a) by Jørgensen et al. b) by Hayashi et al.   
 
Furthermore, both groups investigated on the reaction mechanism, hypothesizing an 
iminium ion covalent catalysis. In fact, within the catalytic cycle, the  key intermediate 
is an iminium ion, which lowers the LUMO energy of the electrophilic double bond of 
enal. The subsequent stereoselective addition of the peroxide anion, followed by the 
cyclization, led to the enantioenriched epoxide (Scheme 29).  
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Scheme 29: proposed mechanism for epoxidation of enals 
 
In the same field, Lattanzi and Zhao have independently developed the enantioselective 
epoxidation of  , -unsaturated ketones, exploiting the peculiarity of α,α-diphenyl 
prolinol (48) as catalyst and using TBHP as the oxidant.57 The mechanistic hypothesis 
for the calchone (90) epoxidation postulates that the α,α-diphenyl prolinol, which bears 
the free hydroxyl function, could act as bifunctional, H-bonding catalyst. The catalyst is 
supposed to be both involved in an ionic couple with the oxidant, and to coordinate the 
carbonylic oxygen via H-bond, thus facilitating the peroxide attack in the  -position of 
the enone function (Scheme 30). 
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Scheme 30: Lattanzi enones epoxidation 
 
The so far reported examples deal with the enantioselective epoxidation of enones and 
enals. Other few cases of asymmetric oxidations of these kind of compounds are 
described in the recent literature,58 whereas not much is reported about unsaturated 
esters and amides.59 The scarcity of specific bibliography probably does not reflect a 
lack of interest, but rather a difficulty to handle these less reactive molecules. However, 
this field is still almost unexplored and is yet to be realized on a wide range of  , -
unsaturated carboxylic derivatives. Consequently the urgency for an efficient and 
effective stereoselective epoxidation of electron-poor alkenes remains a challenging 
endeavour of great interest. 
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3.2 Target molecules 
3.2.1 Spiro oxindoles 
In 1900, Adolf Von Baeyer proposed the nomenclature “spiro compound” for a 
particular class of bicyclic molecules: “A spiro compound has two rings which have 
only one atom in common and the two rings are not linked by a bridge. The rings may 
form part of other ring systems (fused ring, bridged fused ring, system named by von 
Baeyer nomenclature). The common atom is known as a spiro atom.”60 Among such 
molecules, spiro-oxindoles in the last decades strengthened their importance in organic 
chemists priorities; the reasons behind this attention are the growing awareness of the 
biological activity of this molecules as well the synthetic ongoing challenge of building 
quaternary stereocenters.61 Particularly, spiro oxindoles (103) are characterized by an 
oxindole core, one of the most recurring moieties in natural products, which is spiro-
fused with cycles or heterocycles of various dimensions and kinds (Scheme 31). 
Scheme 31: spiro-oxindole frame 
 
Many examples exist of naturally occurring alkaloid-type products and synthetic 
molecules,62 containing oxindole core, well known for their remarkable 
pharmacological activity, as anti-bacterial, anti-cancer, and anti-malaria agents; often 
these molecules have inspired chemists to total synthesis endeavour.63 Noteworthy 
spiro-oxindolic compounds are the natural alkaloids gelsemine 104, spirotriprostatine A 
105, and defrustramine B 106, which have shown interesting biocide activity and whose 
syntheses, during the last decades, have been addressed by a number of research groups 
(Scheme 32).64 These spiro compounds often contain some quaternary stereocenters in 
addition to the spiro center; therefore asymmetric synthesis of such type of molecules 
represents a great goal, because of the depicted features and above all because of the 
challenge of the simultaneous creation of those multiple quaternary stereocenters.65 
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Scheme 32: notheworthy examples of oxindole-derived spiro compounds 
 
The majority of the asymmetric syntheses of spiro oxindoles reported in literature, 
requires enantiopure reagents (chiral pool approach) or metal complexes as either chiral 
ligands or catalysts;  furthermore these approaches often consist of multi-steps 
reactions, or involve difficult methodologies that very often have a narrow substrate 
scope.66 For instance, Matsunaga et al. recently presented an addition of oxindoles 107 
bearing an isothiocyanato group to aldehydes 108 under dinuclear Nickel Shiff base 110 
catalysis (Scheme 33). The homodinuclear metal catalyst provides an easy one step 
access to spirocyclic oxindole compounds, in one step, leading to high 
enantioselectivity  (up to 99% ee) with a high catalyst turnover number (TON, up to 
850), at room temperature.67 
Scheme 33: dinuclear Ni Schiff base catalysis towards spiro-oxindoles 
 
In this panorama, organocatalysis has recently had its breakthrough, thus in the last few 
years many groups focused their attention to organocatalytic enantioselective synthesis 
of spiro-oxindoles.  
A noteworthy example was reported in 2011 by Shao’s group that has developed an 
organocatalytic asymmetric double Michael addition of nitroalkenes 112 to 3-
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substituted spiro-oxindoles 111; this transformation, catalyzed by a thiourea catalyst 
(114) in mild conditions, leads to spirocyclopentaneoxindoles (113) with quite good 
diastereoselectivity and enantioselectivity (up to >30:1 dr; up to >99% ee) (Scheme 
34).68 
Scheme 34: enantioselective synthesis by Shao et al. 
 
Several other examples of organocatalytic asymmetric synthesis of spirocyclopentane 
and spirocyclohexane oxindoles have recently been presented, whereas not much 
attention has so far been addressed to oxindoles spiro fused with three-membered 
rings.66 
3.2.2 Asymmetric synthesis of spiroepoxy oxindoles 
The field of symmetric and nonsymmetric synthesis of highly strained three-membered-
cycle, spiro-fused oxindoles has not been broadly investigated so far, even though these 
include some examples of biologically relevant compounds, such as cyclopropyl 
oxindole scaffolds, like 115, that have shown powerful activity as HIV transcriptase 
inhibitors.69 
Scheme 35: cyclopropyl oxindole 
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Among three-membered ring spiro-fused oxindoles, spiro-epoxy oxindoles are also 
considered pharmacologically interesting compounds; this interest is due to the presence 
of the oxirane moiety, which, because of its high reactivity, is often related to anti-viral 
or cytotoxic  activity. Although in the 60’s Anthony firstly envisioned the spiro-epoxy 
oxindoles high reactivity under various conditions,70 only far more recently other 
research groups have reported about the symmetric synthesis of many interesting 
biocide spiroepoxy-oxindoles. Some of such compounds (117-119) were synthesised as 
racemates by Dandia et al. through nucleophilic epoxidation of the 3-alkenyl oxindoles 
116, using hydrogen peroxide as oxidant, under basic conditions, with microwaves 
irradiation (Scheme 36).71 Many other approaches to spiroepoxy-oxindoles are reported 
in literature, but none of them achieve enantioenriched compounds.72 
Scheme 36: Dandia synthesis of spiro-epoxy oxindoles; 117 and 118 have anti-
fungal and anti-tubercular properties, 119 is active against melanoma 
 
Furthermore, spiroepoxy oxindoles can be considered direct precursors of the 
corresponding alcohols, via the opening of the oxirane ring (Scheme 37). Such 
compounds are among biologically active molecules, such as convolutamidine A, B, 
and C (121-123) that are alkaloids isolated from a marine organism and are known to 
stop leukaemia promyelocytic (AML) cells growth.  
Scheme 37: epoxy oxindoles as direct precursors of convolutamidines 
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Indeed, an asymmetric and possibly organocatalytic approach to these interesting 
molecules, is a desired goal. The past few years have witnessed a rapid progress in the 
asymmetric organocatalytic construction of various spirocyclic oxindoles, nevertheless 
the literature concerning asymmetric synthesis of these molecules, spiro-fused with an 
oxirane ring is surprisingly poor.66 An example was presented in 2007 by Metzner et al. 
in which a chiral sulfide (126) afforded a promising and straightforward entry to the 
nonracemic epoxyoxindole 127 with poor enantioselectivity (30% ee) (Scheme 38). The 
product could be easily converted in the anticancer agent 128, via phenyllithium 
chemoselective addition to the amide.73 
Scheme 38: Shulz et al. presented an asymmetric synthesis of spiroepoxyoxindoles 
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3.3 Results and discussion 
3.3.1 A foreword and first experiments 
As a consequence of the oxindole-derived compounds relevance, Loreto’s research 
group in the last few years has addressed many efforts to study both synthesis of 3-
ylideneoxindoles and their use for the construction of three-membered ring spiro-fused 
oxindoles. In 2009 they presented the facile synthesis of spiroaziridine-oxindoles, 
starting from the corresponding alkenes.74 In 2011 the same group reported about a 
Weitz-Sheffer-type nucleophilic epoxidation of 3-(oxyphosphonylmethylene)-oxindoles 
(129) which allowed them to obtain racemic compounds (for example 130) bearing a 
phosphonate moiety on the epoxidic ring (Scheme 39).75 The reaction showed to be 
highly diastereoselective (up to 85/15 dr), since, starting from the E isomer (129), 
almost only the isomer 130-trans was always isolated.  
The phosphonate moiety in 3-ylidenoxindoles 129 represents a second electron 
withdrawing group (EWG) on the exocyclic double bond, which is then more 
electrophilic and is thus activated towards nucleophilic attack; moreover phosphonate 
group indeed represents an appealing function because it is endowed in many anti-viral 
and anti-bacterial agents, such as phosphomycin.76  
Scheme 39: diastereoselective nucleophilic epoxidation of ylidenoxindoles 
 
In the light of these interesting studies and of the potential interest of an 
enantioselective approach to the appealing spiroepoxy-oxindoles, the possibility of 
synthesizing optically active spiro-epoxyoxindole esters was taken into account. 
On these grounds and in the light of the lack of efficient methodologies for 
enantioselective epoxidation of electron-poor olefins,  the main pourpose of this thesis 
is the development of an efficient, general, organocatalytic asymmetric modification of 
the nucleophilic epoxidation of electron-poor 3-ylideneoxindoles, that could afford the 
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corresponding spiroepoxyoxindoles with high diastereisomeric ratios and high 
enantiomeric excesses. At variance with the above studies,75 the initial investigations 
were performed on the ylidenoxindole 132, carrying a carboxy-ethyl group, more potent 
than the phosphonate group, as a second EWG. Substrate 132 was easily prepared, 
following the procedure reported in literature, from 1-methyl isatin (131) via a Horner-
Wadsworth-Emmons reaction (HWE) (Scheme 40). The epoxidation of E-olefin 132 
could in principle lead to two diastereoisomers, 133-trans and 133-cis, even though an 
excess of trans was expected, because of the E-configuration of the substrate’s double 
bond. 
Scheme 40: epoxidation of carbethoxy derivative 132 and the four epoxy isomers. Stereochemistry is re 
 
In order to choose a chiral organocatalysts, since a number of chiral secondary amines 
exhibit different action mode with respect to the employed substrate, we started to try 
the (S -    diphenylprolinol (catalyst A) in view of the great potential previously 
showed in catalyzing epoxidation of  , -unsaturated ketones.77 Indeed, the so-called 
“chameleon” catalyst, is endowed with two functionalities, a hydroxyl and an amine, 
that makes diphenylprolinol included in the bifunctional catalysts class; for these 
reasons it can establish non-covalent interactions with suitable substrates (Scheme 41). 
Scheme 41: diphenilprolinol (48, catalyst A) as a 
noncovalent catalyst, creates an hydrogen bond net 
with suitable substrates  
 
Taking into account what previously reported about the epoxidation of  , -unsaturated 
ketones,78 the first reaction on 132 was performed with 30 mol% of A. Tert-
butylhydroperoxide (TBHP) was employed as oxidizing agent and the reaction was 
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performed in HPLC grade hexane, even though both the substrate and products were 
barely soluble in such a medium. This first attempt was successful. Despite the starting 
material having the E configuration, after purification of the reaction crude via flash 
chromatography, two products were isolated and identified as trans and cis spiro-
oxiranes (133-trans, 133-cis), whose characterization and configuration assignment is 
reported in section 3.3.3. The reaction resulted to be diastereoselective, with a 
diastereomeric ratio of  64/36 in favour of the trans isomer, and enantioselective, since 
for the trans isomer a 70% e.e. was observed. A lower ee was measured for the cis (22% 
ee) (Scheme 42).79 
Scheme 42: first organocatalytic experiment was performed in presence of 1.1 equivalents of 
TBHP, 30 mol% of catalyst A, in hexane for HPLC (0.38 M solution). 
 
3.3.2 Screening of the catalyst and of reaction conditions 
In the light of the first good result, achieved via diphenylprolinol catalysis, further 
investigation of the reaction conditions were planned, by studying the effects of 
different catalysts, oxidizing agents, solvents, reagents concentration and temperature. 
Starting with a catalyst screening, a few pyrrolidine derivatives, in particular 
commercially available catalysts B-E, were tested under the same conditions (Scheme 
44). Results are reported in Table 1. Catalysts B and C, respectively the methyl- and the 
trimethylsilyl-ether of diphenylprolinol A, led to very poor enantioselectivity (Table 1, 
entries 2,3), probably because of the lack of a pseudo-Lewis acid function that prevents 
the formation of a strong H-bond network. This results strongly suggested the key role 
of the free OH group in the catalyst A, able to establish an H-bond network.  
Subsequently, the reaction was performed with pirrolidine derivatives D, E, bearing 
both Brønsted basic and Lewis acid sites, but bringing some substituents on phenyl 
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rings.80 Particularly, the bulkier catalyst D, endowed with two 3,5-dimethylphenyl 
substituent, led to lower ees and slower reactivity, with respect to catalyst A. 
Furthermore, catalyst E, which bears the electron withdrawing trifluoromethyl 
substituents on both phenyl rings, led to similar enantioselectivity already observed with 
catalyst A, but both in lower yields and lower reactivity (Table 1, entries 4,5). Thus, the 
less expensive diphenylprolinol A appeared to be the best choice for our reaction so far.  
Afterwards, going on with the optimization of the reaction, some variations in the 
reaction conditions were devised, exploring oxidizing agents different from TBHP 
(Scheme 44). However, the use of both hydrogen peroxide, already used by Loreto et al. 
in the diastereoselective epoxidation of ylidenoxindoles,75 and the bulkier cumene 
hydroperoxyde, did not improve ees. In the former case a sharp drop in ees was 
observed, although accompanied by a marked increase in dr, while,  in the latter case, 
the same enantioselectivity as with catalyst A was observed, but with a great drop in 
reactivity, since the reaction time for complete conversion changed from 72 to 400 
hours (Table 1, entries 6, 7).  
Scheme 43: reaction to be optimized; catalysts tested for the initial screening of the 
reaction conditions 
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Table 1: screening of reaction conditions (catalyst, oxidant, solvent, concentration, 
temperature) Reaction conditions: N-methyl--ylideneoxindole 132 (0.5 mmol), TBHP (0.6 
mmol), catalyst (0.15 mmol) in 1.3mL HPLC grade hexane, at RT. ^Yields of the isolated 
products are expressed as the sum of the diastereomers. d.r. were determined by 1H NMR 
of the crude reaction mixture. ees were determined by chiral-phase HPLC analysis. aH2O2 
(30% in water, 0.15 mmol) was employed as the  oxidant. bCumene hydroperoxide (CHP, 
0.15 mmol) was employed as the oxidant. 
entry catalyst time (h) yield (%) dr (trans/cis) e.e. trans (%) e.e. cis (%) 
1 A 72 94 64/36 70 22 
2 B 40 83 25/75 37 2 
3 C 140 95 36/64 58 1 
4 D 110 89 64/36 72 36 
5 E 360 75 66/34 38 22 
6a A 36 84 96/4 2 1 
7b A 400 80 66/34 70 22 
 
Furthermore, the reaction was performed in different solvents, polar and nonpolar, such 
as chloroform, acetonitrile, ethanol, dimethyl sulfoxide, tetrahydrofurane, and toluene 
(see Table 2). Performing the reaction in toluene or chloroform, did not lead to an 
increased stereoselectivity, but instead it decreased the reactivity, even though the 
reaction mixture was completely soluble in such media. The use of polar solvents 
lowered both rate and selectivity. Thus hexane appeared to be the best solvent, in terms 
of selectivity and efficiency, in spite of the poor solubilising power. This evidence could 
be ascribable to phase transfer effects. Later on, the effect of the concentration, was 
explored, by performing the reaction with a different amount of solvent. Higher dilution 
was found to lead to better enantioselectivity (82% ee for 133-trans, Table 2, entry 4) 
with the same reaction rate.  
Moreover, varying the experimental temperature did not seem to affect our reaction, 
since performing the reaction at 4°C similar results were obtained (Table 2, entry 5).  
Thus the best conditions for the enantioselective epoxidation required catalyst A 30 
mol%, in hexane, at room temperature, with TBHP as oxidising agent (Table 2, entry 4). 
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Scheme 44: reaction to be optimized; catalysts tested for the initial screening of the 
reaction conditions 
 
Table 2: Reaction conditions: N-methyl--ylideneoxindole 132 (0.5 mmol), TBHP (0.6 
mmol), catalyst A (0.15 mmol) and solvent at RT. Yields of the isolated products are 
expressed as the sum of the diastereomers. d.r. were determined by 1H NMR of the crude 
reaction mixture. ees were determined by chiral-phase HPLC analysis. *reaction was 
performed at 4°C. 
entry solvent mL time (h) yield (%) dr  (trans/cis) 
ee  
trans (%) 
ee  
cis 
(%) 
1 hexane 0.5 12 96 68/32 45 14 
2 hexane 1.0 48 95 67/33 67 20 
3 hexane 2.0 68 87 64/36 74 26 
4 hexane 2.7 72 95 64/36 82 19 
5* hexane 2.7 72 92 66/34 64 36 
6 hexane 4.0 120 90 55/45 80 25 
7 CHCl3 0.6 240 55 66/34 71 16 
8 CH3CN 0.6 192 90 68/32 46 40 
9 EtOH 1.3 192 70 61/39 48 39 
10 DMSO 1.3 96 83 78/22 33 40 
11 THF 0.6 192 85 68/42 57 29 
12 toluene 0.6 120 73 59/41 69 18 
 
3.3.3 Structural and stereochemical assignment 
After the first optimization of the reaction conditions was done, a structural and 
stereochemical assignment for the products was accomplished, since the epoxidation led 
to new products, namely two diastereoisomers, each one including two enantiomers 
[(2R,3R)-133-trans, (2S,3S-133-trans, (2S,3R)-133-cis, (2R,3S)-133-cis], Scheme 45). 
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Scheme 45: epoxidation products 
 
1H-NMR and  NOESY data 
The trans/cis configuration of the epoxidation products, 133-trans and 133-cis, was 
assigned by 1H-NMR and NOESY analysis. In the 1H-NMR spectra, the differences 
were the shift of the Hc singlet and the shape of the Ha-Hb system, which in one 
spectrum shows the expected multiplet while in the other appears as a quartet (Scheme 
46). In fact protons Ha and Hb are diastereotopic, because of the chiral centres. In the 
light of these evidences, NOESY experiments, whose data are reported below, appeared 
necessary to unambiguously elucidate the configurations (Scheme 47, Scheme 48). 
Indeed: 
i. in the NOESY spectrum of 133-cis (Scheme 47) cross-peaks were found 
between the aromatic 4-H atom [δ 7.04-7.14 (m, 2H, CHarom) ppm] and the 
epoxide proton [δ 4.15 (s, 1H, OCH) ppm], due the spatial proximity of these 
nuclei, unequivocally proving the cis configuration of the minor diastereoisomer 
133-cis. Moreover, further cross-peaks are generated by the spatial interaction 
between the H atom belonging to the N-CH3 [δ 3.22 (s, 3H, CH3N) ppm] group 
and 7-H atom on the aromatic ring [δ 6.89 (dd, J = 7.8Hz, 0.5Hz, 1H, CHarom) 
ppm ]. 
ii. conversely, no NOESY cross peaks for the epoxide proton were found in the 
major 133-trans isomer (Scheme 47). 
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Scheme 46: 1H-NMR segment of the methylene and oxiranic protons 
  
 
Scheme 47: segment of the NOESY spectrum of the 133-cis isomer 
            
Scheme 48: segment of the NOESY spectrum of the 133-trans isomer 
                            
Hc 
Hc 
Ha, Hb 
Ha, Hb 
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Optical Rotation Dispersion Data: assignment of absolute configurations to products 
133 by comparison between calculated and experimental values.  
The absolute configurations for the two diastereoisomers 133, are based on a thorough 
comparison of the aforementioned experiments, analytical data and a quantum 
mechanical ab initio calculation of chiroptical properties. Indeed, once it is 
unambiguously determined via 1H NMR and NOESY experiments, the trans/cis 
configuration of the obtained diastereomers (133-trans and 133-cis) was used to 
simulate the optical rotation dispersion (ORD). This calculation was performed, by 
means of the Time-Dependent Density Functional Theory (TDDFT) method,j using an 
arbitrarily fixed absolute configuration (2R,3R) for the major enantiomer of 133-trans. 
In fact, molecular mechanics provided six conformers (133-trans-A - 133-trans-F, 
Figure 8), which were then fully optimized;k calculated conformers free energies were 
used to carry out Boltzmann’s populations distribution. All optimized conformers differ 
each other by the orientation of the ester moiety (Figure 8). In Figure 9 the most stable 
conformer (2R,3R)-133-trans-A structure is reported. 
Figure 8: structures of the most stable conformers of (2R,3R)-133-
trans optimized at the DFT/B3LYP/6-31G* level of theory 
 
                                                             
j Calculations performed by Giuseppe Mazzeo, Università della Basilicata 
k Molecular mechanics provided six conformers, then fully optimized at DFT/B3LYP/6-31G* level of 
calculation. 
(2R,3R)-133-trans-A (2R,3R)-133-trans-B 
(2R,3R)-133-trans-C (2R,3R)-133-trans-D 
(2R,3R)-133-trans-E (2R,3R)-133-trans-F 
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Figure 9: The most stable conformer (2R,3R)-133-
trans-A calculated at DFT/B3LYP/6-31G* level of 
theory 
 
The calculated optical rotatory power at four different wavelengths (589.3, 546, 435 and 
405 nm), relative free energies, Boltzmann populations for all optimized conformers of 
(2R,3R)-133-trans were compared with the experimental ORD and are shown in Table 
3.  
Table 3: Relative-free energies with respect to the most stable conformer (133-trans-A), populations and 
calculated ORD values (deg [dm g/cm3]-1) obtained at TDDFT/B3LYP/6-31G* level for each conformer 
(133-trans-A - 133-trans-F) at four different wavelengths. Comparison between the total calculated and 
the experimental ORD values in CH2Cl2 (c = 0.55 g/cm3 in CH2Cl2). 
Conformers 
ΔG 
(kcal/mol) 
% pop [α]D [α]546 [α]435 [α]405 
133-trans-A 0.0 45.9 -101 -127 -294 -419 
133-trans -B 0.4 24.3 -51 -64 -153 -220 
133-trans -C 0.5 21.4 -75 -92 -193 -262 
133-trans -D 1.4 4.7 -15 -18 -37 -50 
133-trans -E 1.7 2.7 -7 -8 -18 -25 
133-trans -F 2.2 1.0 -2 -2 -6 -8 
Total 
Calculated 
ORD values 
  -250 -312 -701 -984 
Experimental 
ORD values 
  -101 -134 -295 -395 
 
Data in Table 3 show that the sign, the order of magnitude and the uniform trend in the 
experimental ORD have been correctly reproduced by the calculations, despite the fact 
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that the Boltzmann averaged ORD values are about twice higher than the experimental 
ones. Such differences may result from basis set calculation errors in overestimating 
ORD. Nevertheless, it is important to notice that all calculated conformers OR are 
negative. In fact, problems may arise in the case of flexible molecule having many 
conformers with opposite-signed OR in order to get a more accurate geometries, 
populations and OR computational analysis achieving a reliable absolute configuration 
assignment. In any case the conformers geometry optimization and the ORD calculation 
were performed with other methods (Table 4), in order to check if significantly changes 
may occur in the theoretical predictions of respective conformers and/or in the 
conformational distribution, which could become more significant as in the present case 
where several conformers are involved. Then no significantly differences were found 
(Table 4).  
Table 4: Relative-free energies with respect to the most stable conformer (133-trans-A), populations and 
calculated ORD values (deg [dm g/cm3]-1) obtained at TDDFT/B3LYP/6-31++G(2d,2p) level for each 
conformer (133-trans-A - 133-trans-F) at four different wavelengths. Comparison between the total 
calculated and the experimental ORD values in CH2Cl2 (c = 0.55 g/cm3 in CH2Cl2). 
Conformers 
ΔG 
(kcal/mol) 
% pop [α]D [α]546 [α]435 [α]405 
133-trans-A 0.0 53.9 -115 -145 -337 -478 
133-trans -B 0.6 18.6 -39 -49 -116 -167 
133-trans -C 0.7 17.2 -57 -71 -149 -202 
133-trans -D 1.3 6.4 -20 -25 -51 -68 
133-trans -E 1.8 2.7 -6 -8 -17 -24 
133-trans -F 2.3 1.1 -2 -3 -6 -9 
Total 
Calculated ORD 
values 
  -240 -301 -677 -948 
Experimental 
ORD values 
  -101 -134 -295 -395 
In conclusion a satisfactory agreement between experimental and calculated ORD was 
found; these evidences strongly support the (2R,3R) configuration for the 133-trans 
epoxide (Scheme 48). Likewise, the (2S,3R) configuration to the major enantiomer of 
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133-cis has been assigned by exploiting the same quantum mechanics protocol. In 
particular, the experimental optical rotation value at  = 589.3 nm for the (2’S,3’R)- 
133-cis-A is []D = -105 (c = 0.035 g/cm3 in CHCl3); this value has to be compared with 
the ab initio calculated one []D = -258 [deg (dm g/cm3)-1.80 
Scheme 49: assigned configurations of the major 
enantiomers 
 
 3.3.4 Mechanistic considerations 
Initial hypothesis 
In the light of the experimental evidences and of the calculated configuration (2R,3R) of 
the major stereoisomer (133-trans), a mechanism hypothesis was formulated, which 
agreed with the recent statements regarding the asymmetric epoxidation of ,β-
unsaturated ketones.78 This hypothesized catalytic pathway, depicted in Scheme 50, 
proposes the following: (i) the interaction between TBHP and the catalyst activates the 
oxidizing agent, leading to the tight ion pair 134; (ii) the first regiospecific attack of 134 
at the Cβ carbonl of the substrate is promoted by both the intermediate aromatization and 
formation of a stabilizing H-bond between the OH in the catalyst and the partial 
negative charge on the lactam carbonyl moiety;81 (iii) thus, the reagent approach is 
preferentially driven toward the less-hindered re-face of the double bond, resulting in 
the aromatic and long-living 136 intermediate; and (iv) two alternative evolutions of 136 
may result in either the oxirane (2R,3R)-133-trans (via irreversible direct ring closure) 
or the diastereomer (2S,3R)-133-cis (via intramolecular H-bond breaking and the rapid 
subsequent rotation around the C-Cβ  bond to produce the 137 intermediate).80 
                                                             
l  and  positions are refferred to the lactamic carbonyl group. 
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Scheme 50: initial mechanism hypothesis 
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Further mechanistic considerations 
Our initial mechanism hypothesis has been reconsidered in the light of some DFT 
calculations performed by Prof. Shiina;m these calculations suggest  a slightly different 
reaction mechanism, which is depicted in Scheme 51. Some key steps can be elucidated: 
1. first step (Scheme 51, step A) is the formation of the prolinol-oxidant complex 
(138), which already differs from our initial hypothesis, since it envisages two 
                                                             
m Tokyo University of Science 
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H-bonds between TBHP and the base site of A without deprotonation of the 
oxidant; 
2. in the second step (step B), the nucleophilic attack of 138 at the substrate  -
position and the deprotonation of the oxidant simultaneously gives rise to the 
transition state 139, in which there is no H-bond interaction between the 
carbonyl in the substrate and the catalyst’s hydroxyl. Therefore, substrate 
aromatization is no more conceived as a stabilizing process.  
3. subsequent evolution of the transition state 139 into the intermediate 140 occurs 
with some charge transfers; 
4. afterwards either a proton transfer (step C) or the rotation around the C-Cβ  
bond can occur, leading to intermediates 143 or 141, respectively; 
5. then, the repositioning of the negative charge in the transition states 144 (from 
143; step D) and 142 (from 141; step D’) facilitates the ring closures (steps E 
and E’) to give the trans- or the cis-epoxides, regenerating the catalyst. 
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Scheme 51: new mechanism hypothesis based on Prof. Shina’s DFT calculations
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3.3.5 Substrate scope 
Synthesis of the starting materials 
The above described optimized procedure for the epoxidation of the model 
ylidenoxindole 132 was tested with other substrates in order to check the generality of 
the methodology. In fact, a procedure, to be considered a good one, should be useful for 
a broad scope of compounds. Indeed the evaluation has to be done in terms of 
enantioselectivity, yield and reaction time. Thus a substrate scope was planned bearing 
various substituents on the aromatic ring, such as alkyl or aryl groups and halides 
(Scheme 52). Studying the effect of electron withdrawing or electron donating groups, 
the effect of bulky substituents on different positions of the oxindole ring, could have 
allowed us to give further insights on the reaction mechanism.  
Scheme 52: Plan for the substrate scope 
 
The synthesis of ylidenoxindoles (146 to 156) was accomplished starting from the 
corresponding isatines via methylation of the oxyndole nitrogen followed by a  Horner-
Wadsworth-Emmons (HWE) 3-ylidenation (Scheme 53), following the procedures 
reported in literature.74, 80 Reaction times and yields for the HWE reaction are reported 
in Table 5. The starting olefins, some of which had not been previously synthesized, 
have been fully characterized by proton and carbon NMR spectrometry, IR and HRMS.  
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Scheme 53: Synthesis of N-methylated carboxylates 
 
Table 5: Unless otherwise stated, compounds were synthesized following procedures 
reported in Scheme 53. *for entries 7, 8 and 9 a Wittig reaction was performed instead 
of the HWE reaction. Detailed procedures are reported in the experimental part. ^olefin 
obtained starting directly from commercially available methyl-isatine. 
entry product R1 R2 
N-methylation HWE 
yield time yield time 
1 132 H H 98% 12 h 80% 12 h 
2 146 F H 95% 30 min 60% 5 h 
3 147 Cl H 99% 20 h 76% 5 h 
4 148 I H 94% 1 h 21% 6 h 
5 149 OCF3 H 95% 1 h 67% 5 h 
6 150 i-Pr H 84% overnight 63% 48 h 
  7* 151 NO2 H 89% 30 min 58% 3 h 
   
8*^ 152 OCH3 H 90% 12 h 90% 12 h 
   9* 153 Cl Cl 95% 1 h 89% 2 h 
10 154 H F 96% 30 min 71% 1 h 
11 155 H Cl 98% 30 min 61% 1 h 
12 156 H Br 98% 30 min 56% 1 h 
 
Compound 181 (Scheme 54) was instead obtained through a one pot reaction where an 
acid catalyzed Friedel-Crafts alkylation with diethyl ketomalonate was followed by the 
intramolecular amidation .81(a)  Subsequent saponification and N-methylation gave the 
isatin 180 which was converted into the 3-yliden-derivative 181 by the usual HWE 
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reaction. Intermediate 180 and the new product were fully characterized and the E-
configuration of the double bond was assigned by comparison with the known 3-
ylidenoxindoles.  
Scheme 54: Synthesis of compound 181 by Friedel-Crafts alkylation, followed by saponification, N-
methylation and final HWE ylidenation 
 
Organocatalytic epoxidation on the synthesized compounds 
With the optimized epoxidation procedure in our hands, the reaction was tested on the 
other new N-methyl olefins (Scheme 55, 132-156, 181) and results are reported in Table 
6. The epoxidation reaction always led to the two diastereomers, (Scheme 55, 182-192-
trans, 182-192-cis), which were isolated from the reaction crude via flash 
chromatography. Moreover, all the obtained epoxides have not been previously 
synthesized, thus complete characterization was necessarily done for every trans and cis 
isomer. The epoxidation of compounds endowed with halides in positions 5 or 7 (Table 
6, entries 2-4, 9-12) resulted in good enantiomeric excess for the trans product, except 
for the epoxide bearing a iodine, which instead showed a lower ee (Table 6, entry 4). 
The presence of a bromine (entry 12) or two chlorine atoms (entry 9), led to the highest 
enantioselectivities for the trans product (respectively 88% ee and 85% ee) together 
with an higher ee for the cis isomers too (respectively 53% ee and 58% ee) and a faster 
reaction if compared with that performed on the model unsubstituted 3-ylidenoxyndole. 
In addition, in all reported cases, including isopropyl, nitro and trifluoromethoxy 
compounds (entries 5-6), an inversion of the diastereomeric ratio was observed, in 
favour of the cis products. 
These effects could be ascribable to some supplementary interactions between the 
halide and the catalyst able to stabilize the transition state that precedes the cis isomer 
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formation. It appeared clear that these organocatalytic nucleophilic epoxidation 
outcomes are influenced by halide substituents. 
Furthermore, the naphtyl-derived olefin 181 was as well successfully epoxidized, even 
though products (Scheme 56, 193-trans, 193-cis) resulted to be unstable after some 
hours from purification. This interesting derivatives showed similar enantioselectivity 
(82% ee for the trans isomer), reaction time and yield (entry 13, Table 6). This results 
suggest that the steric hindrance on the aromatic ring does not strongly affect either the 
enantioselectivity or the overall reactivity of the reaction. 
Scheme 55: epoxidation of the 3-ylidenoxindoles 146-156. Results are reported in Table 6. 
 
 Scheme 56: epoxidation of the naftyl-derivatived 3-ylidenoxindole 181. Results are reported in Table 6. 
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Table 6: the epoxidation was performed on 3-ylidenoxindoles 146-156, 181, following the 
optimized procedure, which requires A 30 mol%, 1.1 eq of TBHP, 0.2M in HPLC hexane, at rt.  
entry compound R1 R2 yield time  (h) 
dr  
(trans/cis) 
ee% 
(trans) 
ee% 
(cis) 
1 133 H H 95% 72 63/36 82 19 
2 182 F H 75% 30 48/52 84 30 
3 183 Cl H 92% 42 40/60 76 42 
4 184 I H 97% 24 33/67 60 32 
5 185 OCF3 H 36% 144 40/60 78 30 
6 186 i-Pr H 90% 96 42/58 78 27 
7 187 NO2 H 72% 48 27/73 70 12 
8 188 OCH3 H 98% 48 51/49 80 24 
9 189 Cl Cl 79% 33 37/73 85 53 
10 190 H F 85% 36 34/66 80 27 
11 191 H Cl 88% 38 25/75 81 32 
12 192 H Br 71% 48 30/70 88 58 
13 193 naphtyl derivative 98% 24 51/49 82 10 
 
3.3.6 In-depth catalyst screening 
In the light of preliminary results80 and of the initial reaction conditions screening, 
further efforts were directed to an in-depth variation of the catalyst structure, in order to 
improve the nucleophilic epoxidation in terms of stereoselectivity, efficiency and 
generality of the scope. In fact one of the points that had been disclosed so far is the 
importance of the free OH for the reaction rate and enantioselectivity; according to the 
initial mechanism hypothesis, this pseudo-Lewis acidic function is essential to establish 
an effective H-bond network among the catalyst, the oxidant and the substrate. In the 
light of these considerations, two different ways were envisioned in order to mutate the 
catalyst structure: keeping the pyrrolidinic skeleton and changing the Lewis acidic 
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group or changing the skeleton and both of the functionalities. In both cases the free 
hydroxyl function had to be preserved. 
Analogies between the organocatalytic nucleophilic epoxidation and a biological 
system: enoyl-CoA hydratase 
The first step of the nucleophilic epoxidation is supposed to be the oxa-Michael-like 
addition of the t-BuOO- species to the electrophilic double bond (Scheme 57). Generally 
speaking, the oxa-Michael reactions, i.e. addition reactions of oxygen nucleophiles to 
conjugated systems, have traditionally received much less attention from the scientific 
community compared to the addition of carbon nucleophiles to conjugate acceptor 
systems (Michael reaction). This was mainly due to the lack of reactivity and selectivity 
of these reactions.82 Moreover, the naturally occurring oxa-Michael reaction, which is 
fundamental step in fatty acids metabolism, catalyzed by enoyl-CoA hydratase, requires 
the activation of a water molecule towards the nucleophilic Michael addition to the 
activated acyl-CoA unsaturated thioester. In this specific enzymatic catalytic pathway 
(Scheme 58), the substrate’s carbonyl is activated by an alanine (Ala 98) and a glycine 
(Gly 141) residues, while water molecule is activated by two glutamate residues (Glu 
144 and Glu 164).  
Scheme 57: oxa-Michael-like attack, which led to the first reaction intermediate (intermediate I) 
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Scheme 58: enoyl-CoA hydratase catalyzes an oxa-Michael  
 
Plan of the catalysts screening 
It is well-known how nature inspire chemists in particular in designing catalyst’s 
scaffolds; thus, in the light of the analogy between the epoxidation, which is the 
objective of this thesis, and the oxa-Michael promoted by enoyl-CoA hydratase, some 
syntheses of new catalysts syntheses were planned, in order to better activate the 
substrate, and probably stabilizing the transition state that brings to the desired epoxy 
isomer. Results for catalysts B, C, D, and E, which have been previously discussed, 
showed that catalysts bearing a protected hydroxyl function, failed in leading any 
improvement of the enantioselectivity (Scheme 59). Thus, testing different pyrrolidine-
derived catalysts could have probably facilitated the analysis of stereo-electronic effects 
involved in the reaction. Moreover, the use of catalysts bearing two hydrogen donor 
groups could lead to an increase of the substrate reactivity (the α,β-unsaturated bond 
would be more electrophilic) and could have led to higher stereoselectivity thanks to a 
stronger hydrogen bond network among the substrate/catalyst/oxidant (Scheme 60). 
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Scheme 59: Catalysts which had already been tested 
 
Scheme 60: catalyst’s Brønsted basic and Lewis acid sites seem to be influential for the reaction outcome 
  
 
Thus the initial scope of the catalyst (Scheme 61, catalysts A-E)77, 80, 83 was enlarged to 
other compounds, in which: 
i. the Brønsted basic site was preserved whereas the Lewis acidic site was changed 
to a tetrazolic ring (pirrolidine derivative F) 
ii. the Brønsted basic site was preserved and two hydrogen bond donor were added: 
an hydroxyl group and an amide (pirrolidine derivative G, H)84 
iii. the Brønsted basic site was preserved, linked to a thiourea through a methylene 
(catalysts I,J)85 
iv. the chiral skeleton was changed to an epi-quinine, in which the basic site is a 
tertiary amine and the lewis acid group is a thiourea (Soos catalyst, K)28a 
Catalysts A to G were commercially available, catalysts H, I, J and K were instead 
synthesized, following the reported procedures.28a, 84b, 84c, 85 
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Scheme 61: Catalysts F and G were commercially available; catalysts H - K have been synthesized. 
 
Synthesis of the catalysts 
Once established the structure of the catalysts that could hypothetically be beneficial to 
the purpose, molecules which resulted not to be commercially available (Scheme 61, H, 
I, J, K), were easily synthesized suiting the following routes:  
i. Synthesis of 1-aryl-3-pirrolydin-2-yl-thioureas, catalysts I, J 
Synthesis of catalysts I and J was accomplished starting from (S)-proline, 37, suiting 
procedures previously reported,86 which are depicted in Scheme 62. 
The commercially available (S)-proline, was protected as t-butyl carbamate using di-
tert-butyl anhydride activated by base, in DCM. After crystallization, desired product 
194 was obtained in 92% yield. The following reduction of the carboxyl moiety to 
primary alcohol was accomplished by means of borane solution in THF. Column 
chromatography led to 195 in high yield. Then the oxydrilic function was transformed 
in a better leaving group via pyridine catalysed tosylation. The desired product, 196, 
was isolated in 85% yield after chromatography. Afterwards 196 was converted in the 
azide 197 through an SN2 reaction with sodium azide; the crude was sufficiently pure to 
be used in the following step without any further purification. Then compound 197 was 
reduced to amine via Staudinger reaction, with triphenyl phosphine, leading to 198, 
which was used as crude for the following transformation. The reaction with aryl 
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thioisocianates led to the two intermadiates thioureas, 199 and 200. These compounds 
were then deprotected in presence of TFA, giving the free pyrrolidines, which were then 
purified, yielding to catalysts I and J, respectively in 40% and 16% overall yield. Final 
products, I and J, were fully characterized and the structures of the desired catalysts 
were confirmed. 
Scheme 62: synthesis of 1-aryl-3-pirrolydin-2yl-thioureas, catalysts I and J 
 
 
ii.  
iii.  
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iv. Synthesis of the Soós thiourea, catalyst K 
Catalyst K, the Soós thiourea, was synthesized in a two step synthesis (Scheme 63) 
starting from (-)-quinine (201), a commercially available alkaloid from the species 
cinchona.87 
First step of the synthesis was a Mitsunobu reaction, which transforms the alcoholic 
function into an azide (202). Then the azide was reduced to amine via Staudinger 
reaction, with PPh3, leading to product 205 in 69% overall yield. Then, the second step 
was the reaction with isothiocianate 206, that led to the desired catalyst K, which was 
analyzed by NMR spectroscopy, confirming the expected structure. 
Scheme 63: synthesis of Soós thiourea, catalyst K 
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iii. Synthesis of catalysts H 
Catalysts H, as well, was synthesized starting from (S)-proline (Scheme 64).88 First step 
of the synthesis was the protection of (S)-proline with Cbz group, leading to the 
protected pyrrolidine 207, which was used in the next step without further purification. 
Then, the reaction with ethyl chloroformiate and amino-phenol 208, brought to 
compound 209 in good yield (75%). The following deprotection of the amine was 
accomplished in reducing conditions, by means of cyclohexene on Pd/C, thus avoiding 
the acidic conditions and formation of the ammonium salt. 
Scheme 64: Synthesis of catalyst H 
 
Catalyst screening 
Afterwards, all the new catalysts were used for a wider catalyst screening. To this aim, 
the epoxidation reaction was performed under the previously optimized conditions, 
which required TBHP as oxidizing agent, hexane as solvent, in presence of catalysts F - 
K and at room temperature (Scheme 65). Results are disclosed in Table 7. Tetrazolic 
catalyst F, characterized by the presence of an NH function instead of the free hydroxyl, 
gave interesting results: the enantioselectivity for the trans isomer was similar to the 
one obtained with catalyst A, but for the cis isomer an inversion of sign was observed in 
the ee (Table 7, entry 6); unfortunately, a great decrease of reactivity was observed and 
reaction time increased from 72 to 240 hours.  
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The use of other amidic catalysts was envisioned: G, H, in which the OH function is 
sustained by a NH function, and thioureas I, J, K, in which the OH function is 
substituted by two NH. These were tested and results did not show any increment in 
enantioselectivity. On the contrary, lower ees were observed (entries 7-10, Table 7). The 
only case in which an increment in selectivity was observed is with the use of Soos 
catalyst (entry 11), which gave the trans isomer in 88% ee, even though with a reversed 
diastereomeric ratio, in favour of the cis isomer, and with very poor yield.  
Scheme 65: reaction conditions for the in-depth catalyst screening; catalysts are depicted in Scheme 61. 
 
Table 7: Reagents and conditions (Scheme 65) were the previously optimized: starting material 0.2 
mmol, TBHP 1.1 , hexane 1ml, 0.06 mmol catalyst, rt. Catalysts are depicted in Scheme 61. 
^Measured by 1H-NMR; ^^measured by chiral phase HPLC. 
entry catalyst time (h) yield (%) dr          (trans/cis)^ 
ee 
trans(%)^^ 
ee   
cis(%)^^ 
1 A 72 92 64/36 82 19 
2 B 40 83 25/75 37 2 
3 C 140 95 36/74 58 1 
4 D 110 89 64/36 72 36 
5 E 360 75 66/34 38 22 
6 F 240 4 79/21 83 -22 
7 G 72 20 60/40 -0.7 11 
8 H 48 27 85/15 2 1 
9 I 168 87 60/40 20 34 
10 J 72 10 65/35 33 42 
11 K 144 36 40/60 88 15 
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After this wide catalyst screening, including some further changes in the catalyst 
structure with respect to the previously tested (A-D), some conclusions have been 
drawn: 
i. the reaction seems not to beneficiate of the substitution of the hydroxyl with 
other functions; 
ii. a change of the catalysts scaffold does not bring to and improvement of the 
enantioselectivity so far; 
iii. an additional H-bonding site does not lead to better results; 
iv. the conclusion was that catalyst A was still the best one so far. 
3.3.7 Synthesis of 3-ylidenoxindoles 
The good results achieved for the reaction on N-methylated substrates, suggested the 
possibility of reaching better enantioselectivities by changing the starting material. 
Furthermore, the generality of the reaction had to be tested extensively, by enlarging the 
substrate scope to diversely substituted 3-ylidenoxindoles i (Scheme 66). Moreover, 
such enlargement could be beneficial to a better analysis of the reaction mechanism. For 
the above reasons, a new, wider substrate scope was planned (Scheme 66), including 
compounds i bearing: 
i. a different group at the nitrogen (i, R1 = CO2Et, R2 = aryl group or BOC, R3 = 
H) or both at the nitrogen and at the aromatic ring (i, R1 = CO2Et, R2 = aryl 
group, R3 = alkyl, halide) to check the effect of steric hindrance and 
electronic effects on the reaction outcomes; 
ii. different substituents at the aromatic ring, with the free NH grop (i, R1 = 
CO2Et,  R2 = H, R3 = alkyl, halide), to check the NH effect and the possibility 
of a further H-bond between the substrate and the catalyst-oxidant complex;  
iii. a different EWG at the exocyclic double bond [i, R1 = PO(OEt)2, R2 = CH3, 
phenyl, aryl, R3 = alkyl, H], to check the effect of the electronwithdrawing 
force on the reactivity;75 
iv. an electron releasing group at the exocyclic double bond (i, R1 = alkyl, R2 = 
CH3, R3 = H), to check whether the second EWG is necessary for the 
epoxidation. 
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Scheme 66: Plan for the broader substrate scope 
 
Syntheses of starting 3-ylidenoxindoles, which in most of the cases had not been 
previously synthesized, were accomplished following different procedures,75, 80 starting 
from corresponding isatines, depending on the reactivity and on the commercial 
availability of starting material. 
Synthesis of 3-ylidenoxindoles N-substituted and bearing groups on the aromatic ring 
3-Ylidenoxindoles 210-215, bearing different groups at the nitrogen and on the aromatic 
ring, were synthesised from commercially available isatines 216-221, by means of a 
Horner-Wadsworth-Emmons (HWE) reaction, taking advantage of potassium carbonate 
as base able to deprotonate the triethyl-phosphonoacetate. The formation of the products 
(210-215) shifted the initial acid-base equilibrium towards the deprotonated species. 
The depicted procedure was followed by flash chromatography purification, which led 
to the desired E-olefins in good yields (up to 98%). Results are disclosed in Table 8. All 
products had not been synthesized before, apart from 211, and were fully characterized 
by NMR spectrometry and HRMS.80  
Scheme 67: Synthesis of N-alkylated 3-ylidenoxindoles, via HWE 
reaction, starting from commercially available isatines. 
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Table 8: results corresponding to Scheme 67; detailed procedures are reported in the experimental 
section.  
entry isatine product R1 R2 time (h) yield 
1 216 210 H Ph 42 40% 
2 217 211 H Bn 48 80% 
3 218 212 H 2,4-Cl2-Bn 48 88% 
4 219 213 i-Pr Bn 48 67% 
5 220 214 OCH3 Bn 48 98% 
6 221 215 OCH3 2-NO2-Bn 48 80% 
 
Moreover, a tert-butoxy carbonyl N-protected substrate was synthesized, as depicted in 
Scheme 68. Compound 223 was obtained in good yield, through HWE reaction, in 
presence of potassium carbonate as base. Subsequently, the protection of the nitrogen 
was easily accomplished using di-tert-butyl dicarbonate. Final product 224 was isolated 
after flash chromatography in quantitative yield and fully characterized.69 
Scheme 68: N-Boc protection and HWE reaction 
 
Synthesis of 3-ylidenoxindoles bearing the free NH and substituents on the aromatic 
ring 
. 
Compounds 223, 225-232, endowed with a free NH, and bearing different substituents 
on the aromatic ring, were taken into account. This selection of substrates included: (i) 
olefin 225, without any further substitution on the aromatic ring;89 (ii) substrates 225-
227, 229-231, bearing an halide in position 5 or 7; (iii) compound 232, with two 
chlorides in positions 5 and 7; (iv) compound 228, bearing an OCF3 at 5 position.  
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All substrates were easily prepared, in good yields, by means of HWE reaction, under 
conditions a (Scheme 69). Results are reported in Table 9. For compound 232, the use 
of a Wittig reaction was necessary,90 in acetic acid, and led to the wanted E-olefin  in 
good yields and short reaction times (Scheme 69, Table 9). All compounds were 
purified through flash chromatography and fully characterized by NMR; the double 
bond configuration for compounds that had not been previously synthesized, was 
assigned by analogy with similar known molecules. 
Scheme 69: synthesis of compounds bearing a free NH. Yields and reaction times are depicted 
in Table 6. 
N
H
O
EtO2C
R2
R1
N
H
O
O
R2
R1 a or b
a : Horner Wadsworth Emmons reaction
b : Wittig reaction
P
O
OEt
O
EtO
OEt
K2CO3 ,
Ph3P=CHCO2Et223, 225-232222, 157-164
in THF
in acetic acid
 
Table 9: Reactions were performed in conditions a, Scheme 69. ^reaction was performed in 
conditions b, Scheme 69 
 
entry isatine product R1 R2 time (h) yield (%) 
1 222 223 H H 22 74 
2 157 225 F H 19 54 
3 158 226 Cl H 18 80 
4 159 227 I H 24 40 
5 160 228 OCF3 H 12 44 
6 165 229 H F 18 80 
7 166 230 H Cl 16 42 
8 167 231 H Br 19 50 
9^ 164 232 Cl Cl 3 60 
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Synthesis of phosphonates 233-237, bearing PO(OEt)2 as a second EWG 
As aforementioned, in the last few years Loreto’s laboratories have directed their 
attention and efforts to the synthesis of phosphonate derivatives, namely spiroepoxy-
oxindoles bearing a phosphonate on the oxirane ring.75 Those compounds have been 
previously synthesized by this research group in a diastereoselective way, but not any 
organocatalytic enantioselective procedure had been developed so far, even though this 
particular epoxides could have a potential as biocidal agents. In the light of these 
considerations, this kind of substrates was taken into account for a further substrate 
scope extension. Therefore, compounds 233-237 were synthesized by HWE reaction 
following the reported procedure,75 which requires the LDA as a base and tetraethyl-di-
phosphonate as alkylating agent (Scheme 70, Table 10). The same method was 
employed as well to achieve the new compound 237, which bears a chloride in position 
5 on the aromatic ring. Such compound was obtained in moderate yield and short 
reaction time. Results for compounds 233-237 are reported in Table 10. 
Scheme 70: synthesis of phosphonates 233-237. 
 
Table 10: results for HWE reaction in Scheme 70 
entry isatine product R1 R2 time (h) yield (%) 
1 131 233 CH3 H 22 80 
2 216 234 Ph H 24 76 
3 217 235 Bn H 40 76 
4 218 236 2,4-Cl2-Bn H 72 76 
5 169 237 CH3 Cl 6 30 
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Synthesis of a substrate endowed with an electron releasing group (methyl) on the 
double bond instead of the second EWG 
The synthesis of a substrate that features a methyl group instead of the EWG on the 
exocyclic double bond was accomplished following the procedure depicted in Scheme 
71. A piperidine catalyzed cross-aldol condensation between phenyl ethyl ketone and 
isatin 131 led to a mixture of isomers 238. The crude mixture was subsequently treated 
with concentrated sulphuric acid, to give the benzoic acid elimination. The known 
product 239,81(b) was purified via chromatography and isolated with a 74% overall yield.  
Scheme 71: synthesis of the alkylidenoxindole 239 via an aldol reaction followed by elimination of 
benzoic acid 
 
3.3.8 Enlargement of the substrate scope 
The synthesized compounds, disclosed in the section above, were tested in the 
organocatalytic enantioselective epoxidation. To this purpose, the previously optimized 
reaction conditions (catalyst A, TBHP, hexane, room temperature) were applied. 
Organocatalytic epoxidation of N-substituted 3-ylidenoxindoles, substituted on the 
aromatic ring 
The epoxidation reaction was performed on compounds 210-215 and 224, which are 
endowed with different functional groups on the nitrogen and on the aromatic ring 
(Scheme 72, Table 11) and unknown epoxides 240-246 were obtained. Results, depicted 
in Table 11, show that the diastereoisomeric ratio obtained with the N-methyl derivative 
132 was always maintained, slightly favouring the trans isomer, while, steric hindrance 
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at the nitrogen atom seems to affect pretty much the reactivity and selectivity of the 
reaction; in fact lower e.e.s were observed in most cases for the trans isomer. 
Scheme 72: Synthesis of N-alkylated ylidenoxindoles, via HWE reaction, starting from commercially 
available isatines. 
 
Table 11: the reaction, in Scheme 72, was performed in the optimized conditions. ^for entry 8, 2 
equivalents of TBHP were used. 
entry substrate epoxide R1 R2 time (h) 
yield 
(%) 
dr 
(trans/cis) 
ee       
trans(%) 
ee              
cis (%) 
1 210 240 H Ph 48 80 54/46 74 12 
2 211 241 H Bn 48 92 66/34 56 20 
3 212 242 H 2,4-Cl2-Bn 48 80 56/44 60 20 
4 213 243 i-Pr Bn 192 89 71/29 62 26 
5 214 244 OCH3 Bn 192 80 70/30 52 16 
6 215 245 OCH3 2-NO2-Bn 190 88 70/30 78 20 
7 224 246 H Boc 114 36 66/34 93 36 
  8^ 224 246 H Boc 24 60 66/34 92 36 
On the contrary, the reaction carried on the N-Boc-protected substrate, 224, led to very 
encouraging results, since a 93% ee was achieved for the trans epoxide. The lower 
reactivity for this peculiar substrate (entry 7, reaction time 144 h, yield 36%), with 
respect to the model compound 132, suggested the increase of the oxidant amount to 2 
equivalents. This brought to better yield (60%) in shorter time (24 h) and the ee was 
keeped (entry 8, 92% ee).  
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Organocatalytic epoxidation of 3-ylidenoxindoles bearing the free NH and 
substituents on the aromatic ring 
In the substrates explored so far, the nitrogen atom in the oxindole ring has always been 
protected with an alkyl or aryl group. Then, the substrate scope was directed towards the 
epoxidation of N-unprotected ylidenoxindoles carrying different other functional groups 
on the aromatic ring, in positions 5 and 7. All epoxides were unknown and were isolated 
and characterized after being purified via flash chromatography. In particular, the 
unsubstituted substrate 223 and the halogenated compounds 225-232 have been tested 
(Scheme 73) and results, which are disclosed in Table 12, have been compared with 
those obtained with corresponding N-methyl-protected compounds (Table 6). Looking 
at the data it appears that enantiomeric excesses are generally lower than those 
previously observed; for instance, compound with the 7-bromine, 254, changes its e.e. 
from 88% to 83% (Table 12, entry 8). The diastereoisomeric ratios are generally 
maintained except for the iodine derivative 250 (Table 12, entry 4), which shows an 
inverted dr, in favour of the trans isomer, low reactivity, and sensibly lower ees, 
compared to the corresponding methylated molecule. These experimental outcomes 
suggest a special role of the hydrogen of the amide in the hydrogen-bond network 
existing among substrate/catalyst/oxidant.  
Scheme 73: free NH compounds were tested; results are reported in Table 12 
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Table 12: results referred to Scheme 73 
entry substrate epoxide R1 R2 yield time (h) 
dr     
(trans/cis) 
ee              
trans (%) 
ee                   
cis 
(%) 
1 223 247 H H 96% 144 65/35 49 22 
2 225 248 F H 97% 43 34/66 86 22 
3 226 249 Cl H 83% 140 40/60 46 18 
4 227 250 I H 91% 170 78/22 36 18 
5 228 251 OCF3 H 76% 96 38/62 73 32 
6 229 252 H F 93% 66 23/77 84 40 
7 230 253 H Cl 99% 48 36/64 76 24 
8 231 254 H Br 87% 16 56/44 83 29 
9 232 255 Cl Cl 42% 78 35/65 65 72 
 
In order to understand whether the major enantiomers for NH compounds (247-255) 
were the same as for the corresponding NMe compounds (133, 182-191), a new 
experiment was envisioned, depicted in Scheme 74. In fact, the methylation of 
compound 247-trans, obtained from reaction in Scheme 73 (Table 12, entry 1), led to a 
clean product (133’-trans), characterised by NMR spectrometry as the N-methyl trans 
isomer 133-trans. The ee for such product was checked under the same HPLC 
conditions and revealed that the major enantiomer 133’-trans obtained from 247-trans 
is the enantiomer (2S,3S) of the major isomer 133-trans (2R,3R) obtained from 132. 
Indeed, this result indicates that, at variance with the previous results on substrate 132, 
the first attack on 247-trans occurs at the si face of the double bond. This opens the way 
to other mechanicistic hypothesis in which the NH function would have a key role in the 
selectivity induction. 
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Scheme 74: methylation of 247-trans (entry 1, Table 12) bring to trans isomer with same ee and HPLC 
peaks inverted respective to same compound (133-trans) obtained by direct epoxidation. 
 
Organocatalytic epoxidation of phosphonates 233-237, bearing PO(OEt)2 as a second 
EWG 
The possibility of testing some phosphonate ylidenoxindoles 233-237 in the 
organocatalytic epoxidation, using the optimized conditions, was envisioned. The 
results, displayed in Table 13, show that moderate enantiomeric excess could be 
obtained for the trans isomer, exploiting the new organocatalytic enantioselective 
procedure (Scheme 75); as already observed of carboxylic derivatives, an halide in 
position 5 on the aromatic ring has the effect of inverting the diastereoisomeric ratio 
(entry 5). This study demonstrated that other EWG could as well be positioned on the 
olefinic bond, and the reaction will proceed, even though in this particular case with 
lower selectivity. Same reaction on a N-Boc protected phosphonate yielded to 58% for 
the trans isomer (by TLC scratching), which was not isolated and characterized because 
of a very poor conversion. 
Scheme 75: epoxidation of phophonates 233-237 
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Table 13: results referred to reaction in Scheme 75 
entry substrate epoxide R1 R2 yield time (h) d.r. (trans/cis) 
ee trans 
(%) 
ee cis 
(%) 
1 233 256 CH3 H 80 72 56/44 60 21 
2 234 257 Ph H 95 96 60/40 58 24 
3 235 258 Bn H 80 96 56/44 48 9 
4 236 259 2,4-Cl2-Bn H 83 72 65/35 44 10 
5 237 260 CH3 Cl 65 96 40/60 53 14 
 
In the light of the difference in reactivity between carboxylates and phosphonates in the 
organocatalytic epoxidation, the reaction conditions for these peculiar compounds were 
further tested. Therefore different solvents, oxidizing agents, and some different 
catalysts were explored. Results were not improved either in terms of enantioselectivity 
or in terms of efficiency (Scheme 76, Table 14).  
Scheme 76: conditions screening on phosphonate 231. Conditions are reported in Table 14. 
catalyst
(30 mol%)
N
(EtO)2OP
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O
oxidant
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O
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233 256-trans 256-cis  
 
 
 
 
 
 
 
 
ENANTIOSELECTIVE NUCLEOPHILIC EPOXIDATION OF -YLIDENOXINDOLES 
 
85 
 
Table 14: The reaction on substrate 233, Scheme 76, was performed in solution 0.2M, in presence of 30 
mol% catalyst, 1.1 eq of oxidant, at room temperature. 
entry oxidant catalyst solvent yield (%) time (h) d.r. (trans/cis) ee trans (%) 
1 H2O2 A hexane 89 0.25 91/8 1 
2 H2O2 A hexane 80 6 94/6 3 
3 CHP A hexane 58 23 67/33 60 
4 TBHP A hexane 80 120 56/44 60 
5 TBHP A CHCl3 traces 500 - - 
6 TBHP A hexane/CHCl3 
traces 500 - - 
7 TBHP A EtOH traces 500 - - 
8 TBHP A toluene traces 500 - - 
9 TBHP B hexane 20 96 1/1 48 
10 TBHP D hexane nd 96 - - 
11 TBHP K hexane 20 96 1/1 49 
 
Reaction on substrate 239 
In order to check the generality of this reaction and to explore the effect of the EWG on 
the olefin, the reaction was performed under the optimized conditions on a 
ylidenoxindole which featured a methyl instead of the second EWG on the double bond. 
A lower reactivity was expected in this case, since the lack of the second 
electronwithdrawing group could decrease the electrophilicity of the double bond 
(Scheme 77).  
Surprisingly the reaction was even faster than previously observed with the model 
substrate, reaching complete conversion in 17 hours. Results showed poor 
diastereoselectivity, but moderate enantiomeric excess (72%) for the trans isomer; 
interestingly for the cis isomer better enantioselectivity than the previously observed 
was gained (48% ee). These results are quite encouraging, since the reaction is faster 
and could in principle be slowered performing it at lower temperature, thus probably 
reaching better enantiomeric excesses. Moreover this result indicates that the second 
electron withdrawing group on the double bond lowers the overall reactivity and the 
enantiomeric excess of the cis isomer. Furthermore, as the diastereomeric ratio is 
diminished favouring the cis isomer, probably the lack of the second electron 
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withdrawing group makes the carbon-carbon bond more flexible and free to rotate to 
give the cis isomer.   
Scheme 77: epoxidation of the 3-yilidenoxindole 239, which does not bear any EWG on the double bond 
 
3.4 Conclusions 
In the light of the interesting perspectives in the field of noncovalent organocatalysis 
and of the importance of optically pure oxindolic molecules as intermediates, this part 
of PhD work has been focused on applications of H-bonding bifunctional 
organocatalysis to the enantioselective epoxidation of electron deficient olefins, in 
particular 3-ylidenoxindoles (Scheme 78).  
This matter was explored by: 
1. choice of a model substrate and optimization of the reaction conditions choosing: 
(i) catalyst; (ii) oxidant; (iii) solvent/dilution; (iv) temperature. Different 
bifunctional organocatalysts were tested and the bifunctional catalyst A resulted to 
be the best one in terms of enantioselectivity and reactivity. Best conditions are 
depicted in Scheme 78, requiring TBHP as oxidant, in hexane, at room temperature. 
A 82% ee was achieved for the major diastereoisomer, which was supposed to have 
the trans geometry (133-trans, Scheme 79). 
2. assignment of the absolute configuration of the stereocentres and of the cis/trans 
geometry. The assignment of the stereochemistry of the two products (isomers 133-
trans, 133-cis) was obtained via NOESY NMR experiments, highlighting the 133-
trans as the major product. DFT calculations and a comparison between ORD 
measurements and calculated ORD values indicated the (2R,3R) enantiomer as the 
major for the trans isomer. 
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3. hypothesis for the reaction mechanism, which envisages a hydrogen bond network 
among the catalyst/oxidant/substrate (Scheme 80) and which takes into account the 
importance of using a catalyst endowed with more than one H-bonding groups. 
4. The epoxidation of a scope of substrates bearing different substituents on (i) 
aromatic ring; (ii) on the oxindolic nitrogen; (iii) on the exocyclic double bond 
(Scheme 79). The substrate scope studies offered the possibility of testing the 
generality of the organocatalytic procedure and at the same time the chance of 
understanding the effect of the different substituents. For instance, very good ees 
and an interesting inversion of the diastereoisomeric ratio, ascribable to some 
additional interactions with the hydrogen bond network, was observed in presence 
of halides (192). Moreover a drop in ee and an inversion of sign, were observed for 
compounds bearing the unprotected NH (254). The effect of an electron-releasing 
group on the exocyclic double bond (methyl) was tested, finding moderate ee (260). 
A very encouraging result, was achieved with the Boc protection of the nitrogen 
(246, 92% ee). This result strongly suggests that the best combination could be R1 = 
Boc, R2 = alkyl and that the scope of the substrate could be further enlarged. 
Scheme 78: organocatalytic epoxidation of 3-ylidenoxindoles 
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Scheme 79: results for model substrate (133), for substrates bearing halides , with or without N-methyl 
(192, 254), with NBoc (246), and bearing different groups on the double bond (256, 260) 
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Scheme 80: mechanism hypothesis 
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In conclusion, a promising enantioselective, organocatalytic, nucleophilic epoxidation 
of 3-ylidenoxindoles has been developed and applied to a broad scope of substrates. 
Further elucidations on the hypothesized reaction mechanism are ongoing, as well as a 
further enlargement of the reaction scope. 
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4.1 Confined Brønsted acids Organocatalysis applied to acetalization 
Chiral Brønsted acids have in the last decades proved to be excellent organocatalysts, 
since they can catalyze a number of  chemical transformations, leading to highly 
enantioenriched products.37 One of the reaction classes in which such type of 
asymmetric catalysis has been successfully employed is the acetalization reaction. In 
2005, Antilla et. al reported about a Brønsted acids catalyzed amidation of imines, 
which in fact is a N,N-acetalization.  The reaction, catalyzed by catalyst 264, under mild 
conditions, has proved to be very efficient and selective, even though with a narrow 
substrate scope (Scheme 81).91   
Scheme 81: Brønsted acid catalyzed imine amidation by Antilla et al. 
 
Afterwards, List-group focused its attention on the chiral Brønsted acids catalysis 
developing a wide scope of chiral phosphoric acids, whose utility is well-known, and 
whose milestone is (S)-TRIP (Scheme 82). Such binaphtyl phosphoric acid has been 
employed for a broad scope of reactions and excellent results in terms of 
enantioselectivities have been achieved during the years, by several research groups. In 
the asymmetric N,N and N,O-acetalization this catalyst proved to be very efficient as 
well, reaching very high levels of selectivity.92  
Scheme 82 
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Whereas several goals have been achieved with (S)-TRIP and similar catalysts, 
substrates have always been sterically or electronically biased. In 2012 List et al. 
developed a new concept: confined Brønsted acids, extremely sterically demanding and 
bearing a chiral pocket that resemble those found in enzymes.93 These catalysts have 
been initially used for the asymmetric spiroacetalization of unbiased compounds, to 
obtain biologically relevant spiro-acetals, such as Olean (Scheme 83), with very high 
enantiomeric excesses (96% ee). The new imidophosphoric acid still bears the double 
function, acid and base, on the two phosphosphates, allowing small and unhindered 
molecules to enter the active pocket and to be activated in such a peculiar environment 
towards the chemical transformation (Scheme 84). Afterwards enantioselective 
sulfoxidation  and acetalization were developed by the same research group. Thus, 
confined acids class is starting to grow in applicability and is an evolving field. 
Scheme 83: the asymmetric spiroacetalization reaction catalyzed by confined Brønsted acids (BA) 
 
Scheme 84: bifunctional confined catalysts’s pocket 
 
 4.2 Vicinal diols bearing a quaternary stereocenter 
The stereoselective synthesis of diols bearing a quaternary stereocenter is still 
considered a great challenge by organic chemists. Enantiopure vicinal diols are among 
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the most valuable and versatile synthons and intermediates towards the synthesis of 
biologically active molecules,94 as pactamycin (271) and zaragozic acid C (270) 
(Scheme 85).95  
Scheme 85: 1,2-diols bearing a quaternary stereocenter 
 
A few chemical approaches to the stereoselective synthesis of 1,2-diols (269) bearing a 
quaternary stereocenter are reported in literature, such as dihydroxilation of olefins, 
metal or organocatalyst mediated additions to ketones, pinacol couplings, and 
rearrangements, but none of these can be considered a real general one; some of this 
approaches require kinetic resolution96 and several biochemical methods as well have 
recently been developed;97 for instance an enantioselective hydrolysis of racemic 
epoxides catalyzed by the enzyme epoxide hydrolase have been used towards the 
synthesis of ibuprofen.98 
Despite the big advances in organocatalysis and the great interest of 1,2-diols, there is a 
lack of organocatalytic methods, even though some enantioselective organocatalytic 
synthesis of 1,3-diols have recently been developed.99 
 
4.3 Results and discussion 
4.3.1 Sharpless approach to optically active vicinal diols: catalytic asymmetric 
dihydroxylation  
The goal of this section, vicinal diols, had already been approached by Sharpless and 
Jacobsen in 1988,100 via ligand-accelerated metal catalysis, starting from the olefins: 
they reported a new catalytic process towards vicinal dihydroxylation of olefins, 
achieving substantially improved rates and turnover numbers as well as useful levels of 
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asymmetric induction with respect to the non-catalytic reaction. This osmium catalyzed 
reaction is in most of the cases performed in the presence of potassium osmate, 
potassium ferricyanide, potassium carbonate and chiral ligands, that are the constituents 
of the commercially available ready-mixed oxidizing system known as AD-mix 
(asymmetric dihydroxylation mix) (Scheme 86).101 
Scheme 86: The Sharpless dihydroxylation 
 
The quasi-enantiomeric ligand systems dihydroquinine-phtalazine ( (DHQ)2-PHAL in 
AD-mix α) and dihydroquinidine-ptalazine ( (DHQD)2-PHAL in AD-mix β) are 
constituents of the AD-mix. With the AD, Sharpless provided an useful oxidizing 
methodology that can be exploited with a wide range of substituted alkenes (Scheme 
87).102  
Scheme 87: cinchona alkaloids-derived chiral ligands in AD-mix   and   
 
In fact this reaction, starting from alkene 276, yield to vicinal diol 277, with a 94% of 
enantiomeric excess (Scheme 88). Despite of results in terms of enantioselectivity and 
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broad substrate scope, this reaction still have some weakness from the green chemistry 
principles point of view: osmium, a toxic and expensive metal, is needed, even if in 
catalytic amounts.103 
Scheme 88: application of Sharpless AD for the asymmetric synthesis of diol 277 
 
4.3.2 Strategy  and first experiments 
In the light of confined Brønsted Acids’s great potential in activating sterically unbiased 
molecules towards chemical asymmetric transformations and of the good results in 
organocatalytic asymmetric acetalization of aldehydes of such kind of catalysts, a new 
challenge was envisioned: confined Brønsted Acids catalyzed asymmetric acetalization 
of aldehydes (279), for the kinetic resolution of 1,2-diols (278), bearing a quaternary 
stereocenter (Scheme 89).93, 104 
Scheme 89: kinetic resolution of 1,2-diols via asymmetric organocatalytic acetalization. Configurations 
of the stereocenters of substrate and product are hypothetical. 
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In principle this reaction could lead to two diastereoisomeric acetals (280-M, 280-m) 
and to an enantioenriched substrate (278). An effective kinetic resolution should lead to 
a high diastereomeric ratio, a good enantiomeric ratio for the major diastereoisomer and 
quantitative yields both for product and recovered starting material. Moreover, an 
appealing  feature of this reaction is that product is in principle re-convertible to 
reactant, this is the case of dynamic kinetic resolution. Kinetic resolution is useful if the 
racemate is cheap, the catalyst is highly selective for one enantiomer and effective at 
low loading, and if the reactant and the product are recoverable in high yields and 
stereoselectivities.5 In the light of these considerations and of confined acids catalysts 
potential, this new catalytic system was chosen for the challenge. 
To the purpose of developing an enantioselective methodology which could easily bring 
to enantioenriched starting materials and products, the first experiments (reaction in 
Scheme 90) were carried out starting from the commercially available racemic diol 277 
and two equivalents of isovaleraldehyde 280 (3-methylbutanal), using 5 mol% DPPn 
(Figure 10) as achiral Brønsted acid catalyst, in toluene, at room temperature and in the 
presence of 5Å molecular sieves. This symmetric experiment would have given racemic 
mixture, useful for the possible subsequent asymmetric products identification; 
moreover a success would confirm the hypothesized reactivity. The choice of aldehyde 
280 was driven by some trials with other aldehydes, like pentanal, which brought 
similar results.o This first attempt was successful and it led to the desired racemic 
product in high yield. 
Figure 10: DPP 
 
The first asymmetric experiment was performed on 277 rac, in the presence of thymol-
derived chiral confined catalyst (catalyst I, 5 mol %); conditions were chosen founding 
on previous results in asymmetric acetalization (Scheme 90).93, 104a The selected 
conditions required the use of molecular sieves as desiccants (in order to adsorp water). 
                                                             
n DPP, diphenyl phosphate, commercially available. 
o Trials with other aldehydes have been performer by Ji-Hye Kim, in MPI laboratories. 
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Conversion was checked by TLC and HPLC and the reaction was quenched after 40 
hours, close to 50% conversion, with a few drops of triethylamine. The isolation of 
starting material and of the mixture of the products was quite easy because of the very 
good separation of compounds on silica gel, even though a gradient of eluents was 
carefully applied because of the difference in polarity among the analytes. The mixture 
of product, as well as the recovered substrate, was identified by 1H-NMR and 13C-NMR 
spectroscopy. Chiral phase HPLC and NMR analysis revealed very good results: the 
unreacted diol was recovered as a single enantiomer and acetals with 95/5 dr and 94% 
enantiomeric excess for the major isomer (281-M) and 90% for the minor one (281-m). 
A sample of the same reaction was taken after only 16 hours and it showed that the 
starting material contained only one enantiomer. Thus, since the beginning, the new 
application of asymmetric acetalization appeared promising. 
Scheme 90: first experiment with thymol-derived catalyst and two equivalents of isovaleraldehyde; the 
symmetric version of this reaction was catalyzed by DPP (Figure 10) 
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4.3.3 Catalyst screening 
A catalyst screening was planned, in order to understand whether the thymol-derived 
catalyst (I) could be beaten by other confined BA*. To this purpose reaction in Scheme 
90 was performed, under the same conditions, with catalysts differently substituted on 
the binol scaffold (catalysts I-VI in Scheme 91). Catalyst II (Table 15, entry 2) led to 
very good diastereoselectivity and quite good enantiomeric excess both for recovered 
starting material and for the major diastereoisomer, despite it seemed to be less reactive 
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than thymol-derived catalyst. Bulkier catalysts, such as III and VI showed good 
reactivity, good (even though lower) enantioselectivities, but lower diastereoselectivity 
(entries 3 and 6); instead the 2-Ph-phenyl-substituted (V) and 9-anthracenyl-substituted 
(IV) led to very poor enantioselectivities, poor diastereoselectivity for the former 
catalyst and slow reactivity for the latter (entries 4 and 5). In the light of these results I 
and II appeared the best catalysts, in terms of reactivity and selectivity. 
Scheme 91: catalysts for reaction screening 
 
Table 15: catalyst screening; catalysts are depicted in Scheme 87; dr = 281-M/281-m 
entry catalyst ee 281-M (%) 
ee 281-m       
(%) dr 
ee 277 
(%) 
Conversion 
(time) 
1 I 94 90 95/5 99.9 54%  (40h) 
2 II 94 67 98/2 84 49% (110h) 
3 III 62 99 82/18 96 75% (60h) 
4 IV 30 10 96.5/3.5 2 6%  (130h) 
5 V 50 99 67.5/34.5 4 92% (60h) 
6 VI 91 84 92.5/7.5 90 54% (60h) 
 
In view of lowering the catalyst loading and tuning the reaction conditions, it was 
necessary to point out which catalyst, between I and II, would be the best choice. To 
this purpose, both stereoselectivities and reactivities had to be evaluated. Therefore, two 
reactions were set up on larger scale, in the same conditions, in presence of catalyst I 
(reaction a) and II (reaction b) respectively. The reaction was checked during time in 
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terms of selectivity parameters and conversion. In this case, the possibility to compare 
also the theoretical enantiomeric excess of the diol coming from the products was 
envisioned (“theoretical product diol” in Table 17). In fact the enantiomer which reacts 
faster is in minority in the recovered starting material, but also, in principle, comes from 
the major enantiomer of 281-M and from the minor enantiomer of 281-m (Scheme 92). 
All these considerations are hypothetical. 
Scheme 92: hypothetical products, with relative stereochemistry. Major enantiomer of the major 
diastereoisomer contains the quaternary stereogenic center derived from the diol which corresponds to the 
minor enantiomer in the recovered starting material.  
 
Scheme 93: reaction a, performed with catalyst I 
 
Scheme 94: reaction b, performed with catalyst II 
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Afterwards the reaction’s screening was carried out by collecting small amounts of the 
reaction mixture and checking conversion and stereoselectivity parameters (Scheme 93, 
Scheme 94). Results are disclosed in Table 16 and Table 17. Conversion with triethyl-
substituted catalyst (II) was pretty slow compared to reaction performed with thymol-
derived catalyst (I). In fact, the reaction with II seemed to reach a plateau close to 48% 
conversion, where the reactivity was lowered, whereas with catalyst I reaction reached 
50% conversion just after 6 hours (Graph 1). Moreover, for the reaction performed with 
catalyst I, the ees of 277 and 281-M were always higher with respect to reaction 
performed with catalyst II. The same trend was observed for the aforementioned 
theoretical enantiomeric excess of the diol. 
All of this points are displayed in Graph 2, which show ee values vs percent conversion: 
I. light blue and orange lines represent the theoretical ee respectively for reaction a 
and b: theoretical enantiomeric excess of the product diol is higher with catalyst 
I; 
II. violet and green lines stand for the ee of the recovered starting material 
respectively for reaction a and b: enantiomeric excess of 277 is higher with 
catalyst I; 
III. blue and red lines correspond to the ee of the major product acetal for reaction a 
and b: enantiomeric excess of 281-M is higher with catalyst I. 
In the light of this catalyst screening, catalyst I was chosen for the optimization of the 
conditions. 
 
Table 16: reaction a, performed with 5% mol of catalyst I; * dr = 281-M/281-m 
entry ee 281-M (%) 
ee 281-m 
(%) 
ee 277 
(%) 
theoretical ee    
product diol (%) dr* 
conversion 
(time) 
1 98 49 32 96 36 25%  (1h) 
2 98 49 72 96 36 43%  (3h) 
3 96 3 96 91 23 51%  (6h) 
4 95 47 99 90 30 52%  (8h) 
5 91 70 100 80 14 55% (24h) 
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Table 17: reaction b, performed with 5% mol of catalyst II; * dr = 281-M/281-m 
entry ee 281-M     (%) 
ee 281-m 
(%) ee 277 (%) 
theoretical ee  
product diol (%) dr* 
Conversion 
(time) 
1 97 87 31 94 66 24% (16h) 
2 96 90 58 92 47 38% (40h) 
3 95 82 78 89 32 47% (88h) 
4 94 67 84 89 29 49% (112h) 
5 95 75 85 89 29 49% (136h) 
Graph 1: conversion (%) vs time (h) for reaction performed in presence of catalysts I 
(red line) and catalyst II (blue line); catalyst I is much more reactive. 
 
Graph 2: ees of recovered starting material (SM = 277), of major product (product = 
281-M) and theoretical ees of the product diol (theor prod diol = 281-M theoretical) for 
reactions performed with catalysts I (thymol = I) and II (triethyl = II). 
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4.3.4 Reaction conditions optimization 
In order to reduce the catalyst loading, an optimization of the conditions was performed, 
taking into account reactivity and stereoselectivity. Lowering catalyst loadings 
represented an important target, since sometimes catalysts can be partially  inactivated 
in the reaction medium. At the same time the active catalyst fraction has to be keeped in 
order to have good outcomes. Confined Brønsted acids catalysts had previously been 
used at very low percent molar loading. 104, 105 
Initially the reaction was performed at 20°C, in order to check if the system could work 
at controlled lower temperature without being stacked. This first trial worked similarly 
than at room temperature: same enantioselectivities and quite similar reaction times 
were observed (Scheme 95, Table 18). This meant that we could lower the reaction 
temperature because no sensible reactivity decrease was observed and furthermore it 
opened to the possibility of performing the reaction with 1 mol% I. 
Scheme 95: reaction performed with 5 mol% catalyst I 
 
Table 18: reaction in Scheme 95, results at rt and 20°C 
T (°C) ee 277 (%) Conversion (%) time (h) 
20 96 51 6.5 
RT 96 51 6 
Afterwards, an increase of the amount of aldehyde was envisioned. This could in 
principle be useful to speed the reaction, since this had already served to the purpose in 
the development of asymmetric acetalization of aldehydes.104a Reaction was performed 
with 1 mol% catalyst, in presence of 7 equivalents of isovaleraldehyde and a different 
behaviour of the ee of 281-M was observed. It seemed to vary in a different way close 
to 48% conversion (Table 19 and in Graph 3; blue line in Graph 4). Moreover  
the ee of the 277 was lower than what previously observed: at high conversion it was 
still 89%, and the reaction seemed to stack before 50%. In order to check whether the 
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reactivity would increase with the temperature, reaction was checked at 30°C, but the 
same trend was observed (Table 20, light blue line in Graph 4). Probably in presence of 
such a large excess of aldehyde some other interactions could arise, leading to a 
reduction of reactivity close to 47% conversion and to the lowering of 
enantioselectivity. 
Table 19 results for reaction at 20°C with 1 mol% cat* and 7 equivalents of aldehyde; dr = 281-M/281-
m 
 
 
 
Table 20 results for reaction at 20°C with 1 mol% cat* and 7 equivalents of aldehyde; dr = 281-
M/281-m 
time (h) ee s.m. (%) 
Conversion 
(%) 
ee 281a 
(%) 
ee 281b 
(%) 
theoretical ee 
diol product 
(%) 
dr 
9 77 44 97 4 95 49 
22 87 48 96 49 94 67 
23 89 48 98 68 95 67 
time (h) ee 277 (%) Conversion (%) 
ee 281a 
(%) 
ee 281b 
(%) 
theoretical ee 
diol product (%) dr 
22 89 47 97 63 94 54 
27 89 48 98 30 94 45 
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Graph 3 results for reaction a at 20°C with 1 mol% I and 7 equivalents of 
aldehyde; major product = 281-M; minor product = 281-m; recovered diol = 
277. 
 
Graph 4: enantiomeric excess of the major diastereoisomer product of the 
reaction a, in presence of different amounts of catalyst / aldehyde 
 
 
In the light of this considerations, the reaction was performed with the same amount of 
I, at 30°C, and with only 2 equivalents of aldehyde. The attempt was not successful, 
since the reaction couldn’t reach sufficiently high conversion. It stacked close to  40% 
conversion, when the ee of the diol was still low (Table 21; violet line in Graph 4).  
Table 21 results for reaction a at 30°C with 1 mol% catalyst I and 2 equivalents of aldehyde; dr = 
281a/281b 
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22 68 42 98 8 95 34 
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Thus the reaction was tested with 2 mol% I, with 2 equivalents of aldehyde, at 20°C and 
at 30°C. In the former case great results were achieved. Enantioselectivities were 
similar to the previously obtained in presence of 5 mol% catalyst: after 22 hours, 93% 
ee was measured for both 277 and the theoretical diol product. Furthermore, 97% ee for 
the major acetal and a very high diastereoisomeric ratio were achieved (Table 22 and 
Table 23, green and red lines in Graph 4). The increase of the temperature to 30°C led 
to slightly lower enantiomeric excesses for 281-M (green line in Graph 4) and for the 
theoretical product diol, and it did not speed the reaction. 
Table 22: results for reaction a at 20°C with 2 mol% catalyst I and 2 equivalents of aldehyde; dr = 281-
M/281-m 
time (h) ee 277 (%) Conversion (%) 
ee 281-M 
(%) 
ee 281-m 
(%) 
theoretical ee diol 
product (%) dr 
9 65 40 98 21 96 42 
22 93 50 97 14 93 26 
27 96 51 97 95 94 60 
 
Table 23: results for reaction a at 30°C with 2 mol% cat* and 2 equivalents of aldehyde. dr = 281-
M/281-m 
 
time (h) ee 277 (%) Conversion (%) 
ee 281-M 
(%) 
ee 281-m 
(%) 
theoretical ee diol 
product (%) dr 
9 66 41 98 34 96 30 
27 96 51 97 30 94 38 
 
In view of achieving the same good selectivity and reactivity with the lowest amount of 
catalyst, the reaction was performed in the optimized conditions (20°C, 4 equivalents of 
280) with 1 mol% catalyst loading (Scheme 96). The attempt was successful, since the 
reaction let to 94% ee for the starting diol, 97% ee for both product acetals, very high 
diastereoisomeric ratio (Scheme 96, Table 24, Graph 6). 
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Scheme 96: Reaction in best conditions.  
 
Table 24 results for reaction a at 20°C with 1 mol% I and 4 equivalents of aldehyde; dr 
= 281-M/281-m 
time (h) ee 277 (%) 
conversion 
(%) 
ee 281a 
(%) 
ee 281b 
(%) 
theoretical ee 
diol product 
(%) 
dr 
2 21 18 97 30 95 45 
15 90 48 97 30 95 45 
20 94 49 97 97 94 58 
 
Graph 5 ees for reaction performed with 1 mol % catalyst 1, 4 eq. aldehyde at 20°C. 
Major product = 281-M; minor product = 281-m; recovered diol = 277. 
 
 
The same reaction was performed in the previously optimized conditions on larger 
scale. Both diol and products were isolated and fully characterized after purification via 
flash chromatography. The enantioenriched starting diol 277 was recovered in 46% 
yield and with a 96% ee; the mixture of diastereoisomers was isolated in 50% yield, 58 
dr and 97% ee for both products (Scheme 97). Finally this optimization served to reach 
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the target. The optimized procedure was subsequently used to test the kinetic resolution 
of other diols.  
Scheme 97: reaction on the basic diol in best conditions, performed on larger scale 
 
Furthermore it could be possible to separate enantioenriched starting material from the 
diastereomeric mixture and from the catalyst, which could be recovered and in principle 
employed in other catalytic cycles. The promising results achieved with the model diol, 
are better than those one could reach with Sharpless dihydroxylation’s (vide supra). 
Indeed, dealing with a kinetic resolution, 50% yield is the best one could afford. 
4.3.5 Synthesis of the diols 
In the light of the achieved good results, the kinetic resolution could be tested on other 
1,2-diols, in order to check the scope of the reaction. Thus a synthetic route was 
devised, that could lead as fast as possible to diols in good yields and starting from 
cheap materials. For the basic diol a facile one-step synthesis was considered, starting 
from hydroxy-aceton 282, via Grignard addition with phenyl magnesium bromide 
(Scheme 98). Two equivalents of Grignard reagent have been used, because of the 
presence of the hydroxyl moiety in the substrate. 
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Scheme 98: single-step retrosynthesis for the diol 
 
This procedure was readily, successfully, tried and in 30 minutes led to a crude mixture, 
giving high conversion and good purity. After purification by means of flash 
chromatography, the clean, desired diol was obtained in 90% yield (Scheme 99). 
Scheme 99: synthesis of the basic diol. 
 
Afterwards, the same synthesis was used to get other diols, differently substituted, 
which could be interesting in view of the substrate scope. Thus the Grignard addition 
on, variously substituted hydroxy-ketones, varying the solvent (Scheme 100, Table 26).p 
The reaction worked pretty well for every substrate and all compounds 284-290 were 
easily obtained (reaction times between 15 min and 1.5 h) and characterized.  
Scheme 100: synthesis of diols for substrate scope 
 
 
 
 
 
 
                                                             
p For detailed procedures see experimental part. 
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Table 25: diols obtained with one-step synthesis in Scheme 100. Commercially available 
Grignard reagents have been used. a The Grignard reagent was prepared by the general 
procedure reported in the experimental section.  
 
entry solvent
time 
(min)
yield (%)
1 Et2O 30 90
2 Et2O 60 43
3 Et2O 30 88
4 THF 30 70
5a THF 15 50
6 THF 15 65
7a THF 60 60
8 2MeTHF 90 80
288
289
290
compound
277
284
285
286
287
 
 
4.3.6 Substrate scope 
The substrate scope exploration for the asymmetric kinetic resolution was straightly 
started, in the previously optimized conditions, already successfully applied to the basic 
diol in larger scale. The reaction was initially tried on each diol with 1 mol% catalyst, 
increasing then the catalyst amount only if it was not sufficient to reach 50% conversion 
in short reaction time. For this small screening it was sufficient to check only the ee of 
the diols, without isolating products and starting material. This method could avoid the 
use of large amounts of materials. 
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First of all diol 284 rac was taken into account (Scheme 101). This compound, bearing 
an ethyl instead of the methyl group, on the quaternary stereocenter, reacted more 
slowly than the model diol, and conversion was too slow with 1 mol% catalyst, stacking 
after 20 hours. The ee of 284 was 81% after 24 hours and was still 80% after two days. 
Gratifyingly, with a 2 mol% catalyst loading, after two days, conversion was complete. 
Finally, quenching the reaction after 20 hours, a 96% ee was measured (Table 26). 
Scheme 101: reaction in the optimized conditions: small screening of the catalyst loading 
 
Table 26: small screening of catalyst loading for reaction 
in Scheme 100. Yields are not reported in the table, since 
the study of the ees via HPLC, was adequate to understand 
the reaction trend. 
catalyst loading time (h) ee 284 (%) 
1 mol% 4 30 
1 mol% 24 81 
1 mol% 48 80 
2 mol% 7 74 
2 mol% 52 99 
2 mol% 17 92 
2 mol% 20 96 
 
Thus the reaction was scaled up in these conditions leading to quite good results. After 
20 hours, at 52% conversion, the starting diol 284 was isolated in 46% yield and 99% 
ee. The diastereoisomeric mixture of acetals was isolated in 44% yield, with a d.r. of 
97/3, 96.4% ee for the major isomer and 98.5% ee for the minor (Scheme 102). 
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Scheme 102: reaction  in best conditions, with a 2 mol% 1,  performed on larger scale 
 
Gratifyingly, for the p-methoxy substituted compound 289, 2 mol% catalyst loading 
(Scheme 103) was sufficient to get very good results, disclosed in Table 27. Thus the 
scale up was readily done, quenching the reaction after 16 hours, isolating the diol in 
51% yield and 92% ee and the diastereoisomeric mixture with a 48% yield, 98/2 dr, 
97% ee for 296-M and 96% for 296-m (Scheme 104) 
Scheme 103: reaction on 289 for a small screening of catalyst loading.  
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Table 27 small screening of catalyst loading for 
reaction in Scheme 103. Yields are not reported in the 
table, since the study of the ees via HPLC, was 
adequate to understand the reaction trend. 
catalyst loading time (h) ee 289 (%) 
1 mol% 4 32 
1 mol% 24 62 
1 mol% 48 64 
2 mol% 11 82 
2 mol% 13 88 
2 mol% 14 90 
2 mol% 20 99 
Scheme 104: reaction scaled up for substrate scope, in best conditions, with 2 mol% I 
 
For the p-chlorine substituted compound, the optimization of reaction conditions 
(Scheme 105, Table 28) showed that such substitution did not affect the 
enantioselectivity of the reaction, though the reactivity required a 3 mol% catalyst 
loading. In this case, with 2 mol% , the ee of the diol stacked at 76%. Luckily with a 3 
mol % loading of the catalyst, after 11 hours, a 99 % ee of the diol was observed. The 
scale up of the reaction has been performed, leading to similar good results. 
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Scheme 105: reaction for a small screening of catalyst loading 
 
Table 28: small screening of catalyst loading for reaction in 
Scheme 105. Yields are not reported in the table, since the study of 
the ees via HPLC, was adequate to understand the reaction trend. 
catalyst loading time (h) ee diol (%) 
1 mol % 4 28 
1 mol % 24 34 
1 mol % 48 33 
2 mol % 7 54 
2 mol % 52 76 
3 mol % 11.5 99.2 
3 mol % 20 99.4 
 
4.3.7 Mechanism hypothesis and considerations on the stereochemistry assignment 
This kinetic resolution aroused as an application of the catalytic asymmetric 
acetalization developed by List research group, which brought to very good results in 
this unexplored field; the results of this kinetic resolution appear congruent to the 
hypothesized mechanism, which is supposed to be similar to the previously reported.104a 
In the mechanistic hypothesis (Scheme 106), a reversible addition of the primary 
alcohol moiety of the 277 to the aldehyde 280 occurs; this first step is faster for one of 
the two enantiomers of the diol 277, leading to an enantioenriched recovered diol during 
the catalytic cycles. This addition is followed by the formation of the hemiacetal 
intermediate A. Consequently, protonation of the OH by the catalyst results in the 
expulsion of a water molecule and formation of the oxacarbenium ion intermediate B, 
that is attacked in a stereoselective way by the second hydroxy nucleophile, leading to 
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the acetals 281. Previous studies104a of the acetalization mechanism, proved that the 
most likely intermediate is A, arising from the attack of the primary alcohol; moreover 
the si facial attack was verified by the absolute stereochemistry studies that had been 
done for the asymmetric acetalization. The asymmetry induction is clearly due to the 
sterically demanding catalyst pocket, in which the reaction takes place. 
A confirmation of the stereochemistry assignment of this kinetic resolution will come 
from the optical rotatory power measurements of the recovered diols and from NMR 
bidimensional studies of the diastereomeric mixture of acetals. These studies are still in 
progress. 
Scheme 106: hypothesized reaction mechanism, in the light of previous studies on asymmetric 
acetalization104a. Configurations of the stereocenters have not been assigned yet, but a si attack can be 
hypothesized in the light of previous studies on acetalization reaction. 104a 
 
 
4.4 Conclusions 
In conclusion, an efficient catalytic kinetic resolution of diols bearing a quaternary 
stereocenter have been developed, as an useful application of the catalytic asymmetric 
acetalization.104a 
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With the elected aldehyde, isovaleryc aldehyde, a catalyst screening of some confined 
Brønsted acids have been made, which have brought to the choice of thymol-derived 
catalyst (I) as the most efficient (Scheme 107).  
Scheme 107: among the screened catalysts, I resulted to be the most efficient 
 
The optimization of reaction conditions (Scheme 108) have led to the possibility of 
performing the reaction in a fast, mild and cheap manner. By tuning the aldehyde 
equivalents and the temperature, low catalyst loading (1 mol%) have been reached.  
Scheme 108: kinetic resolution optimized conditions: 4 equivalents of isovaleraldehyde, catalyst I, 5Å 
molecular sieves, in toluene, at 20°C are the best conditions in order to have efficient reaction with the 
least amount of catalyst. 
 
A scope of racemic diols, as starting material, have been easily synthesized, in 
moderate-to high yields, through a Grignard addition to corresponding hydroxy ketones 
(Scheme 109). 
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The optimized methodology have been employed to get very enantioenriched diols, 
with enantiomeric excess up to 99%, product acetals with a very high diastereomeric 
ratios (up to 98/2 dr) and enantioselectivities (up to 99% ee). Both products and starting 
diols have been isolated in good yield, keeping in mind that results are referred to a 
kinetic resolution (Scheme 110). 
This methodology seems not to be influenced by the substitution on the aromatic ring of 
the diol and it represents a further improvement in the organocatalysis field, since it can 
reach results as good as one could do by means of metal-catalyzed processes. 
 
Scheme 109: scope of the starting diols, synthesized by Grignard addition 
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Scheme 110: the preliminary results for substrate scope 
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General experimental 
Solvents and reagents 
All solvents used in the standard procedures were purified by distillation. Absolute 
diethyl ether, tetrahydrofuran and toluene were obtained by distillation over sodium 
with benzophenone as indicator; absolute chloroform and dichloromethane were 
obtained by distillation over calcium hydride, and ethanol, isopropanol and methanol 
were dried by distillation over magnesium. Commercial reagents were obtained from 
various sources and used without further purification. 
Brønsted acid catalysts 
Chiral Brønsted acid catalysts were kindly supplied by the coworkers from the List 
group (MPI, Mülheim an der Ruhr) and were prepared according to the literature 
procedures.93 
Inert gas atmosphere 
Air and moisture sensitive reactions were conducted under an atmosphere of argon (Air 
Liquide, >99.5% purity). Unless otherwise stated, all organocatalytic reactions were 
performed under an ambient atmosphere without the exclusion of moisture or air.  
Thin layer chromatography (TLC) 
Reactions were monitored by thin layer chromatography on silica gel coated plastic 
sheets (0.2 mm, Machery‐Nagel) or on coated aluminium Sigma-Aldrich covered with 
fluorescence indicator UV254. Visualization was accomplished by irradiation with UV 
light at 254 nm and different staining reagents; phosphomolybdic acid (PMA) stain: 
PMA (10 g) in EtOH (100 ml), I2, ninhidrin 5% in EtOH (w/w), KMnO4 alkaline aq. 
solution. 
Column chromatography 
Column chromatography was performed under elevated pressure on silica gel (60, 
particle size 
0.040‐0.063 mm, Merck). 
High pressure liquid chromatography (HPLC) 
HPLC analyses on a chiral stationary phase were performed on a HPLC Thermo Spectra 
System SMC 1000 or on a Shimadzu LC‐2010C systems, equipped with a UV detector. 
Commercial HPLC‐grade solvents were used, and measurements were conducted at 25 
°C. The chiral stationary phase of the columns is specified in each experiment. The 
enantiomeric ratios were determined by comparing the samples with the appropriate 
racemic mixtures. 
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Gas chromatography (GC) 
GC analyses on a chiral stationary phase were performed on HP 6890 and 5890 series 
instruments equipped with a split‐mode capillary injection system and a flame 
ionization detector (FID) using hydrogen as a carrier gas. Detailed conditions are given 
in the individual experiment. The enantiomeric ratios were determined by comparing 
the samples with the appropriate racemic mixtures. 
Nuclear magnetic resonance spectroscopy (NMR) 
Proton, carbon, and phosphorus NMR spectra were recorded on Bruker AV‐500 or 
Bruker AV‐400 or Varian “Gemini” 300 spectrometers in deuterated solvents at room 
temperature (298 K). Proton chemical shifts are reported in ppm (δ) relative to 
tetramethylsilane with the solvent resonance employed as the internal standard (C6D6, δ 
7.16 ppm; DMSO‐d6, δ 2.49 ppm; CDCl3, δ 7.24 ppm; acetone‐d6, δ 2.04 ppm). Data 
are reported as follows: chemical shift, multiplicity (s = singlet, brs = broad singlet, d = 
doublet, dd = double doublet, t = triplet, q = quartet, m = multiplet), coupling constants 
(Hz) and integration. Slight shape deformation of the peaks in some cases due to weak 
coupling is not explicitly mentioned. 13C chemical shifts are reported in ppm from 
tetramethylsilane with the solvent resonance as the internal standard (C6D6, δ 128.06 
ppm; DMSO‐d6, δ 39.5 ppm; CDCl3, δ 77.0 ppm; acetone‐d6, δ 206.0, 29.8 ppm). 
Infrared spectroscopy 
FT-IR analysis were carried out in transmittance, in CHCl3, on a Thermo Nexus 
spectrometer. The wave length range (4000-500 cm-1) has been analyzed with 4 cm-1 
resolution, with 32 scans. 
Mass spectrometry (MS) 
Mass spectra were measured on a Finnigan MAT 8200 (70 eV) or MAT 8400 (70 eV) 
by electron ionization, chemical ionization or fast atom/ion bombardment techniques. 
High resolution mass spectra were obtained on a Finnigan MAT 95 or Bruker APEX III 
FT‐MS (7 T magnet). All masses are given in atomic units/elementary charge (m/z).  
 
 
Specific rotation 
Optical rotations were determined with Jasco Mod. DIP-370 or Autopol IV automatic 
polarimeter (Rudolph Research Analytical) using a 50 mm cell with temperature 
control. The measurements were performed at 25°C at a wavelength λ = 589 nm 
(sodium D‐line). Concentrations (c) are given in g/100 ml. 
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General procedure for preparing 1-methyl-indole-2,3-diones 172, 173. 
N
H
O
N
CH3
O
CH3I, NaH
DMF, Ar atm,
1 h RT
OO
O2N O2N
162 173  
Under an inert atmosphere of argon, to a suspension of isatin 162 (5 mmol) and sodium 
hydride at 60% dispersion in oil (0.17 g, 5 mmol) in DMF (10 mL) was added dropwise 
methyl iodide (0.7 mL, 5 mmol). After 12h under stirring at room temperature, the 
residue was treated with water and entracte with ethyl acetate. The organic layer was 
dried (MgSO4) and the filtrate was concentrated under reduced pressure. The crude 
product was subsequently purified by flash chromatography on silica gel 
(nHexane/EtOAc).106 
Characterization of 1-methyl-indole-2,3-diones 172, 173. 
1-methyl-5-nitroindol-2,3-dione, 173 
Following the above general procedure, the product 173 was 
obtained as an orange solid in 89% yield after purification 
(nHexane/EtOAc=6/4). 1H NMR (CDCl3, 300 MHz, 25°C): δ 
3.36 (s, 3H, NCH3); 7.06 (d, J = 8.7 Hz, 1H, CHarom); 8.48 (d, J = 
2.3 Hz, 1H, CHarom); 8.56 (dd, J = 8.7 Hz, 2.3 Hz, 1H, CHarom) 
ppm.106  
5-isopropyl-1-methylindol-2,3-dione, 172 
Following the above general procedure, the product 172 was 
obtained as a red solid in 84% yield after purification 
(nHexane/EtOAc=7/3). 1H NMR (CDCl3, 300 MHz, 25°C): δ 
1.23 (d, J = 6.9 Hz, 6H, (CH3)2CHCarom); 2.82-2.99 (m, 1H, 
(CH3)2CHCarom); 3.22 (s, 3H, NCH3); 6.81 (dd, J = 7.4 Hz, 1.3 Hz, 1H, CHarom); 7.43-
7.48 (m, 2H, CHarom) ppm. 13C NMR (CDCl3, 75 MHz, 25°C): 23.9 (NCH3), 26.3 
(2xCH3), 33.6 (CH), 109.9 (Carom), 117.6 (Carom), 123.2 (Carom), 136.8 (Carom), 145.0 
(Carom), 149.7 (Carom), 158.6 (C=O), 183.8 (NC=O) ppm. HRMS: exact mass calculated 
for (C12H13NNaO2) requires m/z 203.0901, found m/z 226.0903.  
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General procedure for preparing 1-methylindol-2,3-diones 131, 168-171, 
175, 178 
 
To a solution of indoline-2,3-dione (10.0 g, 68 mmol) and K2CO3 (18.8 g, 136 mmol) in 
50 mL DMF was added CH3I (136 mmol) dropwise slowly at room temperature. Then 
the mixture was stirred and monitored by TLC plates or overnight. When the reaction 
completed, the mixture was diluted by DCM, and water was added. The aqueous phase 
was extracted with DCM. The combined organic layers were then washed with 
saturated brine, dried over anhydrous Na2SO4 and concentrated under reduced pressure 
to give viscous oil, which was purified by chromatography on silica gel 
(nhexane/EtOAc)107 
Characterization of 1-methylindol-2,3-diones 131, 168-171, 175, 178 
1-methylindol-2,3-dione, 131 
Following the above general procedure, the product 131 was obtained 
as a red solid in 98% yield after purification (nHexane/EtOAc=6/4). 
1H NMR (CDCl3, 300 MHz, 25°C): δ 3.21 (s, 3H, NCH3), 6.84 (m, 
1H, CHarom), 7.07 (m, 1H, CHarom),  7.43-7.35 (m, 2H, CHarom) ppm.80 
5-fluoro-1-methylindol-2,3-dione, 168 
Following the above general procedure, the product 168 was 
obtained as a red solid in 95% yield after purification 
(nHexane/EtOAc=7/3). 1H NMR (CDCl3, 300 MHz, 25°C): δ 3.24 
(s, 3H, CH3N), 6.79-6.93 (m, 1H, CHarom), 7.26-7.39 (m, 2H, 
CHarom) ppm.80 
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5-chloro-1-methylindol-2,3-dione, 169 
Following the above general procedure, the product 169 was 
obtained as a red solid in 94% yield after purification 
(nHexane/EtOAc=7/3). 1H NMR (CDCl3, 300 MHz, 25°C): δ 3.24 
(s, 3H, CH3N), 6.79-6.93 (m, 1H, CHarom), 7.26-7.39 (m, 2H, 
CHarom) ppm.80 
5-iodo-1-methylindoline-2,3-dione, 170 
 Following the above general procedure, the product 170 was 
obtained as a red solid in 94% yield after purification 
(nHexane/EtOAc=6/4). 1H NMR (DMSO-d6, 300 MHz, 25°C): δ 
3.12 (s, 3H, CH3N), 6.98 (d, J = 8.8 Hz, 1H, CHarom), 7.77 (s, 1H, 
CHarom), 8.02 (d, J=8.8 Hz, 1H, CHarom) ppm.108 
1-methyl-5-(trifluoromethoxy)indoline-2,3-dione, 171109 
 Following the above general procedure, the product 1e was 
obtained as a red solid in 94% yield after purification 
(nHexane/EtOAc=6/4). 1H NMR (CDCl3, 300 MHz, 25°C): δ 
3.12 (s, 3H, CH3N), 6.98 (d, J = 8.8 Hz, 1H, CHarom), 7.77 (s, 
1H, CHarom), 8.02 (d, J=8.8 Hz, 1H, CHarom) ppm.108 
7-bromo-1-methylindoline-2,3-dione, 178 
Following the above general procedure, the product 178 was obtained 
as a red solid in 94% yield after purification (nHexane/EtOAc=6/4). 
1H NMR (CDCl3, 300 MHz, 25°C): δ 3.64 (s, 3H, CH3N), 6.98 (dd, J 
= 8.0 Hz, J = 7.3 Hz, 1H, CHarom),  7.56  (dd, J = 7.3 Hz, J = 1.3 Hz, 
1H, CHarom), 7.69 (dd, J = 8.0 Hz, J = 1.3 Hz, 1H, CHarom) ppm.110 
 
 
 
N
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5,7-dichloro-1-methylindoline-2,3-dione, 175 
Following the above general procedure, the product 175 was 
obtained as a red solid in 92% yield after purification 
(nHexane/EtOAc=7/3). 1H NMR (CDCl3, 300 MHz, 25°C): δ 3.60 
(s, 3H, CH3N),  7.47-7.52 (m, 2H, CHarom) ppm. 13C NMR (CDCl3, 
75 MHz, 25°C): δ 29.8 (NCH3), 118.4 (Carom), 120.5 (Carom), 124.1 
(Carom), 130.0 (Carom), 139.3 (Carom), 145.4 (Carom), 158.0 (C=O), 181.6 (NC=O) ppm. 
HRMS: exact mass calculated for (C9H5NNaO2) requires m/z 228.9701, found m/z 
228.9705. 
General procedure for preparing 3-ylidenoxindole 180 
 
a) In a round bottomed two neck flask, 24 mL acetic acid with 429mg (3mmol) of 179 
are heated slowly until complete solubilisation. 0.16mL (1.06mmol) of 
diethylketomalonate are added drop by drop and the reaction is heated at 120°C. After 3 
hours the solvent is removed in vacuo and a KOH5% solution is added to the crude. 
This alkaline solution is stirred to the air for 24 h, then HCl 1N is added until acidic ph. 
After one hour at 0°C the precipitate is filtrated and washed with acidic aqueous 
solution. The solid essiccated and used for the following step without further 
purification.  
b) In a two necked flask, under Ar atmosphere, 389mg (1.88mmol) of 1H-
benzo[g]indolo-2,3-dione, in 7mL DMF. Then 384 mg of K2CO3 (2.82 mmol) and 0,14 
mL (1.86 mmol) of CH3I are added slowly. The mixture is heated at 80°C and stirred 
for 30 min. Then 15mL of water are affed and the mixture is extracted with ethyl acetate 
(15mL x 5).  The organic layers are dryed over Na2SO4, the solvent is evaporated and 
the crude is purified via flash chromatography (hexane/EtOAc = 8/2). 253 mg (1.2 
mmol) product are obtained as a red solid. 
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Characterization of 3-ylidenoxindole 180 
 
1-methyl-1H-benzo[g]indole-2,3-dione, 180 
Following the above general procedure, the product 180 was 
obtained as a red solid in 64% yield after purification 
(nHexane/EtOAc=8/2). 1H NMR (CDCl3, 300 MHz, 25°C): δ = 3.82 
(s, 3H, NCH3), 7.44-7.71 (m, 4H, CHarom), 7.85 (d, J = 8.1 Hz, 1H, 
CHarom), 8.42 (d, J = 8.9 Hz, 1H, CHarom) ppm. 13C NMR (CDCl3, 
75 MHz, 25°C): δ = 31.0 (NCH3), 113.5 (Carom), 119.5 (Carom), 121.6 (Carom), 123.9 
(Carom), 124.4 (Carom), 127.4 (Carom), 129.5 (Carom), 130.1 (Carom), 130.5 (Carom), 140.5 
(Carom), 152.6 (C=O), 159.9 (NC=O) ppm. HRMS: exact mass calculated for 
(C13H9NNaO2) requires m/z 211.0604, found m/z 228.0610. 
General procedure for preparing 3-ylideneoxindoles 132, 146-150, 154-156, 
181, 210-215, 223-231 
 
To a stirred solution of isatine (131) (2.7 mmol) in THF (9.0 mL) at 0 °C triethyl 
phosphonoacetate (3.0 mmol) and a solution of K2CO3 (8.7 mmol) in water (1.8 mL) 
were added. The mixture was stirred at 0 °C for 15 min and once reached the room 
temperature was kept under stirring until the reaction completion (TLC hexane /EtOAc). 
Afterwards, diethyl ether (50.0 mL) was added and the organic phase was washed with 
brine, dried with anhydrous Na2SO4 and concentrated under vacuum. The crude product 
132 was subsequently purified by flash chromatography on silica gel (nHexane/EtOAc). 
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Characterization of 3-ylideneoxindoles 132, 146-150, 154-156, 181, 210-215, 
223-231 
 (E)-ethyl 2-(1-methyl-2-oxoindolin-3-ylidene)acetate, 132 
Following the above above general procedure, the single E 
diastereoisomer 132 was obtained as an orange solid in 80% yield 
after purification (nHexane/EtOAc=7/3). IR (CHCl3): ˜ n = 3034, 
3010, 1707, 1609, 1471, 1371 cm1. 1H NMR (CDCl3, 300 MHz, 
25°C): δ 1.35 (t, J = 7.1 Hz, 3H, CH3CH2O), 3.22 (s, 3H, CH3N), 
4.31 (q, J = 7.1 Hz, 2H, CH3CH2O), 6.78 (d, J = 7.8 Hz, 1H, CHarom), 6.89 (s, 1H, 
CH=C), 7.05 (dt, J = 7.9 Hz, 1.1 Hz, 1H, CHarom), 7.35 (dt, J = 7.8 Hz, 1.1 Hz, 1H, 
CHarom), 8.54 (d, J = 7.9 Hz, 1H, CHarom) ppm. 13C NMR (CDCl3, 75 MHz, 25°C): δ 
14.4 (CH3), 26.4 (NCH3), 61.3 (CH2), 108.3 (CH=C), 120.0 (Carom), 122.6 (Carom), 123.0 
(Carom), 128.9 (Carom), 132.6 (Carom), 138.0 (C=C), 146.2 (Carom), 165.8 (OC=O), 167.7 
(C=O)  ppm. HRMS: exact mass calculated for (C13H13NNaO3) requires m/z 254.0793, 
found m/z 254.0790.80  
 (E)-ethyl 2-(5-fluoro-1-methyl-2-oxoindolin-3-ylidene)acetate, 146 
Following the above above general procedure, the single E 
diastereoisomer 146 was obtained as a red-orange solid in 60% 
yield after purification (nHexane/EtOAc=7/3). IR (CHCl3): ˜ n = 
3033, 3012, 2993, 1709, 1655, 1618, 1485, 1471, 1370, 1223 
cm1. 1H NMR (CDCl3, 300 MHz, 25°C): δ 1.36 (t, J = 7.2 Hz, 
3H, CH3CH2O), 3.21 (s, 3H, CH3N), 4.32 (q, J = 7.2 Hz, 2H, CH3CH2O), 6.70 (dd, J = 
8.6 Hz, 4.2 Hz, 1H, CHarom), 6.93 (s, 1H,CH=C), 7.07 (dt, J = 8.6 Hz, 2.7 Hz, 1H, 
CHarom), 8.36 (dd, J = 7.2 Hz, 1H, CHarom) ppm. 13C NMR (CDCl3, 75 MHz, 25°C): δ 
14.3 (CH3), 26.5 (NCH3), 61.5 (CH2), 108.5 [(CH=C) d, JCF = 8.1 Hz], 116.6 [(Carom), d, 
JCF = 27.0 Hz], 118.7 [(Carom), d, JCF = 24.1 Hz], 120.9 [(Carom), d, JCF = 10.7 Hz], 123.9 
(Carom), 139.9 [(Carom), d, JCF = 239.3 Hz], 157.5 (C=C), 160.7 (Carom),  165.5 (OC=O), 
167.3 (C=O) ppm. HRMS: exact mass calculated for (C13H12FNNaO3) requires m/z 
272.0699, found m/z 272.0697.80 
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(E)-ethyl 2-(5-chloro-1-methyl-2-oxoindolin-3-ylidene)acetate, 147 
Following the above above general procedure, the single E 
diastereoisomer 147 was obtained as a red-orange solid in 76% 
yield after purification (nHexane/EtOAc=9/1). IR (CHCl3): ˜ n = 
3034, 3012, 2951, 1716, 1652, 1608, 1476, 1439, 1371, 1344 
cm1. 1H NMR (CDCl3, 300 MHz, 25°C): δ 1.36 (t, J = 7.1 Hz, 
3H, CH3CH2O), 3.20 (s, 3H, CH3N), 4.32 (q, J = 7.1 Hz, 2H, 
CH3CH2O), 6.71 (d, J = 8.4 Hz, 1H, CHarom), 6.92 (s, 1H, HC=), 7.33 (d, J = 8.4 Hz, 
1H, CHarom), 8.58 (s, 1H, CHarom) ppm.13C NMR (CDCl3, 75 MHz, 25°C): δ 14.4 (CH3), 
26.5 (NCH3), 61.6 (CH2), 109.1 (CH=C), 121.1 (Carom), 124.1 (Carom), 128.4 (Carom), 
129.0 (Carom), 132.2 (Carom), 137.1 (C=C), 144.6 (Carom), 165.5 (OC=O), 167.3 (C=O) 
ppm HRMS: exact mass calculated for (C13H12ClNNaO3) requires m/z 288.0403, found 
m/z 288.0404.80 
(E)-ethyl 2-(5-iodo-1-methyl-2-oxoindolin-3-ylidene)acetate, 148 
Following the above above general procedure, the single E 
diastereoisomer 148 was obtained as an orange solid in 21% yield 
after purification (nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3034, 
3017, 3008, 1724, 1706, 1602, 1465, 1369, 1343 cm1. 1H-NMR 
(CDCl3, 300 MHz, 25°C): 1.38 (t, J = 7.1 Hz, 3H, CH3CH2O), 
3.21 (s, 3H, NCH3), 4.34 (q, J = 7.1 Hz, 2H, CH3CH2O), 6.59 (d, J = 8.2 Hz, 1H, 
CHarom), 6.92 (s, 1H, CH=C), 7.69 (dd, J = 8.1 Hz, 1.7 Hz, 1H, CHarom), 8.89 (d, J = 1.4 
Hz, 1H, CHarom) ppm. 13CNMR (CDCl3, 75 MHz, 25°C): δ 14.4 (CH3), 26.5 (NCH3), 
61.7 (CH2), 85.5 (CH=C), 110.3 (Carom), 121.9 (Carom), 123.9 (Carom), 136.6 (Carom), 
137.2 (Carom), 141 (C=C), 145.6 (Carom), 165.4 (OC=O), 166.8 (C=O) ppm. HRMS: 
exact mass calculated for (C13H12INNaO3) requires m/z 379.9760, found m/z 379.9763. 
 (E)-ethyl 2-(1-methyl-2-oxo-5-(trifluoromethoxy)indolin-3-ylidene)acetate, 149 
Following the above above general procedure, the single E 
diastereoisomer 149 was obtained as a red-orange solid in 67% 
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yield after purification (nHexane/EtOAc=1/1). IR (CHCl3): ˜ n = 3029, 3011, 2984, 
1712, 1655, 1618, 1484, 1467, 1371, 1347, 1223 cm1. 1H NMR (CDCl3, 300 MHz, 
25°C): δ 1.36 (t, J = 7.1 Hz, 3H, CH3CH2O), 3.23 (s, 3H, CH3N), 4.33 (q, J = 7.1 Hz, 
2H, CH3CH2O), 6.77 (d, J = 8.5 Hz, 1H, CHarom), 6.95 (s, 1H, CH=C), 7.21-7.34 (m, 
1H, CHarom), 8.53 (s, 1H, CHarom) ppm.13C NMR (CDCl3, 75 MHz, 25°C): δ 14.3 (CH3), 
26.6 (NCH3), 61.7 (CH2), 108.6 (CH=C), 121.8 [(CF3),q, JCF = 127.8  Hz], 122.8 
(2xCarom), 124.5 (Carom), 125.4 (Carom), 137.1 (Carom), 144.7 (C=C), 144.9 (Carom), 165.5 
(OC=O), 167.5 (C=O) ppm. HRMS: exact mass calculated for (C14H12FNNaO4) 
requires m/z 338.0616, found m/z 338.0617.80 
 (E)-ethyl 2-(7-fluoro-1-methyl-2-oxoindolin-3-ylidene)acetate, 154 
Following the above above general procedure, the single E 
diastereoisomer 154 was obtained as an orange-red solid in 71% 
yield after purification (nHexane/EtOAc=95/5). IR (CHCl3): ˜ n = 
3034, 3010, 2983, 1711, 1657, 1624, 1590, 1465, 1368, 1349 cm1. 
1H NMR (CDCl3, 300 MHz, 25°C): δ 1.35 (t, J = 7.1 Hz, 3H, 
CH3CH2O), 3.44 (d, J = 2.9 Hz, 3H, CH3N), 4.31 (q, J = 7.1 Hz, 2H, CH3CH2O), 6.88-
7.02 (m,1H, CHarom), 6.93 (s, 1H, CH=C), 7.03-7.15 (m, 1H, CHarom), 8.36 (d, J = 7.8 
Hz, 1H, CHarom) ppm. 13C NMR (CDCl3, 75 MHz, 25°C): δ 14.3 (CH3), 29.0 (d, JCF = 
6.2 Hz, NCH3), 61.5 (CH2), 120.3 [(CH=C), d, JCF = 19.2 Hz], 122.7 [(Carom), d, JCF = 
3.5 Hz], 123.3 [(Carom), d, JCF = 6.2 Hz], 124.0 (Carom), 124.8 [(Carom), d, JCF = 3.1 Hz)] 
132.7 (Carom), 137.2(C=C), 147.8 [(Carom),d, JCF = 242.7 Hz], 165.5 (OC=O), 167.3 
(C=O) ppm. HRMS: exact mass calculated for (C13H12FNNaO3) requires m/z 272.0699, 
found m/z 272.0701.80 
(E)-ethyl 2-(7-chloro-1-methyl-2-oxoindolin-3-ylidene)acetate, 155 
Following the above above general procedure, the single E 
diastereoisomer 155 was obtained as a red-orange solid in 61% 
yield after purification (nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 
30334, 3002, 2951, 1710, 1649, 1601, 1455, 1366, 1346 cm1.  1H 
NMR (CDCl3, 300 MHz, 25°C): δ 1.35 (t, J = 7.1 Hz, 3H, 
CH3CH2O), 3.60 (s, 3H, CH3N), 4.30 (q, J = 7.1 Hz, 2H, CH3CH2O), 6.93 (s, 1H, 
CH=C), 6.95 (t, J = 7.7 Hz, 1H, CHarom), 7.26 (dd, J = 7.7 Hz, 0.7 Hz, 1H, CHarom), 8.52 
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(dd, J = 7.7 Hz, 0.7 Hz, 1H, CHarom) ppm. 13C NMR (CDCl3, 75 MHz, 25°C): δ 14.3 
(CH3), 30.0 (NCH3), 61.4 (CH2), 115.7 (CH=C), 122.6 (Carom), 123.6 (Carom), 123.8 
(Carom),  127.3 (Carom), 134.5 (Carom), 136.5 (C=C), 141.6 (Carom), 165.4 (OC=O), 167.9 
(C=O) ppm HRMS: exact mass calculated for (C13H12ClNNaO3) requires m/z 288.0403, 
found m/z 288.0401.80 
(E)-ethyl 2-(7-bromo-1-methyl-2-oxoindolin-3-ylidene)acetate, 156 
Following the above above general procedure, the single E 
diastereoisomer 156 was obtained as reddish solid in 56% yield after 
purification (nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3031, 3013, 
3003, 2980, 1709, 1654, 1602, 1472,1452, 1347, 1265 cm1. 1H 
NMR (CDCl3, 300 MHz, 25°C): δ 1.34 (t, J = 7.1 Hz, 3H, 
CH3CH2O), 3.61 (s, 3H, CH3N), 4.30 (q, J = 7.1 Hz, 2H, CH3CH2O), 6.88 (t, J = 7.9 
Hz, 1H, CHarom), 6.92 (s, 1H, CH=C), 7.44 (dd, J = 7.9 Hz, 1.1 Hz, 1H, CHarom), 8.57 
(dd, J = 7.9 Hz, 1.1 Hz, 1H, CHarom) ppm. 13C NMR (CDCl3, 75 MHz, 25°C): δ 14.3 
(CH3), 30.2 (NCH3), 61.4 (CH2), 102.5 (CH=C), 122.9 (Carom),  123.7 (Carom),  123.9 
(Carom),  127.8 (Carom),  136.4 (Carom),  137.9 (C=C),  143.1 (Carom),  165.4 (OC=O), 
168.0 (C=O) ppm. HRMS: exact mass calculated for (C13H12BrNNaO3) requires m/z 
331.9898, found m/z 331.9896.80 
 (E)-ethyl 2-(1-phenyl-2-oxoindolin-3-ylidene)acetate, 210 
Following the above above general procedure, the single E 
diastereoisomer 210 was obtained as an orange solid in 40% yield 
after purification (nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3035, 
3010, 1725, 1711, 1608, 1507, 1370, 1341 cm1. 1H NMR (CDCl3, 
300 MHz, 25°C): δ 1.37 (t, J = 7.0 Hz, 3H, CH3CH2O), 4.33 (q, J = 
7.1 Hz, 2H, CH3CH2O), 6.77 (d, J = 7.4 Hz, 1H, CHarom), 6.98 (s, 1H, CH=C), 7.08 (dt, 
J = 7.7 Hz, 0.9 Hz, 1H, CHarom), 7.27 (dt, J = 7.8 Hz, 1.2 Hz, 1H, CHarom), 7.35-7.45 (m, 
3H, CHarom), 7.47-7.57 (m, 2H, CHarom), 8.63 (d, J = 7.8 Hz, 1H, CHarom) ppm. 13C 
NMR (CDCl3, 75 MHz, 25°C): δ 14.4 (CH3), 61.4 (CH2), 109.7 (CH=C), 120.1 (Carom),  
123.2 (Carom),  123.4 (Carom),  126.8 (Carom),  128.5 (Carom),  129.1 (Carom),  129.9 (Carom),  
132.5 (Carom),  134.2 (Carom),  137.8 (C=C), 146.2 (Carom),  165.8 (OC=O), 167.1 (C=O) 
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ppm. HRMS: exact mass calculated for (C18H15NNaO3) requires m/z 316.0950, found 
m/z 316.0952.80 
(E)-ethyl 2-(1-benzyl-2-oxoindolin-3-ylidene)acetate, 211 
Following the above above general procedure, the single E 
diastereoisomer 211 was obtained as an orange solid in 80% yield 
after purification (nHexane/EtOAc=7/3). IR (CHCl3): ˜ n = 3024, 
3013, 1706, 1604, 1470, 1341 cm1. 1H-NMR (CDCl3, 300 MHz, 
25°C): δ 1.36 (t, J = 7.6  Hz, 3H, CH3CH2O), 4.32 (q, J = 7.6 Hz, 2H, 
CH3CH2O), 4.92 (s, 2H, CH2Ph), 6.67 (d, J = 7.9 Hz, 1H, CHarom), 6.97 (s, 1H, HC=C), 
7.01 (dt, J = 7.7 Hz, 1.0 Hz, 1H, CHarom), 7.19-7.36 (m, 6H, CHarom), 8.55 (ddd, J = 7.8 
Hz, 0.6 Hz, 0.5 Hz, 1H, CHarom) ppm. 13C NMR (CDCl3, 75 MHz, 25°C): δ 14.4 (CH3), 
44.0 (Cbenz), 61.4 (CH2), 109.3 (CH=C), 120.2 (Carom),  123.0 (Carom),  123.1 (Carom),  
127.4 (Carom),  127.9 (Carom),  129.0 (Carom),  129.1 (Carom),  132.5 (Carom),  135.6 (Carom),  
137.8 (C=C),  145.3 (Carom), 165.8 (OC=O),  167.9 (C=O) ppm. HRMS: exact mass 
calculated for (C19H17NNaO3) requires m/z 330.1106, found m/z 330.1102.80 
(E)-ethyl 2-(1-benzyl-5-isopropyl-2-oxoindolin-3-ylidene)acetate, 213 
Following the above above general procedure, the single E 
diastereoisomer 213 was obtained as an orange solid in 67% 
yield after purification (nHexane/EtOAc=8/2). 1H-NMR (CDCl3, 
300 MHz, 25°C): δ 1.20 [d, J = 6.9 Hz, 6H, (CH3)2CH], 1.37 (t, 
J = 7.1 Hz, 3H, CH3CH2O), 2.87 [sept, J = 6.9 Hz, 1H, 
(CH3)2CH], 4.33 (q, J = 7.1 Hz, 2H, CH3CH2O), 4.90 (s, 2H, CH2Ph), 6.59 (d, J = 8.1 
Hz, 1H, CHarom), 6.94 (s, 1H, HC=C), 7.10 (dd, J = 8.0 Hz, 1.5 Hz, 1H, CHarom), 7.20-
7.37 (m, 5H, CHarom), 8.45 (d, J = 1.5 Hz, 1H, CHarom) ppm. 13C NMR (CDCl3, 75 
MHz, 25°C): δ 14.5 (CH3), 24.3 (2xCHCH3), 34.1 (CHCH3), 44.1 (CH2benz), 61.4 (CH2), 
109.1 (CH=C), 120.2 (Carom),  122.7 (Carom),  127.4 (Carom),  127.5 (Carom),  127.9 
(Carom),  129.0 (Carom), 130.4 (Carom),  135.8 (Carom),  138.2 (Carom),  143.4, 143.9 (Carom),  
166.0 (OC=O), 168.1 (C=O) ppm. HRMS: exact mass calculated for (C22H23NNaO3) 
requires m/z 372.1576, found m/z 372.1579.80 
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(E)-ethyl 2-(1-benzyl-5-methoxy-2-oxoindolin-3-ylidene)acetate, 214 
Following the above general procedure, the single E 
diastereoisomer 214 was obtained as an orange solid in 98% 
yield after purification (nHexane/EtOAc=8/2). IR (CHCl3): ˜ n
= 3027, 3009, 2987, 2963, 1729, 1708, 1650, 1612, 1594, 
1483, 1345 cm1. 1H-NMR (CDCl3, 300 MHz, 25°C): δ 1.35 
(t, J = 7.1 Hz, 3H, CH3CH2O), 3.77 (s, 3H, OCH3), 4.31 (q, J = 7.1 Hz, 2H, CH3CH2O), 
4.88 (s, 2H, CH2Ph), 6.54 (d, J = 8.7 Hz, 1H, CHarom), 6.79 (dd, J = 8.7 Hz, 2.3 Hz, 1H, 
CHarom), 6.95 (s, 1H, HC=), 7.177.36 (m, 5H, CHarom), 8.26 (d, J = 2.3  Hz, 1H, 
CHarom) ppm. 13C NMR (CDCl3, 75 MHz, 25°C): δ 14.4 (CH3), 44.1 (CH2benz), 56.1 
(OCH3), 61.4 (CH2), 109.8 (CH=C), 114.8 (Carom), 118.5 (Carom), 120.9 (Carom), 123.2 
(Carom), 127.4 (Carom), 127.9 (Carom), 129.0 (Carom), 135.7 (Carom), 138.4 (Carom), 139.2 
(C=C), 156.0 (Carom), 165.8 (OC=O), 167.8 (C=O) ppm. HRMS: exact mass calculated 
for (C20H19NNaO3) requires m/z 360.1212, found m/z 360.1210.80 
(E)-ethyl 2-(5-methoxy-1-(3-nitrobenzyl)-2-oxoindolin-3-ylidene)acetate, 215 
Following the above general procedure, the single E 
diastereoisomer 215 was obtained as an orange solid in 
80% yield after purification (nHexane/EtOAc=8/2). IR 
(CHCl3): ˜ n = 3034, 3009, 2952, 2922, 2852, 1718, 1700, 
1650, 1593, 1482, 1371 cm1. 1H NMR (CDCl3, 300 MHz, 
25°C): δ 1.37 (t, J = 7.1 Hz, 3H, CH3CH2O), 3.81 (s, 3H, 
OCH3), 4.33 (q, J = 7.1 Hz, 2H, CH3CH2O), 5.32 (s, 2H, 
NCH2), 6.45 (d, J = 8.5 Hz, 1H, CHarom), 6.82 (dd, J = 8.5 Hz, 2.6 Hz, 1H, CHarom), 6.98 
(s, 1H, CH=C), 7.17 (d, J = 6.9 Hz, 1H, CHarom), 7.377.55 (m, 2H, CHarom), 8.16 (dd, J 
= 7.9 Hz, 1.6 Hz, 1H, CHarom), 8.33 (d, J = 2.6 Hz, 1H, CHarom) ppm. 13C NMR (CDCl3, 
75 MHz, 25°C): δ 14.4 (CH3), 41.6 (CH2benz), 56.1 (OCH3), 61.5 (CH2), 109.4 (CH=C), 
115.1 (Carom),  118.6 (Carom),  120.9 (Carom),  123.7 (Carom), 125.8 (Carom),  127.9 (Carom),  
128.7 (Carom),  131.6 (Carom),  134.2 (Carom),  137.9 (Carom),  138.5(Carom),  148.2, 156.4 
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(Carom),  165.7 (OC=O), 168.0 (C=O) ppm. HRMS: exact mass calculated for 
(C20H18N2NaO6) requires m/z 405.1063, found m/z 405.1060.80 
(E)-ethyl 2-(1-(2,4-dichlorobenzyl)-2-oxoindolin-3-ylidene)acetate, 212 
Following the above general procedure, the single E 
diastereoisomer 212 was obtained as an orange solid in 82% 
yield after purification (nHexane/EtOAc=7/3). IR (CHCl3): ˜ n
= 3032, 3010, 2397, 1709, 1698, 1609, 1470, 1372 cm1. 1H-
NMR (CDCl3, 300 MHz, 25°C): δ 1.36 (t, J = 7.1 Hz, 3H, 
CH3CH2O), 4.33 (q, J = 7.1 Hz, 2H, CH3CH2O), 4.98 (s, 2H, 
CH2Ph), 6.60 (d, J = 7.8 Hz, 1H, CHarom), 6.92–7.17 (m, 4H, CH=C, CHarom), 7.26 (t, J 
= 7.8 Hz, 1H, CHarom), 7.40 (t, J = 2.1 Hz, 1H, CHarom), 8.57 (d, J = 7.8 Hz, 1H, CHarom) 
ppm. 13C NMR (CDCl3, 75 MHz, 25°C): δ 14.4 (CH3), 41.1 (CH2benz), 61.5 (CH2), 
109.1 (CH=C), 120.2 (Carom),  123.4 (2xCarom), 127.8 (Carom),  129.0 (Carom),  129.1 
(Carom),  129.7 (Carom),  131.6 (Carom),  132.7 (Carom),  133.7 (Carom),  134.3 (Carom),  
137.5 (C=C),  144.7 (Carom),  165.7 (OC=O), 168.0 (C=O) ppm. HRMS: exact mass 
calculated for (C19H15Cl2NNaO3) requires m/z 398.0327, found m/z 398.0331.80 
(E)-ethyl 2-(1-methyl-2-oxo-1H-benzo[g]indol-3(2H)-ylidene)acetate, 181 
Following the above general procedure, the single E 
diastereoisomer 181 was obtained as an orange solid in 51% yield 
after purification (nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3038, 
3027, 1710, 1644, 1620, 1590, 1466, 1377 cm1. 1H-NMR 
(CDCl3, 300 MHz, 25°C): δ1.39 (t, J = 6.8  Hz, 3H, CH3CH2O); 
3.83 (s, 3H, NCH3); 4.35 (q, J = 6.8  Hz, 2H, CH3CH2O); 6.97 (s, 1H, CH=C); 7.42-
7.53 (m, 3H, CHarom); 7.82 (d, J = 8.2  Hz, 1H, CHarom); 8.41 (d, J = 8.2  Hz, 1H, 
CHarom); 8.63 (d, J = 8.6  Hz, 1H, CHarom) ppm. 13CNMR (CDCl3, 75 MHz, 25°C): δ 
14.3 (CH3), 31.1 (NCH3), 61.4 (CH2), 115.9 (CH=C), 120.9 (Carom), 122.6 (Carom),  
122.8 (Carom),  122.9 (Carom),  124.2 (Carom),  126.1 (Carom),  127.6 (Carom),  129.5 (Carom),  
137.0 (Carom),  137.3 (C=C), 143.5 (Carom),  165.9 (OC=O), 169.4 (C=O) ppm. HRMS: 
exact mass calculated for (C17H15NNaO3) requires m/z 304.0950, found m/z 304.0971. 
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 (E)-ethyl 2-(5-isopropyl-1-methyl-2-oxoindolin-3-ylidene)acetate, 150 
Following the above general procedure, the single E 
diastereoisomer 150 was obtained as an orange solid in 63% 
yield after purification (nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 
3025, 3020, 3011, 1722, 1712, 1612, 1490, 1370 cm1. 1H-NMR 
(CDCl3, 300 MHz, 25°C): δ1.26 (d, J = 7.0 Hz, 6H, (CH3)2CH); 
1.38 (t, J = 7.1 Hz, 3H, CH3CH2O); 2.88 2.98 (m, 1H, (CH3)2CHC); 3.22 (s, 3H, 
NCH3); 4.34 (q, J = 7.0 Hz, 2H, CH3CH2O); 6.72 (d, J = 7.9 Hz, 1H, CHarom); 6.89 (s, 
1H, CH=C); 7.24 (d, J = 7.9 Hz, 1H, CHarom); 8.47 (s, 1H, CHarom) ppm. 13CNMR 
(CDCl3, 75 MHz, 25°C): δ 14.3 (CH3), 24.3 (2xCHCH3), 26.4 (NCH3), 34.0 (CHCH3), 
61.2 (CH2), 108.0 (CH=C), 119.9 (Carom),  122.2 (Carom),  127.2 (Carom),  130.3 (Carom),  
138.3 (Carom), 143.7 (C=C), 144.1 (Carom), 165.8 (OC=O), 167.7 (C=O) ppm. HRMS: 
exact mass calculated for (C16H19NNaO3) requires m/z 296.1263, found m/z 296.1265.  
(E)-ethyl 2-(2-oxoindolin-3-ylidene)acetate, 223 
Following the above general procedure, the single E diastereoisomer 
223 was obtained as an orange solid in 74% yield after purification 
(nHexane/EtOAc=7/3). IR (CHCl3): ˜ n =  3034, 3010, 1707, 1609, 
1471, 1371  cm1. 1H-NMR (CDCl3, 300 MHz, 25°C): δ11.37 (t, J = 
7.1  Hz, 3H, CH3CH2O); 4.31-4.36 (q, J = 7.1 Hz, 2H, CH3CH2O); 
6.86-6.87(m, 2H, CH=C, CHarom); 7.04 (t, J = 7.7 Hz, 1H, CHarom); 7.31 (t, J = 7.7  Hz, 
1H, CHarom); 8.53 (d, J = 7.8  Hz, 1H, CHarom); 8.74 (bs, 1H, NH) ppm. 13CNMR 
(CDCl3, 75 MHz, 25°C): δ 14.3 (CH3), 61.4 (CH2), 110.3 (CH=C), 120.5 (Carom), 122.8 
(Carom), 123.0 (Carom), 129.2 (Carom), 132.7 (Carom), 138.3 (C=C), 143.5 (Carom), 165.7 
(OC=O), 169.5 (C=O) ppm. HRMS: exact mass calculated for (C19H15Cl2NNaO3) 
requires m/z 398.0327, found m/z 398.0331.107 
(E)-ethyl 2-(5-fluoro-2-oxoindolin-3-ylidene)acetate, 225 
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Following the above general procedure, the single E 
diastereoisomer 225 was obtained as an orange solid in 54% yield 
after purification (nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3429, 
3028, 3017, 1709, 1655, 1618, 1485, 1471, 1370 cm1. 1H-NMR 
(CDCl3, 300 MHz, 25°C): δ1.38 (t, J = 7.1 Hz, 3H, CH3CH2O), 
4.34 (q, J = 7.0 Hz, 2H, CH3CH2O), 6.71–6.83 (m, 1H, CHarom), 6.91 (s, 1H), 7.05 (t, J 
= 8.1 Hz, 1H, CHarom), 8.23 (bs, 1H, NH), 8.37 (d, JHF = 9.0 Hz, 1H, CHarom) ppm. 
13CNMR (CDCl3, 75 MHz, 25°C): δ 14.3 (CH3), 61.6 (CH2), 110.6 [(CH=C), d, JC-F = 
7.9 Hz], 116.7 [(Carom), d, JC-F = 26.8 Hz], 118.6 (Carom), 119.0 [(Carom), d, JC-F = 24.7 
Hz], 124.2 (Carom), 133.8 (Carom),  139.4 (C=C),  158.9 [(Carom), d, JC-F = 243.7 Hz], 
165.4 (OC=O), 168.2 (C=O) ppm. HRMS: exact mass calculated for (C12H10FNNaO3) 
requires m/z 258.0542, found m/z 258.0544.111 
(E)-ethyl 2-(5-chloro-2-oxoindolin-3-ylidene)acetate, 226 
Following the above general procedure, the single E 
diastereoisomer 226 was obtained as an orange solid in 80% 
yield after purification (nHexane/EtOAc=7/3). IR (CHCl3): ˜ n = 
3443, 3034, 3012, 1716, 1649, 1608, 1476, 1439, 1368, 1343 
cm1. 1H-NMR (CDCl3, 300 MHz, 25°C): δ1.38 (t, J = 7.0 Hz, 
3H, CH3CH2O), 4.35 (q, J = 7.0 Hz, 2H, CH3CH2O), 6.79 (d, J = 8.4 Hz, 1H, CHarom), 
6.91 (s, 1H), 7.31 (d, J = 8.4 Hz, 1H, CHarom), 7.90 (bs, 1H, NH), 8.61 (s, 1H, CHarom) 
ppm. 13CNMR (CDCl3, 75 MHz, 25°C): δ 14.3 (CH3), 61.7 (CH2), 111.0 (CH=C), 121.8 
(Carom), 124.4 (Carom), 128.5 (Carom), 129.3 (Carom), 131.2 (Carom), 132.4 (Carom), 137.2 
(C=C), 141.6 (Carom), 165.4 (OC=O), 168.5 (C=O) ppm. HRMS: exact mass calculated 
for (C12H10ClNNaO3) requires m/z 274.0247, found m/z 274.0244.111 
(E)-ethyl 2-(5-iodo-2-oxoindolin-3-ylidene)acetate, 227 
Following the above general procedure, the single E 
diastereoisomer 227 was obtained as an orange solid in 70% yield 
after purification (nHexane/EtOAc=7/3). IR (CHCl3): ˜ n 3443, 
3034, 3012, 1716, 1649, 1608, 1476, 1439, 1368, 1343 cm1. 1H-
NMR (CDCl3, 300 MHz, 25°C): δ1.38 (t, J = 7.0 Hz, 3H, 
CH3CH2O), 4.35 (q, J = 7.0 Hz, 2H, CH3CH2O), 6.64 (d, J = 8.4 Hz, 1H, CHarom), 6.89 
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(s, 1H), 7.63-7.68 (m, 2H, CHarom), 8.90 (bs, 1H, NH) ppm. 13CNMR (CDCl3, 75 MHz, 
25°C): δ 14.4 (CH3), 61.7 (CH2), 112.1 (CH=C), 122.6 (Carom), 124.3 (Carom), 134.2 
(Carom), 137.7 (Carom), 140.0 (Carom), 141.1 (C=C), 142.7 (Carom), 165.4 (OC=O),  168.2 
(C=O) ppm. HRMS: exact mass calculated for (C12H10INNaO3) requires m/z 365.9603, 
found m/z 365.9607. 
(E)-ethyl 2-(5-trifluoromethoxy-2-oxoindolin-3-ylidene)acetate, 228 
Following the above general procedure, the single E 
diastereoisomer 228 was obtained as an orange solid in 44% 
yield after purification (nHexane/EtOAc=7/3). IR (CHCl3): ˜ n = 
3443, 3026, 3020, 1724, 1709, 1617, 1470, 1375 cm1. 1H-
NMR (CDCl3, 300 MHz, 25°C): δ1.38 (t, J = 7.1 Hz, 3H, 
CH3CH2O), 4.35 (q, J = 7.1 Hz, 2H, CH3CH2O), 6.85 (d, J = 9.1 Hz, 1H, CHarom), 6.94 
(s, 1H), 7.22 (d, J = 7.8 Hz, 1H, CHarom), 7.80 (bs, 1H, NH), 8.55 (s, 1H) ppm. 13CNMR 
(CDCl3, 75 MHz, 25°C): δ 14.3 (CH3), 61.7 (CH2), 110.5 (CH=C), 120.7 (q, JCF = 
256.9 Hz, OCF3), 121.5 (Carom), 123.0 (Carom), 124.7 (Carom), 125.7 (Carom), 137.3 
(Carom), 141.8 (C=C), 144.8 (Carom), 165.3 (CO2), 168.8 (C=O) ppm. HRMS: exact mass 
calculated for (C13H10F3NNaO5) requires m/z 324.0460, found m/z 324.0465. 
(E)-ethyl 2-(7-fluoro-2-oxoindolin-3-ylidene)acetate, 229 
Following the above general procedure, the single E diastereoisomer 
229 was obtained as an orange solid in 80% yield after purification 
(nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3433, 3029, 3020, 2983, 
1711, 1657, 1626, 1455, 1358 cm1. 1H-NMR (CDCl3, 300 MHz, 
25°C): δ1.38 (t, J = 7.0 Hz, 3H, CH3CH2O), 4.34 (q, J = 7.0 Hz, 2H, 
CH3CH2O), 6.94 (s, 1H), 6.97–7.04 (m, 1H, CHarom), 7.12 (t, J = 8.3 Hz, 1H, CHarom), 
7.82 (bs, 1H, NH), 8.37 (d, J = 8.3 Hz, 1H, CHarom) ppm. 13CNMR (CDCl3, 75 MHz, 
25°C): δ 14.3 (CH3) 61.5 (CH2), 119.4 [d, JCF = 16.9 Hz, (CH=C)], 122.9 (d, JCF = 3.7 
Hz, Carom), 123.3 (d, JCF = 5.7 Hz, Carom), 124.4 (HC=C), 124.9 (d, JCF = 3.3  Hz, Carom), 
130,7 (d, JCF = 12.5 Hz, Carom), 137.5 (d, JCF = 3.4 Hz, C=C), 147.1 (d, JCF = 243.3 Hz, 
Carom), 165.4 (OC=O), 168.5 (C=O)ppm. HRMS: exact mass calculated for 
(C12H10FNNaO3) requires m/z 258.0542, found m/z 258.0545.112 
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 (E)-ethyl 2-(7-chloro-2-oxoindolin-3-ylidene)acetate, 230 
Following the above general procedure, the single E diastereoisomer 
230 was obtained as an orange solid in 42% yield after purification 
(nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3445, 3030, 3020, 1710, 
1649, 1601, 1455, 1366, 1346 cm1. 1H-NMR (CDCl3, 300 MHz, 
25°C): δ1.37 (t, J = 7.0 Hz, 3H, CH3CH2O), 4.33 (q, J = 7.0 Hz, 2H, 
CH3CH2O), 6.93 (s, 1H, HC=C); 6.99 (t, 1H, J = 7.7 Hz, CHarom);  7.30 (d, J = 7.7 Hz, 
1H, CHarom), 8.46 (d, J = 7.7 Hz, 1H, CHarom) 8.65 (bs, 1H, NH), ppm. 13CNMR 
(CDCl3, 75 MHz, 25°C): δ 14.3 (CH3), 61.6 (CH2), 115.5 (HC=C), 121.9 (Carom), 123.0 
(Carom), 127.4 (Carom), 127.7 (Carom), 134.1 (Carom), 137.9 (Carom), 141.1 (C=C), 165.4 
(OC=O), 168.3 (C=O) ppm. HRMS: exact mass calculated for (C12H10ClNNaO3) 
requires m/z 274.0247, found m/z 274.0249.112 
(E)-ethyl 2-(7-bromo-2-oxoindolin-3-ylidene)acetate, 231 
Following the above general procedure, the single E diastereoisomer 
231 was obtained as an orange solid in 50% yield after purification 
(nHexane/EtOAc=7/3). IR (CHCl3): ˜ n = 3440, 3027, 3016, 2980, 
1709, 1654, 1615, 1472,1452, 1347 cm1. 1H-NMR (CDCl3, 300 
MHz, 25°C): δ1.37 (t, J = 7.1 Hz, 3H, CH3CH2O), 4.33 (q, J = 7.1 Hz, 
2H, CH3CH2O), 6.91 (s, 1H, C-(9)), 6.96 (t, J = 7.7 Hz, 1H, CHarom), 7.45 (d, J = 8.5 
Hz, 1H, CHarom), 7.75 (bs, 1H, NH), 8.52 (d, J = 8.5 Hz, 1H, CHarom) ppm. 13CNMR 
(CDCl3, 75 MHz, 25°C): δ 14.3 (CH3), 61.5 (CH2), 103.3 (HC=C), 121.8 (Carom), 124.0 
(Carom), 124.5 (Carom), 127.9 (Carom), 134.9 (Carom), 138.2 (Carom), 142.6 (C=C), 165.3 
(OC=O), 167.9 (C=O)  ppm. HRMS: exact mass calculated for (C12H10BrNNaO3) 
requires m/z 317.9742, found m/z 317.9739. 
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General procedure for preparing 3-ylideneoxindoles 151, 152 
N
O
EtO2C
CH3
O2NPh3P=CHCO2Et
N
O
O
CH3
O2N
toluene
2h 80°C
151173  
To a solution of the corresponding isatin (5 mmol, 1equiv) in toluene (30 mL) was 
added the Wittig reagent (5 mmol, 1 equiv) and the mixture was stirred at reflux. After 
the reaction was complete, the solution was removed under reduced pressure and the 
residue was purified by flash chromatography directly to afford the purified product. 
Characterization of 3-ylideneoxindoles 151, 152 
(E)-ethyl 2-(1-methyl-5-nitro-2-oxoindolin-3-ylidene)acetate, 151 
Following the above general procedure, the single E 
diastereoisomer 151 was obtained as an orange solid in 58% yield 
after purification (nHexane/EtOAc=6/4). IR (CHCl3): ˜ n = 3025, 
3020, 3011, 1724, 1715, 1613, 1523, 1366, 1340 cm1. 1H-NMR 
(CDCl3, 300 MHz, 25°C):   1.41 (t, J = 7.1 Hz, 3H, 
CH3CH2O); 3.32 (s, 3H, NCH3); 4.39 (q, J = 7.1 Hz, 2H, CH3CH2O); 6.91 (d, J = 8.7 
Hz, 1H, CHarom); 7.04 (s, 1H, CH=C); 8.35 (dd, J = 8.7, 2.3 Hz, 1H, CHarom); 9.48 (d, J 
= 2.3 Hz, 1H, CHarom) ppm. 13CNMR (CDCl3, 75 MHz, 25°C): δ 14.3 (CH3), 26.9 
(NCH3), 62.1 (CH2), 108.0 (CH=C), 120.1 (Carom),  124.6 (Carom),  126.0 (Carom),  128.7 
(Carom),  135.6 (Carom),  143.8 (C=C), 150.7 (Carom),  165.0 (OC=O), 167.7 (C=O) ppm. 
HRMS: exact mass calculated for (C13H12N2NaO5) requires m/z 299.0644, found m/z 
299.0646.113 
(E)-ethyl 2-(5-methoxy-1-methyl-2-oxoindolin-3-ylidene)acetate, 152114 
Following the above general procedure, the single E 
diastereoisomer 152 was obtained as an orange solid in 90% yield 
after purification (nHexane/EtOAc=6/4). IR (CHCl3): ˜ n = 3019, 
2942, 2819, 1708, 1597, 1479, 1368, 1344, 1029, 772 cm1. 1H-
NMR (CDCl3, 300 MHz, 25°C):   1.37 (t, J = 7.2 Hz, 3H, CH3CH2O); 3.21 (s, 3H, 
N
O
EtO2C
CH3
O2N
151
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NCH3), 3.84 (s, 3H, OCH3), 4.33 (q, J = 7.2 Hz, 2H, CH3CH2O), 6.69 (d, J = 10.0 Hz, 
1H, CHarom), 6.91 (s, 1H, CH=C), 6.91-6.96 (m, 1H, CHarom), 8.28 (s, 1H, CHarom) ppm. 
General procedure for preparing 3-ylideneoxindoles 153, 232 
 
In a round bottomed flask 150 mg (0,65 mmol) of isatin were stirred in 1mL of acetic 
acid. After the addition of 226 mg (0,65 mmol) of phosphorane, the mixture was stirred 
at 80°C for two hours. Then the solvent was removed in vacuo and the crude was 
purified via flash column chromatography (eluent 8/2 hexane/EtOAc), leading to 172 
mg (0,56 mmol) of pure product. 
Characterization of 3-ylideneoxindoles 153, 232 
(E)-ethyl 2-(5,7-dichloro-1-methyl-2-oxoindolin-3-ylidene)acetate, 153 
Following the above general procedure, the single E 
diastereoisomer 153 was obtained as an orange solid in 89% yield 
after purification (nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3029, 
3016, 1726, 1714, 1574, 1453, 1374, 1339 cm1. 1H-NMR 
(CDCl3, 300 MHz, 25°C): δ1.36 (t, J = 6.9 Hz, 3H, CH3CH2O); 
3.54 (s, 3H, NCH3); 4.31 (q, J = 6.9 Hz, 2H, CH3CH2O); 6.90 (s, 1H, CH=C); 7.23 (s, 
1H, CHarom); 8.51 (s, 1H, CHarom) ppm. 13CNMR (CDCl3, 75 MHz, 25°C): δ 14.4 (CH3), 
30.0 (NCH3), 61.9 (CH2), 116.1 (CH=C), 123.3 (Carom), 125.4 (Carom),  127.6 (Carom),  
128.4 (Carom),  133.7 (Carom),  135.7 (C=C), 140.3 (Carom),  165.2 (OC=O), 167.5 (C=O) 
ppm. HRMS: exact mass calculated for (C17H15NNaO3) requires m/z 322.0014, found 
m/z 322.0017.  
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(E)-ethyl 2-(5,7-dichloro-2-oxoindolin-3-ylidene)acetate, 232 
Following the above general procedure, the single E 
diastereoisomer 232 was obtained as an orange solid in 70% yield 
after purification (nHexane/EtOAc=7/3). IR (CHCl3): ˜ n = 430, 
3029, 3010, 1736, 1710, 1612, 1450, 1291 cm1. 1H-NMR 
(CDCl3, 300 MHz, 25°C): δ1.38 (t, J = 6.6 Hz, 3H, CH3CH2O), 
4.35 (m, 2H, CH3CH2O), 6,96 (s, 1H, CH=C); 7,35 (s, 1H, CHarom); 8,16 (bs, 1H, NH); 
8,54 (s, 1H, CHarom) ppm. 13CNMR (CDCl3, 75 MHz, 25°C): δ 14.3 (CH3), 61.9 (CH2), 
115.7 (HC=C), 122.4 (Carom),  125.9 (Carom), 127.7 (Carom), 128.6 (Carom), 131.6 (Carom), 
137.0 (Carom), 139.5 (Carom), 165.1 (OC=O), 167.6 (C=O) ppm. HRMS: exact mass 
calculated for (C12H9Cl2NNaO3) requires m/z 307.9857, found m/z 307.9859. 115 
General procedure for preparing 3-ylideneoxindoles 233-237 
 
To a stirred solution of tetraethyl methylenebis(phosphonate) (2.6 mmol, 749 mg) in 
anhydrous THF (2 mL) under Ar at 0 °C, LDA (2 m in THF, 1.43 mL, 2.86 mmol) was 
added dropwise. After 30 min, the mixture was warmed to room temp., stirred for an 
additional 30 min and cooled again to 0 °C. At this temperature, a solution of isatine 7 
(2 mmol) in anhydrous THF (8 mL) was slowly added. The reaction mixture was 
allowed to reach room temp., and stirred until complete (monitored by TLC; 
hexane/ethyl acetate). Saturated aqueous NH4Cl salution was slowly added, and the 
aqueous layer was extracted with ethyl acetate (3x50 mL). The combined organic 
phases were dried with anhydrous Na2SO4 and concentrated under reduced pressure to 
give the crude product, which was subsequently purified by flash chromatography on 
silica gel (hexane/ethyl acetate). 
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Characterization of 3-ylideneoxindoles 233-237 
(E)-diethyl ((1-methyl-2-oxoindolin-3-ylidene)methyl)phosphonate, 233 
Following the above general procedure1, the single E 
diastereoisomer 233 was obtained as a pale orange solid in 66% 
yield after purification (nHexane/EtOAc=1/1). 1H-NMR (CDCl3, 
300 MHz, 25°C): δ 1.33 (t, J = 7.1 Hz, 3H, CH3CH2O), 1.34 (t, J = 
7.1 Hz, 3H, CH3CH2O), 3.22 (s, 3H, CH3N), 4.06–4.23 [m, 4H, 
(CH3CH2O)2P], 6.78 (d, J = 7.6 Hz, 1H, CHarom), 6.80 (d, JHP = 13.4 Hz, 1H, CHP=O), 
7.06 (dt, J = 7.6, 1.1 Hz, 1H, CHarom), 7.36 (m, 1H, CHarom), 8.45 (d, J = 7.6 Hz, 1H, 
CHarom) ppm. 
(E)-diethyl ((2-oxo-1-phenylindolin-3-ylidene)methyl)phosphonate, 234 
Following the above general procedure1, the single E 
diastereoisomer 234 was obtained as a pale orange solid in 76% 
yield after purification (nHexane/EtOAc=1/1). 1H-NMR (CDCl3, 
300 MHz, 25°C): δ 1.21 [t, J = 7.1 Hz, 6H, (CH3CH2O)2P], 4.13–
4.28 [m, 4H, (CH3CH2O)2P], 6.78 (d, J = 7.9 Hz, 1H, CHarom), 6.91 
(d, JHP = 13.1 Hz, 1H, CHP=O), 7.10 (dt, J = 7.7, 1.0 Hz, 1H, CHarom), 7.24–7.33 (m, 
1H, CHarom), 7.37–7.46 (m, 3H, CHarom), 7.49–7.58 (m, 2H, CHarom), 8.55 (d, J = 7.7 Hz, 
1H, ArH)ppm. 
(E)-diethyl ((2-oxo-1-benzylindolin-3-ylidene)methyl)phosphonate, 235 
Following the above general procedure1, the single E 
diastereoisomer 235 was obtained as a pale orange solid in 56% 
yield after purification (nHexane/EtOAc=1/1). 1H-NMR (CDCl3, 
300 MHz, 25°C): δ 1.36 [t, J = 7.0 Hz, 6H, (CH3CH2O)2P], 4.07–
4.26 [m, 4H, (CH3CH2O)2P], 4.93 (s, 2H, CH2N), 6.69 (d, J = 7.9  
Hz, 1H, CHarom), 6.88 (d, JHP = 13.3 Hz, 1H,CHP=O), 7.04 (dt, J = 7.7, 0.96 Hz, 1H, 
CHarom), 7.21–7.34 (m, 6H, CHarom), 8.47 (d, J = 7.7 Hz, 1H, CHarom) ppm. 
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(E)-diethyl ((1-(2,4-dichlorobenzyl)-2-oxoindolin-3-ylidene)methyl)phosphonate, 
236 
Following the above general procedure1, the single E 
diastereoisomer 236 was obtained as a pale orange solid in 
72% yield after purification (nHexane/EtOAc=1/1). 1H-
NMR (CDCl3, 300 MHz, 25°C): δ 1.37 [t, J = 7.1 Hz, 6H, 
(CH3CH2O)2P], 4.10–4.27 [m, 4H, (CH3CH2O)2P], 5.00 (s, 
2H, CH2N), 6.62 (d, J = 7.8 Hz, 1H, CHarom), 6.89 (d, JHP = 
13.0 Hz, 1H, CHP=O), 7.01–7.18 (m, 4H, CHarom), 7.23–7.32 (m, 1H, CHarom), 8.51 (d, 
J = 7.6 Hz, 1H, CHarom) ppm. 
 (E)-diethyl ((5-chloro-1-methyl-2-oxoindolin-3-ylidene)methyl)phosphonate, 237 
Following the above general procedure, the single E 
diastereoisomer 237 was obtained as an orange amorphous solid in 
30% yield after purification (nHexane/EtOAc=6/4). IR (CHCl3): 
˜ n = 1727, 1606 cm1. 1H-NMR (CDCl3, 300 MHz, 25°C): δ 1.34 
[t, J = 7.0 Hz, 6H, (CH3CH2O)2P], 3.20 (s, 3H, CH3N), 4.12–4.21 
[m, 4H, (CH3CH2O)2P], 6.71 (d, J = 8.2 Hz, 1H, CHarom), 6.85 (d, JHP = 13.0 Hz, 1H, 
CHP=O), 7.31 (d, J = 8.2 Hz, 1H, CHarom), 8.49 (s, 1H, CHarom) ppm. 13CNMR (CDCl3, 
75 MHz, 25°C): δ 16.4 (CH3), 26.5 (NCH3), 62.7 (d, JCP = 5.6 Hz, 2xCH2), 109.2 
(HC=C), 121.1 (d, JCP = 7.0 Hz, Carom), 121.4 (Carom, d, JCP = 189.5 Hz), 128.0 (Carom),  
128.5 (Carom),  132.0 (Carom),  140.5 (Carom, d, JCP = 4.9 Hz), 144.2 (Cbenz), 166.2 [(C=O), 
d, JC-P = 25.7 Hz] ppm. HRMS: exact mass calculated for (C14H17ClNNaO4P) requires 
m/z 352.0627, found m/z 352.0631. 
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Procedure for preparing 3-ylideneoxindole 239 
 
In a round bottomed flask, isatine 131 (800 mg), phenyl ethyl ketone (0.7 mL), and a 30 
mol% of piperidine (0.4 mL) were stirred in EtOH, at room temperature, for 24 hours. 
The solvent was evaporated in vacuo, then the crude was then treated with concentrated 
sulphuric acid (4 mL) and stirred for 10 minutes. The reaction mixture was slowly 
poured in could water and extracted with DCM. The organic layers were dried over 
anhydrous Na2SO4 and concentrated under reduced pressure. Purification via flash 
chromatography yielded to the product 239 as a pale yellow solid. 
Characterization of 3-ylideneoxindole 239 
(E)-3-ethylidene-1-methylindol-2-one, 239 
Following the above procedure, the single E diastereoisomer 239 was 
obtained as an orange solid in 74% yield after purification (DCM/Et2O 
= 95/5). 1H-NMR (CDCl3, 300 MHz, 25°C): δ1.37 (t, J = 7.1  Hz, 3H, 
CH3CH2O); 4.31-4.36 (q, J = 7.1 Hz, 2H, CH3CH2O); 6.86-6.87(m, 
2H, CH=C, CHarom); 7.04 (t, J = 7.7 Hz, 1H, CHarom); 7.31 (t, J = 7.7  
Hz, 1H, CHarom); 8.53 (d, J = 7.8  Hz, 1H, CHarom); 8.74 (bs, 1H, NH) ppm.2 
 
 
 
EXPERIMENTAL PART 
 
144 
 
Procedure for preparing 3-yilideneoxindole 224 
 
In a round bottomed flask, 262mg of Boc2O were added drop by drop to a solution of 
223 (217 mg, 1 mmol) and DMAP (12 mg, 0.1 mmol) in CH3CN (10mL). The solution 
was stirred at room temperature overnight. The solvent was removed under reduced 
pressure and the crude was purified via flash chromatography, yielding 314 mg (0.99 
mmol) of clean product as a yellow solid.  
Characterization of 3-yilideneoxindole 224 
(E)-tert-butyl 3-(2-ethoxy-2-oxoethylidene)-2-oxoindoline-1-carboxylate, 224 
Following the above procedure, the single E diastereoisomer 224 was 
obtained as an orange solid in 99% yield after purification 
(nHexane/EtOAc=9/1). IR (CHCl3): ˜ n = 2979, 1757, 1728, 1600, 
1462, 1368, 1328, 1303 cm-1. 1H-NMR (CDCl3, 300 MHz, 25°C): δ 
1.38 (t, J = 7.2 Hz, 3H, CH3CH2O), 1.65 (s, 9H, (CH3)3C), 4.33 (q, J 
= 7.2 Hz, 2H, OCH2CH3), 6.91 (s, 1H, CH=C), 7.17-7.31 (m, 2H, CHarom), 7.41-7.45 
(m, 1H, CHarom), 8.67-8.69 (m, 1H, CHarom). 13CNMR (CDCl3, 75 MHz, 25°C): δ = 14.0 
(CH3), 27.8 (3xCH3), 61.0 (CH2), 84.2 (CH3C), 114.6 (HC=C), 119.7(Carom), 
122.7(Carom), 124.2(Carom), 128.1(Carom), 132.4(Carom), 136.1 (Carom), 141.5 (Carom), 
148.5 (tBuCOC=O), 164.9 (OC=O), 165,3 (NC=O) ppm.107 
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General procedure for the Asymmetric Epoxidation  
  
To a solution of the catalyst A (38 mg, 0.15 mmol) and trans-3-ylideneoxindoles (0.5 
mmol) in nHexane for HPLC grade (2.7 mL) was added TBHP (5.5 M in decane 
solution, 0.6 mmol, 0.11 mL) at room temperature (25°C). The resultant heterogeneous 
mixture was maintained under stirring until the reaction completion (TLC 
nHexane/EtOAc). Afterwards, the crude reaction mixture was purified via flash 
chromatography on silica gel (nHexane/EtOAc) to furnish the epoxy oxindoles trans 
and cis. 
Characterization of epoxides 133, 182-193, 240-260 
(2'R,3'R)-ethyl 1-methyl-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 133-
trans 
Following the above general procedure, trans diastereoisomer 133-
trans was obtained as a whitish solid in 61% yield after purification 
(nHexane/EtOAc=7/3). IR (CHCl3): ˜ n = 3033, 3010, 2984, 1736, 
1709, 1618, 1495, 1473, 1376, 1347 cm1. 1H-NMR (CDCl3, 300 
MHz, 25°C): δ 1.26 (t, J = 7.2 Hz, 3H, CH3CH2O), 3.25 (s, 3H, 
CH3N), 4.18 (s, 1H, OCH), 4.24 (dq, J = 10.9 Hz, 7.2 Hz, 1H, CH3CHHO), 4.29 (dq, J 
= 10.9 Hz, 7.2 Hz, 1H, CH3CHHO), 6.89 (ddd, J = 7.9 Hz, 0.9 Hz, 0.6 Hz, 1H, CHarom), 
7.04 (dt, J = 7.7 Hz, 0.9 Hz, 1H, CHarom), 7.39 (dt, J = 7.9 Hz, 1.3 Hz, 1H, CHarom), 7.45 
(ddd, J = 7.7 Hz, 1.3 Hz, 0.6 Hz, 1H, CHarom) ppm. 13C-NMR (CDCl3, 75 MHz, 25°C): 
δ 14.3 (CH3), 27.0 (NCH3), 60.0 (CH2), 60.3 (CO), 62.4 (OCH), 109.1 (Carom), 119.5 
(Carom), 123.3 (Carom), 125.0 (Carom), 131.3 (Carom), 145.9 (Carom), 165.9, 170.1 (C=O) 
ppm. HRMS: exact mass calculated for (C13H13NNaO4) requires m/z 270.0742, found 
m/z 270.0741. Chiral-phase HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 nm, 
nHexane/EtOH=7/3, flow rate 1.0mL/min]: Tmajor = 11.91 min, Tminor = 14.97 min ee = 
82%. [α] D = -93 (c = 1.6 g/cm3 in CH2Cl2). 
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(2'S,3'R)-ethyl 1-methyl-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 133-cis 
Following the above general procedure, cis diastereoisomer 
133-cis was obtained as a pale yellow solid in 34% yield after 
purification (nHexane/EtOAc=7/3). IR (CHCl3): ˜ n = 3034, 
3010, 2933, 1759, 1733, 1621, 1472, 1375, 1345 cm1. 1H 
NMR (CDCl3, 300 MHz, 25°C): δ 1.35 (t, J = 7.2 Hz, 3H, CH3CH2O), 3.22 (s, 3H, 
CH3N), 4.15 (s, 1H, OCH), 4.34 (q, J = 7.2 Hz, 2H, CH3CH2O), 6.89 (dd, J = 7.8 Hz, 
0.5 Hz, 1H, CHarom), 7.04-7.14 (m, 2H, CHarom), 7.40 (ddd, J = 7.9 Hz, 6.2 Hz, 2.8 Hz, 
1H, CHarom) ppm. 13C NMR (CDCl3, 75 MHz, 25°C): δ 14.3 (CH3), 26.9 (NCH3), 60.3 
(CH2), 60.4 (CO), 62.3 (OCH), 109.2 (Carom), 121.4 (Carom), 122.6 (Carom), 123.2 (Carom), 
131.4 (Carom), 145.5 (Carom), 165.0, 169.0 (C=O) ppm. HRMS: exact mass calculated for 
(C13H13NNaO4) requires m/z 270.0742, found m/z 270.0739. Chiral-phase HPLC 
analysis: [Daiacel Chiralpack IC 5μ, =254 nm, nHexane/EtOH=7/3, flow rate 
1.0mL/min]: Tmajor = 14.60 min, Tminor = 19.82 min, ee = 19%. [α]D = -105 (c = 0.035 
g/cm3 in CHCl3). 
(2'R,3'R)-ethyl 5-fluoro-1-methyl-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 
182-trans 
Following the above general procedure, trans diastereoisomer 
182-trans was obtained as a whitish solid in 36% yield after 
purification (nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3032, 3009, 
2952, 2925, 1756, 1735, 1612, 1579, 1461, 1367, 1338 cm1. 1H-
NMR (CDCl3, 300 MHz, 25°C): δ 1.29 (t, J = 7.1 Hz, 3H, 
CH3CH2O), 3.25 (s, 3H, CH3N), 4.19 (s, 1H, OCH), 4.22 4.36 (m, 2H, CH3CH2O), 
6.82 (dd, J = 8.6 Hz, 4.4 Hz, 1H, CHarom), 7.10 (dt, J = 8.6 Hz, 2.7 Hz, 1H, CHarom), 7.26 
(dd, J = 8.6 Hz, 2.7 Hz, 1H, CHarom) ppm. 13C-NMR (CDCl3, 75 MHz, 25°C): δ 14.3 
(CH3), 27.1 (NCH3), 60.0 (CH2), 60.2 (CO), 62.6 (OCH), 109.6 (d, JCF = 8 Hz, CHarom), 
113.5 (d, JCF = 27 Hz, CHarom), 117.7 (d, JCF = 24 Hz, CHarom), 121.2 (d, JCF = 9 Hz, 
CHarom), 141.9 (d, JCF = 2 Hz, CHarom), 159.5 (d, JCF = 242 Hz, CHarom), 165.6, 169.9 
(C=O) ppm. HRMS: exact mass calculated for (C13H12FNNaO4) requires m/z 288.0648, 
found m/z 288.0647. Chiral-phase HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 
nm, nHexane/EtOH=7/3, flow rate 1.0mL/min]: Tmajor = 12.10 min, Tminor = 9.10 min ee 
= 84%. [α] D = -211 (c = 0.0052 g/cm3 in CHCl3). 
N
EtO2C
CH3
O
O
F
182-trans
EXPERIMENTAL PART 
 
147 
 
(2'S,3'R)-ethyl 5-fluoro-1-methyl-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 
182-cis 
Following the above general procedure, cis diastereoisomer 
182-cis was obtained as a pale yellow solid in 39% yield after 
purification (nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3030, 
3010, 2985, 1764, 1735, 1613, 1581, 1461, 1367, 1333 cm1. 
1H-NMR (CDCl3, 300 MHz, 25°C): δ 1.35 (t, J = 7.1 Hz, 3H, CH3CH2O), 3.22 (s, 3H, 
CH3N), 4.13 (s, 1H, OCH), 4.34 (q, J = 7.1 Hz, 2H, CH3CH2O), 6.80 (m, 2H, CHarom), 
7.10 (dt, J = 8.8 Hz, 2.6 Hz, 1H, CHarom) ppm. 13C-NMR (CDCl3, 75 MHz, 25°C): δ 
14.3 (CH3), 27.0 (NCH3), 60.0 (CO), 60.4 (CH2), 62.4 (OCH), 109.9 (d, JCF = 8 Hz, 
CHarom), 110.8 (d, JCF = 26 Hz, CHarom), 117.8 (d, JCF = 23 Hz, CHarom), 123.0 (d, JCF = 
9 Hz, CHarom), 141.4 (Carom), 159.5 (d, JCF = 243 Hz, CHarom), 164.6, 168.7 (C=O) ppm. 
HRMS: exact mass calculated for (C13H12FNNaO4) requires m/z 288.0648, found m/z 
288.0650. Chiral-phase HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 nm, 
nHexane/EtOH=7/3, flow rate 1.0mL/min]: Tmajor = 14.15 min, Tminor = 15.85 min, ee = 
30%. [α]D = -131 (c = 0.0084 g/cm3 in CHCl3). 
(2'R,3'R)-ethyl 5-chloro-1-methyl-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 
183-trans 
Following the above general procedure, trans diastereoisomer 
183-trans was obtained as a whitish solid in 37% yield after 
purification (nHexane/EtOAc=85/15). IR (CHCl3): ˜ n = 3033, 
3006, 2980, 1754, 1751, 1615, 1496, 1466, 1440 cm1. 1H-NMR 
(CDCl3, 300 MHz, 25°C): δ 1.30 (t, J = 7.1 Hz, 3H, CH3CH2O), 
3.25 (s, 3H, CH3N), 4.18 (s, 1H, OCH), 4.22-4.43 (m, 2H, CH3CH2O), 6.83 (d, J = 8.4  
Hz, 1H, CHarom), 7.37 (dd, J = 8.4 Hz, 2.2 Hz, 1H, CHarom), 7.47 (d, J = 2.2 Hz, 1H, 
CHarom  ppm. 13C-NMR (CDCl3, 75 MHz, 25°C): δ 14.3 (CH3), 27.0 (NCH3), 59.9 
(CH2), 60.0 (CO), 62.6 (OCH), 110.0 (Carom), 121.2 (Carom), 125.5 (Carom), 128.9 (Carom), 
131.1 (Carom), 144.4 (Carom), 165.5, 169.6 (C=O) ppm. HRMS: exact mass calculated for 
(C13H12ClNNaO4) requires m/z 304.0353, found m/z 304.0355. Chiral-phase HPLC 
analysis: [Daiacel Chiralpack IC 5μ, =254 nm, nHexane/EtOH=7/3, flow rate 
1.0mL/min]: Tmajor = 12.97 min, Tminor = 9.68 min ee = 76%. [α] D = - 62 (c = 0.0091 
g/cm3 in CHCl3). 
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 (2'S,3'R)-ethyl 5-chloro-1-methyl-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 
183-cis 
Following the above general procedure, cis diastereoisomer 
183-cis was obtained as a pale yellow solid in 55% yield 
after purification (nHexane/EtOAc=7/3). IR (CHCl3): ˜ n = 
3032, 3009, 2331, 1758, 1735, 1618, 1495, 1466, 1359, 1343 
cm1. 1H-NMR (CDCl3, 300 MHz, 25°C): δ 1.35 (t, J = 7.2 Hz, 3H, CH3CH2O), 3.22 (s, 
3H, CH3N), 4.13 (s, 1H, OCH), 4.34 (q, J = 7.2 Hz, 2H, CH3CH2O), 6.82 (d, J = 8.3  
Hz, 1H, CHarom), 7.07 (d, J = 2.1 Hz, 1H, CHarom), 7.37 (dd, J = 8.3 Hz, 2.1 Hz, 1H, 
CHarom) ppm.13C NMR (CDCl3, 75 MHz, 25°C): δ 14.3 (CH3), 27.0 (NCH3), 59.9 (CO), 
60.4 (CH2), 62.4 (OCH), 110.2 (Carom), 123.0 (Carom), 123.1 (Carom), 128.9 (Carom), 131.3 
(Carom), 143.9 (Carom), 164.5, 168.6 (C=O) ppm. HRMS: exact mass calculated for 
(C13H12ClNNaO4) requires m/z 304.0353, found m/z 304.0352. Chiral-phase HPLC 
analysis: [Daiacel Chiralpack IC 5μ, =254 nm, nHexane/EtOH=7/3, flow rate 
1.0mL/min]: Tmajor = 14.46 min, Tminor = 17.91 min, ee = 42%. [α]D = -61 (c = 0.0070 
g/cm3 in CHCl3). 
(2'R,3'R)-ethyl 5-iodo-1-methyl-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate 
184-trans 
 Following the above general procedure, trans diastereoisomer 
184-trans was obtained as a pale yellow solid in 32% yield after 
purification (nHexane/EtOAc=7/3). IR (CHCl3): ˜ n = 3028, 3017, 
3008, 1736, 1727, 1611, 1535, 1486, 1358, 1340 cm1. 1H-NMR 
(CDCl3, 300 MHz, 25°C): 1.33 (t, J = 7.1 Hz, 3H, CH3CH2O); 
3.24 (s, 3H, NCH3); 3.94-4.41 (m, 3H, CH3CH2O, OCH); 6.69 (t, J = 8.2  Hz, 1H, 
CHarom); 6.68-6.78 (m, 2H, CHarom) ppm. 13CNMR (CDCl3, 75 MHz, 25°C): 14.3 (CH3), 
27.0 (NCH3), 59.6 (CO), 60.0 (CH2), 62.6 (OCH), 85.6 (Carom), 111.0 (Carom), 121.7 
(Carom), 133.6 (Carom), 140.0 (Carom), 145.4 (Carom), 165.5 , 169.3 (C=O) ppm. HRMS: 
exact mass calculated for (C13H12INNaO4) requires m/z 395.9709, found m/z 395.9712. 
Chiral-phase HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 nm, 
nHexane/EtOH=70/30, flow rate 1.0mL/min]: Tmajor = 13.04 min, Tminor = 10.19 min ee 
= 61%. [α] D = -9 (c = 0.0140 g/cm3 in CHCl3) 
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(2'S,3'R)-ethyl 5-iodo-1-methyl-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate 
184-cis 
 Following the above general procedure, cis diastereoisomer 
184-cis was obtained as a pale yellow solid in 32% yield after 
purification (nHexane/EtOAc=7/3). IR (CHCl3): ˜ n = 3025, 
3017, 3008, 1753, 1736, 1611, 1486, 1465, 1430, 1340 cm1. 
1H-NMR (CDCl3, 300 MHz, 25°C): 1.35 (t, J = 7.1 Hz, 3H, CH3CH2O); 3.21 (s, 3H, 
NCH3); 4.14 (s, 1H, OCH); 4.35 (dq, J = 9.8 Hz, 7.1 Hz, 1H, CH3CHHO); 4.38 (dq, J = 
9.8 Hz, 7.1 Hz, 1H, CH3CHHO); 6.69 (d, J = 8.2 Hz, 1H, CHarom); 7.37 (s, 1H, CHarom); 
7.71 (dd, J = 8.2 Hz, 1.5 Hz, 1H, CHarom) ppm. 13CNMR (CDCl3, 75 MHz, 25°C): 14.3 
(CH3), 27.0 (NCH3), 59.6 (CO), 60.0 (CH2), 62.6 (OCH), 85.6 (Carom) 111.0 (Carom), 
121.7 (Carom), 133.6 (Carom), 140.0 (Carom), 145.4 (Carom), 165.5, 169.3 (C=O) ppm. 
HRMS: exact mass calculated for (C13H12INNaO4) requires m/z 395.9709, found m/z 
395.9712. Chiral-phase HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 nm, 
nHexane/EtOH=70/30, flow rate 1.0mL/min]: Tmajor = 14.94 min, Tminor = 19.58 min ee 
= 61%. [α] D = -9 (c = 0.0140 g/cm3 in CHCl3) 
 (2'R,3'R)-ethyl 1-methyl-2-oxo-5-(trifluoromethoxy)spiro[indoline-3,2'-oxirane]-
3'-carboxylate, 185-trans 
Following the above general procedure, trans diastereoisomer 
185-trans was obtained as a whitish solid in 28% yield after 
purification (nHexane/EtOAc=7/3). IR (CHCl3): ˜ n = 3038, 
3010, 2986, 1757, 1739, 1626, 1492, 1470, 1369, 1348 cm1. 
1H-NMR (CDCl3, 300 MHz, 25°C): δ 1.28 (t, J = 7.1 Hz, 3H, 
CH3CH2O), 3.27 (s, 3H, CH3N), 4.20 (s, 1H, OCH), 4.27 (q, J = 7.1 Hz, 2H, 
CH3CH2O), 6.89 (d, J = 8.5 Hz, 1H, CHarom), 7.19-7.33 (m, 1H, CHarom), 7.40 (s, 1H, 
CHarom) ppm. 13C-NMR (CDCl3, 75 MHz, 25°C): δ 14.3 (CH3), 27.1 (NCH3), 59.9 
(CO), 60.1 (CH2), 62.7 (OCH), 109.6 (Carom), 119.3 (Carom), 120.7 [(OCF3), q, JCF = 
277.4 Hz], 121.1 (Carom), 124.5 (Carom), 144.5 (Carom), 145.2 (Carom), 165.5 , 169.9 (C=O) 
ppm. HRMS: exact mass calculated for (C14H12F3NNaO5) requires m/z 354.0565, found 
m/z 354.0566. Chiral-phase HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 nm, 
nHexane/EtOH=7/3, flow rate 1.0mL/min]: Tmajor = 7.73 min, Tminor = 6.05 min ee = 
78%. [α] D = -171 (c = 0.0033 g/cm3 in CHCl3) 
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(2'S,3'R)-ethyl 1-methyl-2-oxo-5-(trifluoromethoxy)spiro[indoline-3,2'-oxirane]-3'-
carboxylate, 185-cis 
Following the above general procedure, cis 
diastereoisomer 185-cis was obtained as a pale yellow 
solid in 42% yield after purification 
(nHexane/EtOAc=7/3). IR (CHCl3): ˜ n = 3030, 3009, 2983, 
1761, 1735, 1628, 1495, 1469, 1372, 1349 cm1. 1H NMR 
(CDCl3, 300 MHz, 25°C): δ 1.35 (t, J = 7.1 Hz, 3H, CH3CH2O), 3.24 (s, 3H, CH3N), 
4.15 (s, 1H, OCH), 4.34 (q, J = 7.1 Hz, 2H, CH3CH2O), 6.89 (d, J = 8.4 Hz, 1H, 
CHarom), 6.99 (s, 3H, CHarom), 7.19 -7.36 (m, 1H, CHarom) ppm. 13C-NMR (CDCl3, 75 
MHz, 25°C): δ 14.3 (CH3), 27.1 (NCH3), 59.9 (CO), 60.5 (CH2), 62.4 (OCH), 109.9 
(Carom), 116.6 (Carom), 120.7 [(OCF3), q, JCF = 257.5 Hz], 123.0 (Carom), 124.5 (Carom), 
144.1 (Carom), 145.3 (Carom), 164.4, 168.8 (C=O) ppm. HRMS: exact mass calculated for 
(C14H12F3NNaO5) requires m/z 354.0565, found m/z 354.0563. Chiral-phase HPLC 
analysis: [Daiacel Chiralpack IC 5μ, =254 nm, nHexane/EtOH=7/3, flow rate 
1.0mL/min]: Tmajor = 7.43 min, Tminor = 8.53 min, ee = 30%. [α]D = -101 (c = 0.0056 
g/cm3 in CHCl3). 
(2'R,3'R)-ethyl 7-fluoro-1-methyl-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 
190-trans 
Following the above general procedure, trans diastereoisomer 190-
trans was obtained as a whitish solid in 29% yield after purification 
(nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3042, 3016, 2987, 1743, 
1703, 1636, 1601, 1493, 1479, 1373, 1341, 1226 cm1. 1H NMR 
(CDCl3, 300 MHz, 25°C): δ 1.35 (t, J = 7.2 Hz, 3H, CH3CH2O), 
3.43 (d, JHF = 2.7 Hz, 3H, CH3N), 4.13 (s, 1H, OCH), 4.34 (q, J = 7.2 Hz, 2H, 
CH3CH2O), 6.88 (dd, J = 7.3 Hz, 1.1 Hz, 1H, CHarom), 6.97-7.21 (m, 2H, CHarom) ppm. 
13C-NMR (CDCl3, 75 MHz, 25°C): δ 14.3 (CH3), 29.7 (NCH3, d, JCF = 5.9 Hz), 60.1 
(CO), 60.3 (CH2), 62.5 (OCH), 119.4 [(Carom), d, JCF = 19.1 Hz], 120.9 [(Carom), d, JCF = 
3.4 Hz], 122.5 [(Carom), d, JCF = 3.4 Hz], 124.0 [(Carom), d, JCF = 6.4 Hz], 132.4 [(Carom), 
d, JCF = 8.9 Hz], 148.3 [(Carom), d, JCF = 244.4 Hz], 165.5, 169.9 (C=O) ppm. HRMS: 
exact mass calculated for (C13H13FNNaO4) requires m/z 288.0648, found m/z 288.0646. 
Chiral-phase HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 nm, 
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nHexane/EtOH=7/3, flow rate 1.0mL/min]: Tmajor = 11.67 min, Tminor = 10.47 min ee = 
80%. [α] D = -60 (c = 0.0230 g/cm3 in CHCl3). 
(2'S,3'R)-ethyl 7-fluoro-1-methyl-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 
190-cis 
Following the above general procedure, cis diastereoisomer 190-
cis was obtained as a pale yellow solid in 56% yield after 
purification (nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3033, 
3004, 2985, 1759, 1738, 1636, 1604, 1484, 1372, 1338 cm1. 1H 
NMR (CDCl3, 300 MHz, 25°C): δ 1.35 (t, J = 7.1 Hz, 3H, 
CH3CH2O), 3.43 (d, JHF = 7.3 Hz, 3H, CH3N), 4.13 (s, 1H, OCH), 4.34 (q, J = 7.2 Hz, 
2H, CH3CH2O), 6.82-7.21 (m, 3H, CHarom) ppm. 13C NMR (CDCl3, 75 MHz, 25°C): δ 
14.2 (CH3), 29.4 (NCH3, d, JCF = 5.6  Hz), 59.9 (CO), 60.6 (CH2), 62.3 (OCH), 118.3 
[(Carom), d, JCF = 3.4 Hz], 119.4 [(Carom), d, JCF = 19.4  Hz], 123.9 [(Carom), d, JCF = 6.3 
Hz], 124.3 [(Carom), d, JCF = 3.6 Hz], 131.8 (Carom), 148.1 [(Carom), d, JCF = 245.2  Hz], 
164.5, 168.7 (C=O) ppm. HRMS: exact mass calculated for (C13H12FNNaO4) requires 
m/z 288.0648, found m/z 288.0645. Chiral-phase HPLC analysis: [Daiacel Chiralpack 
IC 5μ, =254 nm, nHexane/EtOH=7/3, flow rate 1.0mL/min]: Tmajor = 11.83 min, Tminor 
= 14.18 min, ee = 32%. [α]D = -18 (c = 0.0610 g/cm3 in CHCl3). 
(2'R,3'R)-ethyl 7-chloro-1-methyl-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 
191-trans 
Following the above general procedure, trans diastereoisomer 191-
trans was obtained as a whitish solid in 22% yield after purification 
(nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3029, 3002, 2989, 1755, 
1738, 1613, 1464, 1359, 1338, 1250 cm1. 1H-NMR (CDCl3, 300 
MHz, 25°C): δ 1.26 (t, J = 7.1 Hz, 3H, CH3CH2O), 3.63 (s, 3H, 
CH3N), 4.15-4.38 (m, 2H, CH3CH2O), 4.19 (s, 1H, OCH), 6.95 (t, J = 7.7 Hz, 1H, 
CHarom), 7.30 (d, J = 7.7 Hz, 1H, CHarom), 7.34 (d, J = 7.7 Hz, 1H, CHarom), ppm. 13C-
NMR (CDCl3, 75 MHz, 25°C): δ 14.3 (CH3), 30.5 (NCH3), 59.7 (CO), 60.6 (CH2), 62.5 
(OCH), 116.7 (Carom), 122.5 (Carom), 123.4 (Carom), 124.0 (Carom), 133.6 (Carom), 141.5 
(Carom), 165.4, 170.5 (C=O) ppm. HRMS: exact mass calculated for (C13H12ClNNaO4) 
requires m/z 304.0353, found m/z 304.0352. Chiral-phase HPLC analysis: [Daiacel 
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Chiralpack IC 5μ, =254 nm, nHexane/EtOH=7/3, flow rate 1.0mL/min]: Tmajor = 12.63 
min, Tminor = 11.17 min ee = 82%. [α] D = -200 (c = 0.0198 g/cm3 in CHCl3) 
(2'S,3'R)-ethyl 7-chloro-1-methyl-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 
191-cis 
Following the above general procedure, cis diastereoisomer 191-
cis was obtained as a pale yellow solid in 66% yield after 
purification (nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3043, 3012, 
2974, 1759, 1730, 1618, 1589, 1467, 1369, 1336, 1261 cm1. 1H 
NMR (CDCl3, 300 MHz, 25°C): δ 1.35 (t, J = 7.2 Hz, 3H, 
CH3CH2O), 3.59 (s, 3H, CH3N), 4.11 (s, 1H, OCH), 4.34 (q, J = 7.2 Hz, 2H, 
CH3CH2O), 6.92-7.11 (m, 2H, CHarom), 7.32 (dd, J = 7.5 Hz, 1.8 Hz, 1H, CHarom) ppm. 
13C NMR (CDCl3, 75 MHz, 25°C): δ 14.1 (CH3), 30.1 (NCH3), 59.4 (CO), 60.7 (CH2), 
62.2 (OCH), 116.6 (Carom), 120.9 (Carom), 124.1 (Carom), 133.4 (Carom), 141.0 (Carom), 
164.3, 169.2 (C=O) ppm. HRMS: exact mass calculated for (C13H12ClNNaO4) requires 
m/z 304.0353, found m/z 304.0355. Chiral-phase HPLC analysis: [Daiacel Chiralpack 
IC 5μ, =254 nm, nHexane/EtOH=7/3, flow rate 1.0mL/min]: Tmajor = 13.28 min, Tminor 
= 14.08 min, ee = 32%. [α]D = -116 (c = 0.0140 g/cm3 in CHCl3). 
 (2'R,3'R)-ethyl 7-bromo-1-methyl-2-oxospiro[indoline-3,2'-oxirane]-3'-
carboxylate, 192-trans 
Following the above general procedure, trans diastereoisomer 192-
trans was obtained as a whitish solid in 21% yield after purification 
(nHexane/EtOAc=9/1). IR (CHCl3): ˜ n = 3032, 3009, 2951, 2925, 
1756, 1735, 1612, 1578, 1461, 1367, 1338 cm1. 1H-NMR (CDCl3, 
300 MHz, 25°C): δ 1.26 (t, J = 7.2 Hz, 3H, CH3CH2O), 3.64 (s, 3H, 
CH3N), 4.15 4.40 (m, 2H, CH3CH2O), 4.19 (s, 1H, OCH), 6.88 (t, J = 7.6 Hz, 1H, 
CHarom), 7.39 (d, J = 7.6 Hz, 1H, CHarom), 7.48 (d, J = 7.6 Hz, 1H, CHarom) ppm. 13C-
NMR (CDCl3, 75 MHz, 25°C): δ 14.3 (CH3), 30.7 (NCH3), 59.7 (CO), 60.7 (CH2), 62.5 
(OCH), 103.4 (Carom), 122.8 (Carom), 123.9 (Carom), 124.4 (Carom), 136.9 (Carom), 143.0 
(Carom), 165.4, 170.8 (C=O) ppm. HRMS: exact mass calculated for (C13H12BrNNaO4) 
requires m/z 347.9847, found m/z 347.9846. Chiral-phase HPLC analysis: [Daiacel 
N
EtO2C
CH3
O
O
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192-trans
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Chiralpack IC 5μ, =254 nm, nHexane/EtOH=7/3, flow rate 1.0mL/min]: Tmajor = 12.08 
min, Tminor = 10.57 min ee = 88%. [α] D = -200 (c = 0.0119 g/cm3 in CHCl3) 
(2'S,3'R)-ethyl 7-bromo-1-methyl-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 
192-cis 
Following the above general procedure, cis diastereoisomer 192-
cis was obtained as a pale yellow solid in 50% yield after 
purification (nHexane/EtOAc=9/1). IR (CHCl3): ˜ n = 3030, 
3008, 2985, 1764, 1735, 1612, 1581, 1461, 1367, 1333 cm1. 1H 
NMR (CDCl3, 300 MHz, 25°C): δ 1.34 (t, J = 7.1 Hz, 3H, 
CH3CH2O), 3.60 (s, 3H, CH3N), 4.11 (s, 1H, OCH), 4.33 (q, J = 7.1 Hz, 2H, 
CH3CH2O), 6.88-7.03 (m, 2H, CHarom), 7.49 (dd, J = 8.0 Hz, 1.3 Hz, 1H, CHarom), ppm. 
13C NMR (CDCl3, 75 MHz, 25°C): δ 14.3 (CH3), 30.4 (NCH3), 59.6 (CO), 60.9 (CH2), 
62.4 (OCH), 103.6 (Carom), 121.5 (Carom), 124.3 (Carom), 124.6 (Carom), 137.0 (Carom), 
142.7 (Carom), 164.5, 169.5 (C=O) ppm. HRMS: exact mass calculated for 
(C13H12BrNNaO4) requires m/z 347.9847, found m/z 347.9844. Chiral-phase HPLC 
analysis: [Daiacel Chiralpack IC 5μ, =254 nm, nHexane/EtOH=7/3, flow rate 
1.0mL/min]: Tmajor = 14.35 min, Tminor = 16.40 min, ee = 58%. [α]D = -92 (c = 0.0043 
g/cm3 in CHCl3). 
(2'R,3'R)-ethyl 1-phenyl-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 240-
trans 
Following the above general procedure, trans diastereoisomer 240-
trans was obtained as a whitish solid in 43% yield after purification 
(nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3034, 3010, 2981, 1742, 
1732, 1619, 1598, 1508, 1468, 1376 cm1. 1H NMR (CDCl3, 300 
MHz, 25°C): δ 1.31 (t, J = 7.1 Hz, 3H, CH3CH2O), 4.22-4.42 (m, 2H, 
CH3CH2O), 4.28 (s, 1H, OCH)¸ 6.87 (dd, J = 8.0 Hz, 0.6 Hz, 1H, CHarom), 7.05 (dt, J = 
7.6 Hz, 1.0 Hz, 1H, CHarom), 7.31 (dt, J = 7.9 Hz, 1.3 Hz, 1H, CHarom), 7.28-7.31 (m, 
3H, CHarom), 7.48-7.59 (m, 3H, CHarom) ppm. 13C NMR (CDCl3, 75 MHz, 25°C): δ 14.4 
(CH3), 60.5 (CH2, CO), 62.5 (OCH), 110.5 (Carom), 119.4 (Carom), 123.8 (Carom), 125.3 
(Carom), 126.7 (Carom), 128.8 (Carom), 130.0 (Carom), 131.2 (Carom), 134.0 (Carom), 146.0 
(Carom), 165.8, 169.5 (C=O) ppm. HRMS: exact mass calculated for (C18H15NNaO4) 
N
EtO2C
Ph
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O
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requires m/z 332.0899, found m/z 332.0897. Chiral-phase HPLC analysis: [Daiacel 
Chiralpack IC 5μ, =254 nm, nHexane/EtOH=7/3, flow rate 1.0mL/min]: Tmajor =17.28 
min, Tminor = 10.28 min, ee = 74%. [α]D = -172 (c = 0.0110 g/cm3 in CHCl3). 
(2'S,3'R)-ethyl 1-phenyl-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 240-cis 
Following the above general procedure, cis diastereoisomer 240-
cis was obtained as a whitish solid in 37% yield after purification 
(nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3037, 3006, 2399, 1734, 
1717, 1620, 1470, 1358 cm1. 1H-NMR (CDCl3, 300 MHz, 
25°C): δ 1.33 (t, J = 7.1 Hz, 3H, CH3CH2O), 4.24 (s, 1H, OCH), 
4.33 (q, J = 7.1 Hz, 2H, CH3CH2O), 6.89 (d, J = 8.0 Hz, 1H, CHarom), 7.07-7.21 (m, 2H, 
CHarom) 7.33 (dt, J = 7.6 Hz, 1.6 Hz, 1H, CHarom), 7.36-7.59 (m, 5H, CHarom) ppm. 13C-
NMR (CDCl3, 75 MHz, 25°C): δ 14.3 (CH3), 60.4 (CO), 60.8 (CH2), 62.4 (OCH), 110.5 
(Carom), 121.2 (Carom), 122.9 (Carom), 123.8 (Carom), 126.6 (Carom), 128.7 (Carom), 130.0 
(Carom), 131.4 (Carom), 134.0 (Carom), 145.6 (Carom), 164.9, 168.5 (C=O) ppm. HRMS: 
exact mass calculated for (C18H15NNaO4) requires m/z 332.0899, found m/z 332.0903. 
Chiral-phase HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 nm, 
nHexane/iPrOH=7/3, flow rate 1.0mL/min]: Tmajor = 12.90 min, Tminor = 10.62 min, ee = 
12%. [α]D=+ 309 (c = 0.0030 g/cm3 in CHCl3) 
 
 
(2'R,3'R)-ethyl 1-benzyl-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 241-trans 
Following the above general procedure, trans diastereoisomer 241-
trans was obtained as a pale yellow solid in 61% yield after 
purification (nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3055, 3035, 
3003, 1735, 1689, 1601 cm1. 1H NMR (CDCl3, 300 MHz, 25°C): δ 
1.28 (t, J = 7.2 Hz, 3H, CH3CH2O), 4.18-4.40 (m, 2H, CH3CH2O), 
4.26 (s, 1H, OCH), 4.90 (d, J = 15.6 Hz, 1H, CHHPh), 4.96 (d, J = 15.6 Hz, 1H, 
CHHPh), 6.80 (dd, J = 7.9 Hz, 0.6 Hz 1H, CHarom), 6.85 (dt, J = 7.7 Hz, 0.6 Hz, 1H, 
CHarom), 7.22-7.35 (m, 6H, CHarom), 7.45 (dd, J = 7.7 Hz, 0.8 Hz 1H, CHarom) ppm. 13C-
NMR (CDCl3, 75 MHz, 25°C): δ 14.3 (CH3), 44.7 (CH2benz), 60.1 (CH2), 60.3 (CO), 
N
Ph
O
O CO2Et
240-cis
EXPERIMENTAL PART 
 
155 
 
62.4 (OCH), 110.1 (Carom), 119.6 (Carom), 123.3 (Carom), 125.1 (Carom), 127.6 (Carom), 
128.1 (Carom), 129.1 (Carom), 131.2 (Carom), 135.2 (Carom), 145.1 (Carom), 165.8, 170.3 
(C=O) ppm. HRMS: exact mass calculated for (C19H17NNaO4) requires m/z 346.1055, 
found m/z 346.1058. Chiral-phase HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 
nm, nHexane/EtOH=7/3, flow rate1.0mL/min]: Tmajor = 11.13 min, Tminor = 8.38 min, ee 
= 56%. [α]D = - 110 (c = 0.0290 g/cm3 in CHCl3). 
(2'S,3'R)-ethyl 1-benzyl-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 241-cis 
Following the above general procedure, cis diastereoisomer 241-
cis was obtained as a pale yellow solid in 31% yield after 
purification (nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3037, 3007, 
2399, 1734, 1709, 1610, 1470, 1358 cm1. 1H NMR (CDCl3, 300 
MHz, 25°C): δ 1.36 (t, J = 7.2 Hz, 3H, CH3CH2O), 4.19 (s, 1H, 
OCH), 4.29-4.47 (m, 2H, CH3CH2O), 4.86 (d, J = 15.6 Hz, 1H, CHHPh), 4.95 (d, J = 
15.6 Hz, 1H, CHHPh), 6.74 (d, J = 7.9 Hz, 1H, CHarom), 6.99-7.14 (m, 2H, CHarom), 
7.21-7.38 (m, 6H, CHarom) ppm. 13C NMR (CDCl3, 75 MHz, 25°C): δ 14.3 (CH3), 44.5 
(CH2benz), 60.6 (CO), 60.8 (CH2), 62.3 (OCH), 110.2 (Carom), 121.4 (Carom), 122.6 
(Carom), 123.3 (Carom), 127.6 (Carom), 128.1 (Carom), 129.1 (Carom), 131.3 (Carom), 135.3 
(Carom), 144.6 (Carom), 164.9, 169.3 (C=O) ppm. HRMS: exact mass calculated for 
(C19H17NNaO4) requires m/z 346.1055, found m/z 346.1053. Chiral-phase HPLC 
analysis: [Daiacel Chiralpack IB 5μ, =254 nm, nHeptane/EtOH/DEA=70/30/0.1, flow 
rate 1.0mL/min]: Tmajor = 12.43 min, Tminor = 14.59 min, ee = 20%. [α]D = -62 (c = 
0.0150 g/cm3 in CHCl3). 
(2'R,3'R)-ethyl 1-benzyl-5-isopropyl-2-oxospiro[indoline-3,2'-oxirane]-3'-
carboxylate, 243-trans 
Following the above general procedure, trans diastereoisomer 
243-trans was obtained as a pale yellow solid in 63% yield 
after purification (nHexane/EtOAc=9/1). IR (CHCl3): ˜ n = 
3027, 3009, 2959, 2927, 1747, 1729, 1625, 1491, 1371 cm1. 
1H NMR (CDCl3, 300 MHz, 25°C): δ 1.15 (d, J = 6.9 Hz, 3H, CH3CHCH3), 1.16 (d, J = 
6.9 Hz, 3H, CH3CHCH3), 1.30 (t, J = 7.1 Hz, 3H, CH3CH2O), 2.81 (sept, J = 6.9 Hz, 
1H, CH3CHCH3), 4.19-4.36 (m, 2H, CH3CH2O), 4.26 (s, 1H, OCH), 4.88 (d, J = 15.5 
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Hz, 1H, CHHPh), 4.95 (d, J = 15.5 Hz, 1H, CHHPh), 6.72 (d, J = 8.1 Hz, 1H, CHarom), 
7.11 (dd, J = 8.1 Hz, 1.9 Hz, 1H, CHarom), 7.207.37 (m, 6H, CHarom) ppm. 13C NMR 
(CDCl3, 75 MHz, 25°C): δ 14.4 (CH3), 24.0 (CHCH3), 24.3 (CHCH3), 34.0 (CHCH3), 
44.8 (CH2benz), 60.1 (CH2), 60.4 (CO), 62.4 (OCH), 109.9 (Carom), 119.5 (Carom), 123.2 
(Carom), 127.7 (Carom), 128.1 (Carom), 129.0 (Carom), 129.1 (Carom), 135.4 (Carom), 142.9 
(Carom), 144.3 (Carom), 165.9, 170.4 (C=O) ppm. HRMS: exact mass calculated for 
(C22H23NNaO4) requires m/z 388.1525, found m/z 388.1521. Chiral-phase HPLC 
analysis: [Daiacel Chiralpack IC 5μ, =254 nm, nHexane/EtOH=7/3, flow rate 
1.0mL/min]: Tmajor =10.60 min, Tminor = 6.83 min, ee = 62%. [α]D = -90 (c = 0.0560 
g/cm3 in CHCl3). 
(2'S,3'R)-ethyl 1-benzyl-5-isopropyl-2-oxospiro[indoline-3,2'-oxirane]-3'-
carboxylate, 243-cis 
Following the above general procedure, cis diastereoisomer 
243-cis was obtained as a pale yellow solid in 26% yield 
after purification (nHexane/EtOAc=9/1). IR (CHCl3): ˜ n = 
3063, 3037, 2964, 2928, 2872, 1759, 1731, 1628, 1603, 
1492 cm1. 1H NMR (CDCl3, 300 MHz, 25°C): δ 1.17 [d, J 
= 6.9 Hz, 6H, (CH3)2CH], 1.36 (t, J = 7.2 Hz, 3H, CH3CH2O), 2.82 [sept, J = 6.9 Hz, 
1H, (CH3)2CH], 4.19 (s, 1H, OCH), 4.28-4.44 (m, J = 7.2 Hz, 2H, CH3CH2O), 4.84 (d, J 
= 15.5 Hz, 1H, CHHPh), 4.94 (d, J = 15.5 Hz, 1H, CHHPh), 6.69 (d, J = 8.1 Hz, 1H, 
CHarom), 6.96 (d, J = 1.8 Hz, 1H, CHarom), 7.12 (dd, J = 8.1 Hz, 1.8 Hz, 1H, CHarom), 
7.207.35 (m, 5H, CHarom) ppm. 13C NMR (CDCl3, 75 MHz, 25°C): δ 14.3 (CH3), 24.1 
(CHCH3), 24.2 (CHCH3), 33.9 (CHCH3), 44.5 (CH2benz), 60.5 (CO), 60.6 (CH2), 62.2 
(OCH), 110.0 (Carom), 120.7 (Carom), 121.2 (Carom), 127.6 (Carom), 128.0 (Carom), 129.0 
(Carom), 129.2 (Carom), 135.4 (Carom), 142.4 (Carom), 144.3 (Carom), 164.9, 169.3 (C=O) 
ppm. HRMS: exact mass calculated for (C22H23NNaO4) requires m/z 388.1525, found 
m/z 388.1527. Chiral-phase HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 nm, 
nHexane/EtOH =7/3, flow rate 1.0mL/min]: Tmajor = 9.84 min, Tminor = 9.21 min, ee = 
26%. [α] D = -37 (c = 0.0390 g/cm3 in CHCl3) 
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(2'R,3'R)-ethyl 1-benzyl-5-methoxy-2-oxospiro[indoline-3,2'-oxirane]-3'-
carboxylate, 244-trans 
Following the above general procedure, trans diastereoisomer 
244-trans was obtained as a pale yellow solid in 56% yield 
after purification (nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 
3091, 3067, 2988, 2960, 2837, 1731, 1690, 1602, 1490, 1474, 
1456, 1370 cm1. 1H NMR (CDCl3, 300 MHz, 25°C): δ 1.30 
(t, J = 7.1  Hz, 3H, CH3CH2O), 3.71 (s, 3H, OCH3), 4.16-4.41 (m, 2H, CH3CH2O), 4.26 
(s, 1H, OCH), 4.88 (d, J = 15.7 Hz, 1H, CHHPh), 4.94 (d, J = 15.7 Hz, 1H, CHHPh), 
6.68 (d, J = 8.4 Hz, 1H, CHarom), 6.79 (dd, J = 8.4 Hz, 2.7 Hz, 1H, CHarom), 7.11 (d, J = 
2.7 Hz, 1H, CHarom), 7.207.38 (m, 5H, CHarom) ppm. 13C NMR (CDCl3, 75 MHz, 
25°C): δ 14.4 (CH3), 44.8 (CH2benz), 56.0 (OCH3), 60.2 (CH2), 60.5 (CO), 62.5, 110.7 
(Carom), 111.7 (Carom), 116.5 (Carom), 120.7 (Carom), 127.7 (Carom), 128.1 (Carom), 129.1 
(Carom), 135.3 (Carom), 138.3 (Carom), 156.4 (Carom), 165.9, 170.1 (C=O) ppm. HRMS: 
exact mass calculated for (C20H19NNaO5) requires m/z 376.1161, found m/z 376.1163 
Chiral-phase HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 nm, 
nHexane/EtOH=7/3, flow rate 1.0mL/min]: Tmajor = 14.49 min, Tminor = 10.21 min, ee = 
52%. [α]D = +21 (c = 0.0100 g/cm3 in CHCl3).  
(2'S,3'R)-ethyl 1-benzyl-5-methoxy-2-oxospiro[indoline-3,2'-oxirane]-3'-
carboxylate, 244-cis 
Following the above general procedure, cis 
diastereoisomer 244-cis was obtained as a pale yellow 
solid in 24% yield after purification 
(nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3079, 3024, 
2986, 2962, 2939, 1758, 1731, 1605, 1495, 1477, 1437, 
1370 cm1. 1H NMR (CDCl3, 300 MHz, 25°C): δ 1.39 (t, J = 7.2 Hz, 3H, CH3CH2O), 
3.75 (s, 3H, OCH3), 4.19 (s, 1H, OCH), 4.29-4.54 (m, 2H, CH3CH2O), 4.85 (d, J = 15.7 
Hz, 1H NCHH), 4.97 (d, J = 15.7 Hz, 1H NCHH), 6.62-6.91 (m, 3H, CHarom), 
7.237.42 (m, 5H, CHarom) ppm. 13C NMR (CDCl3, 75 MHz, 25°C): δ 14.3 (CH3), 44.6 
(CH2benz), 56.1 (OCH3), 60.6 (CO), 60.7 (CH2), 62.3 (OCH), 109.5 (Carom), 110.9 
(Carom), 116.1 (Carom), 122.5 (Carom), 127.6 (Carom), 128.1 (Carom), 129.1 (Carom), 135.3 
(Carom), 137.8 (Carom), 156.6 (Carom), 164.8, 169.0 (C=O) ppm. HRMS: exact mass 
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calculated for (C20H19NNaO5) requires m/z 376.1161, found m/z 376.1162 Chiral-phase 
HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 nm, nHexane/EtOH=7/3, flow rate 
1.0mL/min]: Tmajor = 14.38 min, Tminor = 10.11 min, ee = 16%. [α]D = -180 (c = 0.0090 
g/cm3 in CHCl3). 
(2'R,3'R)-ethyl 5-methoxy-1-(2-nitrobenzyl)-2-oxospiro[indoline-3,2'-oxirane]-3'-
carboxylate, 245-trans 
Following the above general procedure, trans 
diastereoisomer 245-trans was obtained as a pale yellow 
solid in 55% yield after purification 
(nHexane/EtOAc=7/3). IR (CHCl3): ˜ n = 3049, 3004, 2987, 
2958, 2929, 1736, 1701, 1601, 1529, 1491, 1474, 1371 
cm1. 1H NMR (CDCl3, 300 MHz, 25°C): δ 1.32 (t, J = 7.1 
Hz, 3H, CH3CH2O), 3.74 (s, 3H, OCH3), 4.23-4.42 (m, 2H, CH3CH2O), 4.28 (s, 1H, 
OCH), 5.33 (d, J = 18.2 Hz, 1H, NCHH), 5.38 (d, J = 18.2 Hz, 1H, NCHH), 6.56 (d, J = 
8.5 Hz, 1H, CHarom), 6.81 (dd, J = 8.5 Hz, 2.6 Hz, 1H, CHarom), 7.17 (d, J = 2.5 Hz, 1H, 
CHarom), 7.207.28 (m, 1H, CHarom), 7.46 (dt, J = 7.9 Hz, 1.3 Hz, 1H, CHarom), 7.55 (dt, 
J = 7.9 Hz, 1.3 Hz, 1H, CHarom), 8.17 (dd, J = 7.9 Hz, 1.3 Hz, 1H, CHarom) ppm. 13C 
NMR (CDCl3, 75 MHz, 25°C): δ 14.4 (CH3), 42.2 (CH2benz), 56.1 (OCH3),  60.3 (CH2), 
60.5 (CO), 62.6 (OCH), 110.4 (Carom), 112.1 (Carom), 116.7 (Carom), 120.7 (Carom), 125.8 
(Carom), 128.1 (Carom), 128.9 (Carom), 131.1 (Carom), 134.4 (Carom), 137.8 (Carom), 148.2 
(Carom), 156.8 (Carom), 165.7, 170.5 (C=O) ppm. HRMS: exact mass calculated for 
(C20H18N2NaO7) requires m/z 421.1012, found m/z 421.1013. Chiral-phase HPLC 
analysis: [Daiacel Chiralpack IC 5μ, =254 nm, nHexane/EtOH=7/3, flow rate 
1.0mL/min]: Tmajor = 24.70 min, Tminor = 23.14 min, ee = 78%. [α]D = -105 (c = 0.0060 
g/cm3 in CHCl3 ). 
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(2'S,3'R)-ethyl 5-methoxy-1-(2-nitrobenzyl)-2-oxospiro[indoline-3,2'-oxirane]-3'-
carboxylate, 245-cis 
Following the above general procedure, cis 
diastereoisomer 245-cis was obtained as a pale yellow 
solid in 26% yield after purification 
(nHexane/EtOAc=7/3). IR (CHCl3): ˜ n = 3030, 3016, 
2928, 2957, 2853, 1759, 1734, 1607, 1530, 1496, 1437 
cm1. 1H NMR (CDCl3, 300 MHz, 25°C): δ 1.34 (t, J = 7.1 
Hz, 3H, CH3CH2O), 3.76 (s, 3H, OCH3), 4.22 (s, 1H, OCH), 4.34 (q, J = 7.1 Hz, 2H, 
CH3CH2O), 5.27 (d, J = 18.0 Hz, 1H, NCHH), 5.38 (d, J = 18.0 Hz, 1H, NCHH), 6.58 
(d, J = 8.5 Hz, 1H, CHarom), 6.73-6.88 (m, 2H, CHarom), 7.187.28 (m, 1H, CHarom), 
7.387.61 (m, 2H, CHarom), 8.15 (d, J = 7.4 Hz, 1H, CHarom) ppm. 13C NMR (CDCl3, 75 
MHz, 25°C): δ 14.3 (CH3), 41.9 (CH2benz), 56.1 (OCH3), 60.6 (CH2), 60.8 (CO), 62.5 
(OCH), 109.8 (Carom), 110.6 (Carom), 116.3 (Carom), 116.6 (Carom), 122.4 (Carom), 125.8 
(Carom), 128.0 (Carom), 128.9 (Carom), 131.1 (Carom), 134.4 (Carom), 137.3 (Carom), 157.0 
(Carom), 164.7, 169.4 (C=O) ppm. HRMS: exact mass calculated for (C20H18N2NaO7) 
requires m/z 421.1012, found m/z 421.1010. Chiral-phase HPLC analysis: [Daiacel 
Chiralpack IA 5μ, =254 nm, nHeptane/EtOH/DEA =70/30/0.1, flow rate 1.0mL/min]: 
Tmajor = 17.20 min, Tminor = 18.05 min, ee = 20%. [α] D = +125 (c = 0.0020 g/cm3 in 
CHCl3). 
(2'R,3'R)-ethyl 1-(2,4-dichlorobenzyl)-2-oxospiro[indoline-3,2'-oxirane]-3'-
carboxylate, 242-trans 
 Following the above general procedure, trans 
diastereoisomer 242-trans was obtained as a pale 
yellow solid in 49% yield after purification 
(nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3012, 1767, 
1739, 1603, 1472 cm1. 1H-NMR (CDCl3, 300 MHz, 
25°C): δ 1.29 (t, J = 7.1 Hz, 3H, CH3CH2O), 4.19-4.39 
(m, 2H, CH3CH2O), 4.26 (s, 1H, OCH), 4.98 (d, J = 17.7 Hz, 1H, NCHH), 5.04 (d, J = 
17.7 Hz, 1H, NCHH), 6.74 (d, J = 7.8 Hz, 1H, CHarom), 7.05 (dt, J = 7.7 Hz, 0.9 Hz, 1H, 
CHarom), 7.08 (d, J = 8.6 Hz, 1H, CHarom), 7.16 (dd, J = 8.6 Hz, 2.0 Hz, 1H, CHarom), 
7.29 (dt, J = 7.8 Hz, 1.3 Hz, 1H, CHarom), 7.41 (d, J = 2.0 Hz, 1H, CHarom), 7.48 (ddd, J 
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= 7.7 Hz, 1.3 Hz, 0.9 Hz 1H, CHarom) ppm. 13C NMR (CDCl3, 75 MHz, 25°C): δ = 14.3 
(CH3), 41.6 (CH2benz), 60.2 (OCH3, OCH), 62.5 (CO), 110.0 (Carom), 119.5 (Carom), 
123.7 (Carom), 125.3 (Carom), 127.9 (Carom), 129.4 (Carom), 129.8 (Carom), 131.2 (Carom), 
131.4 (Carom), 133.8 (Carom), 134.6 (Carom), 144.5 (Carom), 165.7, 170.6 (C=O) ppm. 
HRMS: exact mass calculated for (C19H15Cl2NNaO4) requires m/z 414.0276, found m/z 
414.0279. Chiral-phase HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 nm, 
nHexane/EtOH=7/3, flow rate 1.0mL/min]: Tmajor = 10.83 min, Tminor = 8.47 min, ee = 
60%. [α]D = -127 (c = 0.0260 g/cm3 in CHCl3). 
(2'S,3'R)-ethyl 1-(2,4-dichlorobenzyl)-2-oxospiro[indoline-3,2'-oxirane]-3'-
carboxylate, 242-cis 
Following the above general procedure, cis 
diastereoisomer 242-cis was obtained as a pale yellow 
solid in 35% yield after purification 
(nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3022, 3012, 
2399, 1745, 1737, 1602, 1472, 1357cm1. 1H NMR 
(CDCl3, 300 MHz, 25°C): δ 1.34 (t, J = 7.1 Hz, 3H, 
CH3CH2O), 4.22 (s, 1H, OCH), 4.29-4.41 (m, J = 7.1 Hz, 2H, CH3CH2O) 4.96 (d, J = 
17.1 Hz, 1H, NCHH), 5.02 (d, J = 17.1 Hz, 1H, NCHH), 6.73 (d, J = 7.9 Hz, 1H, 
CHarom), 7.03-7.18 (m, 4H, CHarom), 7.33 (dt, J = 7.8 Hz, 1.6 Hz, 1H, CHarom), 7.40 (d, J 
= 2.0 Hz, 1H, CHarom) ppm. 13C NMR (CDCl3, 75 MHz, 25°C): δ 14.4 (CH3), 41.4 
(CH2benz), 60.6 (CO), 60.7 (OCH), 62.4 (OCH3), 110.1 (Carom), 121.3 (Carom), 122.8 
(Carom), 123.7 (Carom), 128.0 (Carom), 129.4 (Carom), 129.8 (Carom), 131.2 (Carom), 131.5 
(Carom), 133.8 (Carom), 134.6 (Carom), 144.1 (Carom), 164.7, 169.5 (C=O) ppm. HRMS: 
exact mass calculated for (C19H15Cl2NNaO4) requires m/z 414.0276, found m/z 
414.0277. Chiral-phase HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 nm, 
nHeptane/DCM/EtOH/DEAH=50/50/1/0.1, flow rate 1.0mL/min]: Tmajor = 7.00 min, 
Tminor = 9.00 min, ee = 20%. [α] D = -274 (c = 0.014 g/cm3 in CHCl3). 
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(2'R,3'R)-ethyl 1-methyl-2-oxo-1,2-dihydrospiro[benzo[g]indole-3,2'-oxirane]-3'-
carboxylate 193-trans 
Following the above general procedure, trans diastereoisomer 193-
trans was obtained as a pale red solid in 50% yield after purification 
(nHexane/EtOAc=8/2). 1H-NMR (CDCl3, 300 MHz, 25°C):   1.26-
1.30 (m, 3H, CH3CH2O); 3.88 (s, 3H, NCH3); 4.21-4.31 (m, 3H, 
OCH, CH3CH2O), 7.50-7.55 (m, 4H, CHarom); 7.86-7.88 (m, 1H, 
CHarom), 8.40-8.43 (m, 1H, CHarom) ppm. HRMS: exact mass calculated for 
(C17H15NNaO4) requires m/z 320.0899, found m/z 320.0701. Chiral-phase HPLC 
analysis: [Daiacel Chiralpack IC 5μ, =254 nm, nHexane/EtOH=70/30, flow rate 
1.0mL/min]: Tmajor = 18.48 min, Tminor = 13.56 min ee = 82%. [α] D = -20.15 (c = 0.0059 
g/cm3 in CHCl3) 
(2'S,3'R)-ethyl 1-methyl-2-oxo-1,2-dihydrospiro[benzo[g]indole-3,2'-oxirane]-3'-
carboxylate 193-cis 
 Following the above general procedure, cis diastereoisomer 
193-cis was obtained as a pale red solid in 48% yield after 
purification (nHexane/EtOAc=8/2). 1H-NMR (CDCl3, 300 
MHz, 25°C):   1.39 (t, J = 7.0 Hz, 3H, CH3CH2O); 3.83 (s, 
3H, NCH3); 4.27 (s, 1H, OCH), 4.39 (q, J = 7.0 Hz, 2H, 
CH3CH2O), 7.16 (d, J = 8.1 Hz, 1H, CHarom), 7.51-7.54 (m, 1H, CHarom); 7.60 (d, J = 
8.2 Hz, 1H, CHarom), 7.87-7.90 (m, 1H, CHarom); 8.38-8.41 (m, 1H, CHarom)  ppm. 
HRMS: exact mass calculated for (C11H11NNaO2) requires m/z 320.0899, found m/z 
320.0701. Chiral-phase HPLC analysis: [Daiacel Chiralpack IB 5μ, =254 nm, 
nHeptane/EtOH/DEA=70/30/0.1, flow rate 1.0mL/min]: Tmajor = 8.91 min, Tminor = 9.71 
min ee = 10%. 
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(trans)-(2'R,3'R)-ethyl 5,7-dichloro-1-methyl-2-oxospiro[indoline-3,2'-oxirane]-3'-
carboxylate 189-trans 
 Following the above general procedure, trans diastereoisomer 
189-trans was obtained as a pale red solid in 29% yield after 
purification (nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3031, 3006, 
1740, 1729, 1578, 1463, 1337, 1309 cm1. 1H-NMR (CDCl3, 300 
MHz, 25°C): 1.31 (t, J = 7.1 Hz, 3H, CH3CH2O); 3.62 (s, 3H, 
NCH3); 4.18 4.40 (m, 3H, CH3CH2O, OCH); 7.34 (s, 1H, CHarom); 7.40 (s, 1H, CHarom) 
ppm. 13CNMR (CDCl3, 75 MHz, 25°C): 14.3 (CH3), 30.5 (NCH3), 59.4, 60.6, 62.8, 
117.0 (Carom), 123.6 (Carom), 124.0 (Carom), 129.0 (Carom), 132.9 (Carom), 140.2 (Carom), 
165.1, 170.1 (C=O) ppm.  HRMS: exact mass calculated for (C13H11Cl2NNaO4) requires 
m/z 337.9963, found m/z 337.9961. Chiral-phase HPLC analysis: [Daiacel Chiralpack 
IC 5μ, =254 nm, nHexane/EtOH=70/30, flow rate 1.0mL/min]: Tmajor = 11.74 min, 
Tminor = 9.48 min ee = 85%. [α] D = -96 (c = 0.0160 g/cm3 in CHCl3) 
(cis)-(2'S,3'R)-ethyl 5,7-dichloro-1-methyl-2-oxospiro[indoline-3,2'-oxirane]-3'-
carboxylate 189-cis 
Following the above general procedure, cis diastereoisomer 
189-cis was obtained as a pale red solid in 50% yield after 
purification (nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3034, 
3003, 1759, 1740, 1583, 1463, 1334, 1306 cm1. 1H-NMR 
(CDCl3, 300 MHz, 25°C):    1.36 (t, J = 7.1 Hz, 3H, 
CH3CH2O); 3.59 (s, 3H, NCH3); 4.12 (s, 1H, OCH); 4.35 (q, J = 7.1 Hz, 2H, 
CH3CH2O); 6.97 (s, 1H, CHarom); 7.35 (s, 1H, CHarom) ppm. 13CNMR (CDCl3, 75 MHz, 
25°C):   14.2 (CH3), 30.2 (NCH3), 59.2, 60.7, 62.5, 117.1 (Carom), 121.4 (Carom), 125.3 
(Carom), 128.9 (Carom), 132.8 (Carom), 139.7 (Carom), 164.0, 168.8 (C=O) ppm.  HRMS: 
exact mass calculated for (C13H11Cl2NNaO4) requires m/z 337.9963, found m/z 
337.9961. Chiral-phase HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 nm, 
nHexane/EtOH=70/30, flow rate 1.0mL/min]: Tmajor = 21.69 min, Tminor = 20.20 min ee 
= 53%. [α] D = -42 (c = 0.0220 g/cm3 in CHCl3) 
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(trans)-(2'R,3'R)-ethyl 5,7-dichloro-1-methyl-2-oxospiro[indoline-3,2'-oxirane]-3'-
carboxylate 186-trans 
Following the above general procedure, trans diastereoisomer 
186-trans was obtained as a pale yellow solid in 38% yield after 
purification (nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3025, 3011, 
2959, 1739, 1727, 1625, 1494, 1471, 1369, 1346 cm1. 1H-NMR 
(CDCl3, 300 MHz, 25°C):    1.20 (d, J = 6.8 Hz, 6H, 
(CH3)2CHCarom); 1.29 (t, J = 7.1 Hz, 3H, CH3CH2O); 2.80 2.95 (m, 1H, 
(CH3)2CHCarom); 3.26 (s, 3H, NCH3); 4.18 4.40 (m, 3H, CH3CH2O, OCH); 6.84 (d, J = 
7.9 Hz, 1H, CHarom); 7.24 (d, J = 7.9 Hz, 1H, CHarom); 7.33 (m, 2H, CHarom) ppm. 
13CNMR (CDCl3, 75 MHz, 25°C):   14.3 (CH3), 24.2 (2xCH3),  26.9 (NCH3), 34.0 
(CHCH3), 59.9, 60.3, 62.3, 108.9 (Carom), 119.3 (Carom), 123.0 (Carom), 129.0 (Carom), 
143.6 (Carom), 144.3 (Carom), 165.9, 170.0 (C=O) ppm.  HRMS: exact mass calculated 
for (C16H19NNaO4) requires m/z 312.1212, found m/z 312.1215. Chiral-phase HPLC 
analysis: [Daiacel Chiralpack IC 5μ, =254 nm, nHexane/EtOH=70/30, flow rate 
1.0mL/min]: Tmajor = 14.85 min, Tminor = 8.42 min ee = 78%. [α] D = -79 (c = 0.0220 
g/cm3 in CHCl3) 
(cis)-(2'S,3'R)-ethyl 5,7-dichloro-1-methyl-2-oxospiro[indoline-3,2'-oxirane]-3'-
carboxylate 186-cis 
Following the above general procedure, cis diastereoisomer 
186-cis was obtained as a pale yellow solid in 52% yield 
after purification (nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 
3025, 3011, 2959, 1739, 1727, 1625, 1494, 1471, 1369, 1346 
cm1. 1H-NMR (CDCl3, 300 MHz, 25°C):    1.22 (d, J = 
6.8 Hz, 6H, (CH3)2CHCarom); 1.36 (t, J = 7.1 Hz, 3H, CH3CH2O); 2.80 2.95 (m, 1H, 
(CH3)2CHCarom); 3.23 (s, 3H, NCH3); 4.18 (s, 1H, OCH); 4.30 4.40 (m, 3H, 
CH3CH2O, OCH); 6.83 (d, J = 7.9 Hz, 1H, CHarom); 6.98 (s, 1H, CHarom); 7.28 (d, J = 
7.9 Hz, 1H, CHarom) ppm. 13CNMR (CDCl3, 75 MHz, 25°C):    14.2 (CH3), 24.2 
(2xCH3), 26.8 (NCH3), 33.9 (CHCH3), 60.2, 60.3, 62.1, 109.0 (Carom), 120.5 (Carom), 
121.1 (Carom), 129.2 (Carom), 143.2 (Carom), 144.3 (Carom), 164.9, 168.9 (C=O) ppm. 
HRMS: exact mass calculated for (C16H19NNaO4) requires m/z 312.1212, found m/z 
312.1215. Chiral-phase HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 nm, 
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nHexane/EtOH=70/30, flow rate 1.0mL/min]: Tmajor = 13.73 min, Tminor = 15.19 min ee 
= 79%. [α] D = -33 (c = 0.0250 g/cm3 in CHCl3) 
(trans)- (2'R,3'R)-ethyl 1-methyl-5-nitro-2-oxospiro[indoline-3,2'-oxirane]-3'-
carboxylate 187-trans 
Following the above general procedure, trans diastereoisomer 
187-trans was obtained as a pale yellow solid in 19% yield after 
purification (DCM 100%). IR (CHCl3): ˜ n = 3031, 3017, 3009, 
1754, 1743, 1617, 1533, 1494, 1340 cm1. 1H-NMR (CDCl3, 300 
MHz, 25°C):    1.34 (t, J = 7.1 Hz, 3H, CH3CH2O); 3.35 (s, 
3H, NCH3); 4.23 4.42 (m, 3H, CH3CH2O, OCH); 7.03 (d, J = 8.9 Hz, 1H, CHarom); 
8.37 (d, J = 7.4 Hz, 2H, CHarom) ppm. 13CNMR (CDCl3, 75 MHz, 25°C):    14.2 
(CH3), 27.4 (NCH3), 59.4, 60.1, 62.9, 108.9 (Carom), 120.4 (Carom), 121.1 (Carom), 128.0 
(Carom), 143.8 (Carom), 150.9 (Carom), 165.1, 170.1 (C=O) ppm. HRMS: exact mass 
calculated for (C13H12N2NaO6) requires m/z 315.0593, found m/z 315.0596. Chiral-
phase HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 nm, nHexane/EtOH=70/30, 
flow rate 1.0mL/min]: Tmajor = 23.13 min, Tminor = 22.02 min ee = 70%. [α] D = -29 (c = 
0.0180 g/cm3 in CHCl3) 
(cis)- (2'S,3'R)-ethyl 1-methyl-5-nitro-2-oxospiro[indoline-3,2'-oxirane]-3'-
carboxylate 187-cis 
Following the above general procedure, cis diastereoisomer 
187-cis was obtained as a pale yellow solid in 53% yield 
after purification (DCM 100%). IR (CHCl3): ˜ n = 3029, 
3017, 3009, 1754, 1729, 1630, 1527, 1494, 1463, 1340 
cm1. 1H-NMR (CDCl3, 300 MHz, 25°C):    1.37 (t, J = 
7.1 Hz, 3H, CH3CH2O); 3.33 (s, 3H, NCH3); 4.29 (s, 1H, OCH); 4.36 (dq, J = 9.2 Hz, 
7.1 Hz, 1H, CH3CHHO); 4.38 (dq, J = 9.2 Hz, 7.1 Hz, 1H, CH3CHHO); 7.03 (d, J = 8.9 
Hz, 1H, CHarom); 8.02 (d, J = 1.9 Hz, 1H, CHarom); 8.39 (dd, J = 8.7 Hz, 2.2 Hz, 1H, 
CHarom) ppm. 13CNMR (CDCl3, 75 MHz, 25°C):    14.1 (CH3), 27.3 (NCH3), 59.2 
(CO), 60.4 (CH2), 62.5 (CH), 109 (Carom), 118.5 (Carom), 122.2 (Carom), 128.1 (Carom), 
143.2 (Carom), 150.5 (Carom), 163.9, 169.1 (C=O) ppm. HRMS: exact mass calculated for 
(C13H12N2NaO6) requires m/z 315.0593, found m/z 315.0596. Chiral-phase HPLC 
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analysis: [Daiacel Chiralpack IB 5μ, =254 nm, nHeptane/EtOH/DEA=70/30/0.1, flow 
rate 1.0mL/min]: Tmajor = 12.89 min, Tminor = 14.80 min ee = 12%. [α] D = -29 (c = 
0.0160 g/cm3 in CHCl3) 
(2'R,3'R)-ethyl 5-methoxy-1-methyl-2-oxospiro[indoline-3,2'-oxirane]-3'-
carboxylate 188-trans 
Following the above general procedure, trans diastereoisomer 
188-trans was obtained as a pale yellow solid in 50% yield 
after purification (hexane/EtOAc = 8/2). IR (CHCl3): ˜ n = 
1735, 1734, 1614, 1492, 1467, 1358, 1260 cm1. 1H-NMR 
(CDCl3, 300 MHz, 25°C):    1.28 (t, J = 7.1 Hz, 3H, 
CH3CH2O); 3.23 (s, 3H, NCH3); 3.75 (s, 3H, OCH3); 4.18 (s, 1H, OCH); 4.22-4.25 (m, 
2H, CH3CH2O); 6.80 (d, J = 8.5 Hz, 1H, CHarom); 6.92 (d, J = 8.5 Hz, 1H, CHarom); 7.09 
(s, 1H, CHarom) ppm. 13CNMR (CDCl3, 75 MHz, 25°C):   14.3 (CH3), 26.9 (NCH3), 
56.0, 59.9, 62.3, 120.5 (Carom), 139.1 (Carom), 156.3 (Carom), 165.8 (Carom), 169.8 (C=O) 
ppm. HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 nm, nHeptane/EtOH=70/30, 
flow rate 1.0mL/min]: Tmajor = 16.33 min, Tminor = 11.45 min ee = 80%. [α] D = -10 (c = 
0.0451 g/cm3 in CHCl3) 
(2'S,3'R)-ethyl 5-methoxy-1-methyl-2-oxospiro[indoline-3,2'-oxirane]-3'-
carboxylate 188-cis 
Following the above general procedure, trans 
diastereoisomer 188-cis was obtained as a pale yellow solid 
in 50% yield after purification (hexane/EtOAc = 8/2). IR 
(CHCl3): ˜ n = 1763, 1603, 1502, 1367, 1290 cm1.1H-NMR 
(CDCl3, 300 MHz, 25°C):    1.34 (t, J = 7.2 Hz, 3H, CH3CH2O); 3.18 (s, 3H, NCH3); 
3.75 (s, 3H, OCH3); 4.12 (s, 1H, OCH); 4.33 (q, J = 7.2 Hz, 2H, CH3CH2O); 6.69 (s, 
1H, CHarom); 6.69 (d, J = 8.5 Hz, 1H, CHarom); 6.90 (d, J = 8.5 Hz, 1H, CHarom) ppm. 
13CNMR (CDCl3, 75 MHz, 25°C):   14.1 (CH3), 26.7 (NCH3), 56.0, 60.3, 62.1, 109.4 
(Carom), 109.7 (Carom), 122.4 (Carom), 138.6 (Carom), 156.5 (Carom), 164.8 (Carom), 168.6 
(C=O) ppm. HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 nm, 
nHeptane/EtOH=70/30, flow rate 1.0mL/min]: Tmajor = 16.35 min, Tminor = 19.33 min ee 
= 24%. [α] D = -4 (c = 0.0390 g/cm3 in CHCl3) 
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(2'R,3'R)-ethyl 5-fluoro-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 248-trans 
Following the above general procedure, trans diastereoisomer 248-
trans was obtained as a white solid in 32% yield after purification 
(nHexane/EtOAc=7/3). IR (CHCl3): ˜ n = 3429, 3207, 3031, 2979, 
1715, 1767, 1752, 1630, 1481, 1319, 1231, 1204 cm1. 1H-NMR 
(CDCl3, 300 MHz, 25°C):   1.32 (t, 3H, J = 7.1 Hz, CH3CH2O); 
4.19 (s, 1H, OCH); 4.26-4.36 (m, 2H, CH3CH2O); 6.88 (m, 1H, CHarom); 7.06 (t, 1H, J = 
8.4 Hz, CHarom); 7.24 (m, 1H, CHarom); 8.66 (s, 1H, NH) ppm. 13CNMR (CDCl3, 75 
MHz, 25°C):    14.3 (CH3), 60.0 (CO), 60.5 (CH2), 62.7 (CH), 111.9 (d, JCF = 7.9 Hz, 
Carom), 113.5 (d, JCF = 26.7 Hz, Carom), 117.9 (d, JCF = 23.9 Hz, Carom), 121.3 (d, JCF = 
9.1 Hz, Carom), 138.8 (Carom), 159.3 (d, JCF = 242.2 Hz, Carom), 165.4 (OC=O), 172.3 
(C=O) ppm. HRMS: exact mass calculated for (C12H10FNNaO4) requires m/z 274.0492, 
found m/z 274.0497. Chiral-phase HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 
nm, nHexane/EtOH=90/10, flow rate 1.0mL/min]: Tmajor = 10.44 min, Tminor = 9.05 min 
ee = 86%. [α] D = -132 (c = 0.0155 g/cm3 in CHCl3) 
(2'S,3'R)-ethyl 5-fluoro-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 248-cis 
Following the above general procedure, cis diastereoisomer 
248-cis was obtained as a white solid in 58% yield after 
purification (nHexane/EtOAc=7/3). IR (CHCl3): ˜ n = 3429, 
3207, 3031, 2979, 1715, 1767, 1752, 1630, 1481, 1319, 1231, 
1204 cm1. 1H-NMR (CDCl3, 300 MHz, 25°C):    1.35 (t, 3H, J = 7.0 Hz, CH3CH2O); 
4.15 (s, 1H, OCH); 4.35 (q, 2H, J = 7.0 Hz, CH3CH2O ); 6.84–6.93 (m, 2H, CHarom); 
7.07 (t, 1H, J = 8.6 Hz, CHarom); 8.44 (s, 1H, NH) ppm. 13CNMR (CDCl3, 75 MHz, 
25°C):   14.3 (CH3), 60.0 (CH2), 60.5(CO), 62.7 (CH), 111.9 (d, JCF = 7.9 Hz, Carom), 
113.5 (d, JCF = 26.7 Hz, Carom), 117.9 (d, JCF = 23.9 Hz, Carom), 121.3 (d, JCF = 9.1 Hz, 
Carom), 138.8 (Carom), 159.3 (d, JCF = 242.2 Hz, Carom), 165.4 (OC=O), 172.3 (C=O) 
ppm. HRMS: exact mass calculated for (C12H10FNNaO4) requires m/z 274.0492, found 
m/z 274.0497. Chiral-phase HPLC analysis: [Daiacel Chiralpack IB 5μ, =254 nm, 
nHeptane/EtOH/DEA=70/30/0.1, flow rate 1.0mL/min]: Tmajor = 5.22 min, Tminor = 5.97 
min ee = 22%. [α] D = -381 (c = 0.0221 g/cm3 in CHCl3) 
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(2'R,3'R)-ethyl 5-chloro-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 249-trans 
Following the above general procedure, trans diastereoisomer 249-
trans was obtained as a white solid in 33% yield after purification 
(nHexane/EtOAc=1/1). IR (CHCl3): ˜ n = 3433, 3213, 3021, 1764, 
1755, 1602, 1441, 1240, 1228, 1213  cm1. 1H-NMR (CDCl3, 300 
MHz, 25°C):   1.32 (t, 3H, J = 7.1 Hz, CH3CH2O); 4.19 (s, 1H, OCH); 4.26-4.36 (m, 
2H, CH3CH2O); 6.88 (m, 1H, CHarom); 7.06 (t, 1H, J = 8.4 Hz, CHarom); 7.24 (m, 1H, 
CHarom); 8.66 (s, 1H, NH) ppm. 13CNMR (CDCl3, 75 MHz, 25°C):   14.3 (CH3), 60.0 
(CH2), 60.5 (CO), 62.7 (CH), 112.1 (Carom), 123.3 (Carom), 125.9 (Carom), 129.0 (Carom), 
131.3 (Carom), 140.3 (Carom), 165.4 (OC=O), 171.8 (C=O) ppm. HRMS: exact mass 
calculated for (C12H10ClNNaO4) requires m/z 290.0196, found m/z 290.0198. Chiral-
phase HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 nm, nHexane/EtOH=70/30, 
flow rate 1.0mL/min]: Tmajor = 5.15 min, Tminor = 4.66 min ee = 86%. [α] D = -43 (c = 
0.0108 g/cm3 in CHCl3) 
(2'S,3'R)-ethyl 5-chloro-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 249-cis 
Following the above general procedure, cis diastereoisomer 
249-cis was obtained as a white solid in 50% yield after 
purification (nHexane/EtOAc=1/1). IR (CHCl3): ˜ n = 3433, 
3265, 3024, 1761, 1733, 1633, 1481, 1277, 1200 cm1. 1H-
NMR (CDCl3, 300 MHz, 25°C):    1.34 (t, 3H, J = 7.2 Hz, CH3CH2O); 4.16 (s, 1H, 
OCH); 4.34 (q, 2H, J = 7.2  Hz, CH3CH2O ); 6.92 (d, 1H, J = 8.3 Hz, CHarom); 7.08 ( s, 
1H, CHarom); 7.33 (d, 1H, J = 8.3 Hz, CHarom); 8.65 (s, 1H, NH) ppm. 13CNMR (CDCl3, 
75 MHz, 25°C):   14.2 (CH3), 60.1 (CO), 60.5 (CH2), 62.4 (CH), 112.4 (Carom), 123.3 
(Carom), 128.9 (Carom), 131.3 (Carom), 131.4 (Carom), 140.9 (Carom), 164.2 (OC=O), 170.7 
(C=O) ppm. HRMS: exact mass calculated for (C12H10ClNNaO4) requires m/z 
290.0196, found m/z 290.0198. Chiral-phase HPLC analysis: [Daiacel Chiralpack IC 
5μ, =254 nm, nHeptane/EtOH/DEA=70/30/0.1, flow rate 1.0mL/min]: Tmajor = 5.30 
min, Tminor = 6.13 min ee = 18%. [α] D = -29 (c = 0.0164 g/cm3 in CHCl3) 
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(2'R,3'R)-ethyl 5-iodo-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 250-trans 
Following the above general procedure, trans diastereoisomer 
250-trans was obtained as a white solid in 71% yield after 
purification (nHexane/EtOAc=1/1). IR (CHCl3): ˜ n = 1765, 1760, 
1602, 1441, 1240, 1228 cm1. 1H-NMR (CDCl3, 300 MHz, 25°C): 
  1.34 (t, 3H, J = 7.0 Hz, CH3CH2O); 4.17-4.40 (m, 3H, CHO, 
CH3CH2O); 6.76 (d, 1H, J = 8.3 Hz, CHarom); 7.67 (d, 1H, J = 8.3 Hz, CHarom); 7.76 (s, 
1H, CHarom), 8.73 (bs, 1H, NH) ppm. 13CNMR (CDCl3, 75 MHz, 25°C):    14.4 
(CH3), 59.8 (CO), 60.1 (CH2), 62.7 (CH), 85.6 (Carom), 113.0 (Carom), 122.0 (Carom), 
134.2 (Carom), 140.1 (Carom), 142.4 (Carom), 165.4 (OC=O), 171.2 (C=O) ppm. HRMS: 
exact mass calculated for (C12H10INNaO4) requires m/z 381.9552, found m/z 381.9555. 
Chiral-phase HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 nm, 
nHexane/EtOH=90/10, flow rate 1.0mL/min]: τmajor = 11.56 min, τminor = 9.81 min ee = 
36%. [α] D = -23 (c = 0.0120 g/cm3 in CHCl3) 
(2'S,3'R)-ethyl 5-iodo-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 250-cis 
Following the above general procedure, cis diastereoisomer 
250-cis was obtained as a white solid in 20% yield after 
purification (nHexane/EtOAc=1/1). 1H-NMR (CDCl3, 300 
MHz, 25°C):    1.35 (t, 3H, J = 7.1 Hz, CH3CH2O); 4.18 (s, 
1H, OCH); 4.25-4.43 (m, 2H, CH3CH2O ); 6.77 (d, 1H, J = 8.2 
Hz, CHarom); 7.67 (d, 1H, J = 8.2 Hz, CHarom); 7.76 ( s, 1H, CHarom); 8.81 (s, 1H, NH) 
ppm. 13CNMR (CDCl3, 75 MHz, 25°C):    14.2 (CH3), 60.1 (CO), 60.5 (CH2), 62.4 
(CH), 112.4 (Carom), 123.3 (Carom), 128.9 (Carom), 131.3 (Carom), 131.4 (Carom), 140.9 
(Carom), 164.2 (OC=O), 170.7 (C=O) ppm. HRMS: exact mass calculated for 
(C12H10INNaO4) requires m/z 381.9552, found m/z 381.9555. Chiral-phase HPLC 
analysis: [Daiacel Chiralpack IB 5μ, =254 nm, nHeptane/EtOH/DEA=70/30/0.1, flow 
rate 1.0mL/min]: τmajor = 5.46 min, τminor = 6.43 min ee = 18%. [α] D = -2 (c = 0.0101 
g/cm3 in CHCl3) 
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(2'R,3'R)-ethyl 2-oxo-5-(trifluoromethoxy)spiro[indoline-3,2'-oxirane]-3'-
carboxylate, 251-trans 
Following the above general procedure, trans diastereoisomer 
251-trans was obtained as a white solid in 29% yield after 
purification (nHexane/EtOAc=7/3). IR (CHCl3): ˜ n = 3433, 
3210, 3028, 1764, 1724, 1630, 1478, 1371, 1234, 1197 cm1. 
1H-NMR (CDCl3, 300 MHz, 25°C):   1.31 (t, 3H, J = 7.0 Hz, 
CH3CH2O); 4.20 (s, 1H, OCH); 4.31 (q, 2H, J = 7.0  Hz, CH3CH2O ); 6.97 (d, 1H, J = 
8.4 Hz, CHarom); 7.22-7.26 (m, 1H, CHarom); 7.41 (s, 1H, CHarom); 8.41 (bs, 1H, NH) 
ppm. 13CNMR (CDCl3, 75 MHz, 25°C):    14.2 (CH3), 60.1 (CO), 60.0 (CH2), 62.7 
(CH), 111.6 (Carom), 119.6 (Carom), 120.6 (q, JCF = 256.0 Hz, CF3), 121.3 (Carom), 124.6 
(Carom), 141.3 (Carom), 145.1 (Carom), 165.3 (OC=O), 171.7 (C=O) ppm. HRMS: exact 
mass calculated for (C13H10F3NNaO5) requires m/z 340.0409, found m/z 340.0410. 
Chiral-phase HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 nm, 
nHexane/EtOH=95/5, flow rate 1.0mL/min]: τmajor = 12.04 min, τminor = 9.15 min ee = 
73%. [α] D = -56.53 (c = 0.0168 g/cm3 in CHCl3) 
(2'S,3'R)-ethyl 2-oxo-5-(trifluoromethoxy)spiro[indoline-3,2'-oxirane]-3'-
carboxylate, 251-cis 
Following the above general procedure, cis 
diastereoisomer 251-cis was obtained as a white solid in 
47% yield after purification (nHexane/EtOAc=7/3). IR 
(CHCl3): ˜ n = 3433, 3207, 3015, 1764, 1724, 1636, 1584, 
1487, 1264, 1234 cm1. 1H-NMR (CDCl3, 300 MHz, 25°C):   1.35 (t, 3H, J = 7.0 Hz, 
CH3CH2O); 4.19 (s, 1H, OCH); 4.35 (q, 2H, J = 7.0  Hz, CH3CH2O ); 6.99-7.01 (m, 2H, 
CHarom); 7.23 (s, 1H, CHarom); 8.57 (bs, 1H, NH) ppm. 13CNMR (CDCl3, 75 MHz, 
25°C):   14.2 (CH3), 60.3 (CO), 60.5 (CH2), 62.5 (CH), 112.4 (Carom), 116.6 (Carom), 
120.6 (q, JCF = 257.3 Hz, CF3), 122.3 (Carom), 124.7 (Carom), 141.3 (Carom), 145.1 (Carom), 
164.3 (OC=O), 171.3 (C=O) ppm. HRMS: exact mass calculated for (C13H10F3NNaO5) 
requires m/z 340.0409, found m/z 340.0410. Chiral-phase HPLC analysis: [Daiacel 
Chiralpack IB 5μ, =254 nm, nHeptane/EtOH/DEA=70/30/0.1, flow rate 1.0mL/min]: 
τmajor = 4.44 min, τminor = 5.31 min ee = 32%. [α] D = -20.7 (c = 0.0133 g/cm3 in CHCl3) 
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(2'R,3'R)-ethyl 7-fluoro-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 252-trans 
Following the above general procedure, trans diastereoisomer 252-
trans was obtained as a white solid in 21% yield after purification 
(nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3433, 3031, 2976, 2930, 
1752, 1737, 1639, 1493, 1234, 1228 cm1. 1H-NMR (CDCl3, 300 
MHz, 25°C):   1.30 (t, 3H, J = 7.0 Hz, CH3CH2O); 4.20 (s, 1H, 
OCH); 4.25-4.30 (m, 2H, CH3CH2O ); 7.01-7.05 (m, 1H, CHarom); 7.14 (t, 1H, J = 9.2 
Hz, CHarom); 7.28 (d, 1H, J = 9.2 Hz, CHarom); 7.84 (s, 1H, NH) ppm. 13CNMR (CDCl3, 
75 MHz, 25°C):   14.3 (CH3), 60.0 (CO), 60.1 (CH2), 62.5 (CH), 118.4 (d, JCF = 17 
Hz, Carom), 121.1 (d, JCF = 3.6 Hz, Carom), 122.2 (Carom), 124.0 (d, JCF = 5.9 Hz, Carom), 
129.9 (Carom), 147.4 (d, JCF = 244.7 Hz, Carom), 165.3 (OC=O), 170.5 (C=O) ppm. 
HRMS: exact mass calculated for (C12H10FNNaO4) requires m/z 274.0492, found m/z 
274.0493. Chiral-phase HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 nm, 
nHexane/EtOH=8/2, flow rate 1.0mL/min]: τmajor = 7.88 min, τminor = 8.60 min ee = 
84%. [α] D = -63.2 (c = 0.0150 g/cm3 in CHCl3) 
(2'S,3'R)-ethyl 7-fluoro-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 252-cis 
Following the above general procedure, cis diastereoisomer 252-
cis was obtained as a white solid in 72% yield after purification 
(nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 3433, 3201, 3056, 2988, 
1773, 1761, 1605, 1328, 1252 cm1. 1H-NMR (CDCl3, 300 MHz, 
25°C):    1.36 (t, 3H, J = 7.1 Hz, CH3CH2O); 4.18 (s, 1H, 
OCH); 4.36 (q, 2H, J = 7.1 Hz, CH3CH2O ); 6.92 (d, 1H, J = 7.4 Hz, CHarom); 7.01-7.17 
(m, 2H, CHarom); 8.42 (s, 1H, NH) ppm. 13CNMR (CDCl3, 75 MHz, 25°C):   14.1 
(CH3), 60.3 (CO), 60.5 (CH2), 62.4 (CH), 118.4 (d, JCF = 8.6 Hz, Carom), 118.6 (d, JCF = 
5.1 Hz, Carom), 124.0 (Carom), 124.2 (d, JCF = 3.5 Hz, Carom), 129.8 (d, JCF = 13.2 Hz, 
Carom), 147.5 (d, JCF = 246.1 Hz, Carom), 164.5 (OC=O), 170.6 (C=O) ppm. HRMS: 
exact mass calculated for (C12H10FNNaO4) requires m/z 274.0492, found m/z 274.0493. 
Chiral-phase HPLC analysis: [Daiacel Chiralpack IB 5μ, =254 nm, 
nHeptane/EtOH/DEA=70/30/0.1, flow rate 1.0 mL/min]: τmajor = 5.08 min, τminor = 5.78 
min ee = 40%. [α] D = -44.4 (c = 0.0291 g/cm3 in CHCl3) 
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 (2'R,3'R)-ethyl 7-chloro-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 253-
trans 
Following the above general procedure, trans diastereoisomer 253-
trans was obtained as a white solid in 35% yield after purification 
(nHexane/EtOAc=7/3). IR (CHCl3): ˜ n = 3420, 3177, 3009, 1764, 
1749, 1624, 1478, 1316, 1234, 1189 cm1. 1H-NMR (CDCl3, 300 
MHz, 25°C):   1.29 (t, 3H, J = 6.8 Hz, CH3CH2O); 4.20-4.31 (m, 
2H, CH3CH2O, OCH); 7.01 (t, 1H, J = 8.1 Hz, CHarom); 7.36 (t, 2H, J = 8.1 Hz, CHarom); 
8.14 (s, 1H, NH)  ppm. 13CNMR (CDCl3, 75 MHz, 25°C):   14.2 (CH3), 60.1 (CH2), 
60.7 (CO), 62.5 (CH), 116.3 (Carom), 121.3 (Carom), 123.6 (Carom), 124.1 (Carom), 131.1 
(Carom), 140.4 (Carom), 165.3 (OC=O), 171.2 (C=O)  ppm. HRMS: exact mass calculated 
for (C12H10ClNNaO4) requires m/z 290.0196, found m/z 290.0197. Chiral-phase HPLC 
analysis: [Daiacel Chiralpack IC 5μ, =254 nm, nHexane/EtOH=8/2, flow rate 
1.0mL/min]: τmajor = 7.72 min, τminor = 10.00 min ee = 76%. [α] D = -186.6 (c = 0.0220 
g/cm3 in CHCl3) 
(2'S,3'R)-ethyl 7-chloro-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 253-cis  
Following the above general procedure, cis diastereoisomer 253-
cis was obtained as a white solid in 63% yield after purification 
(nHexane/EtOAc=7/3). IR (CHCl3): ˜ n = 3426, 3201, 3003, 1764, 
1736, 1627, 1478, 1328, 1237, 1200 cm1. 1H-NMR (CDCl3, 300 
MHz, 25°C):    1.35 (t, 3H, J = 7.1 Hz, CH3CH2O); 4.16 (s, 
1H, OCH); 4.38 (q, 2H, J = 7.1 Hz, CH3CH2O); 7.03-7.05 (m, 2H, CHarom); 7.35 (d, 1H, 
J = 7.4 Hz, CHarom); 8.02 (s, 1H, NH)  ppm. 13CNMR (CDCl3, 75 MHz, 25°C):   14.2 
(CH3), 60.5 (CH2), 60.6 (CO), 62.4 (CH), 116.4 (Carom), 121.0 (Carom), 123.1 (Carom), 
124.1 (Carom), 131.2 (Carom), 140.0 (Carom), 164.3 (OC=O), 170.2 (C=O) ppm. HRMS: 
exact mass calculated for (C12H10ClNNaO4) requires m/z 290.0196, found m/z 
290.0197. Chiral-phase HPLC analysis: [Daiacel Chiralpack IB 5μ, =254 nm, 
nHeptane/EtOH/DEA=70/30/0.1, flow rate 1.0mL/min]: τmajor = 5.24 min, τminor = 5.67 
min ee = 24%. [α] D = -27.9 (c = 0.0168 g/cm3 in CHCl3) 
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(2'R,3'R)-ethyl 7-bromo-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 254-
trans 
Following the above general procedure, trans diastereoisomer 254-
trans was obtained as a white solid in 49% yield after purification 
(nHexane/EtOAc=7/3). IR (CHCl3): ˜ n = 3414, 3210, 3006, 1742, 
1730, 1621, 1444, 1316, 1234 cm1. 1H-NMR (CDCl3, 300 MHz, 
25°C):   1.29 (t, 3H, J = 7.1 Hz, CH3CH2O); 4.20 (s, 1H, OCH); 
4.23-4.37 (m, 2H, CH3CH2O ); 6.96 (t, 1H, J = 7.9 Hz, CHarom); 7.42 (d, 1H, J = 7.9 
Hz, CHarom); 7.48 (d, 1H, J = 7.9 Hz, CHarom); 8.06 (s, 1H, NH)  ppm. 13CNMR (CDCl3, 
75 MHz, 25°C):   14.3 (CH3), 60.1 (CH2), 61.0 (CO), 62.6 (CH), 104.1 (Carom), 121.4 
(Carom), 124.3 (Carom), 124.5 (Carom), 133.9 (Carom), 141.9 (Carom), 165.3 (OC=O), 170.5 
(C=O) ppm. HRMS: exact mass calculated for (C12H10BrNNaO4) requires m/z 
333.9691, found m/z 333.9693. Chiral-phase HPLC analysis: [Daiacel Chiralpack IC 
5μ, =254 nm, nHexane/EtOH=7/3, flow rate 1.0mL/min]: τmajor = 6.14 min, τminor = 
7.18 min ee = 83%. [α] D = -15.85 (c = 0.0132 g/cm3 in CHCl3) 
(2'S,3'R)-ethyl 7-bromo-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 254-cis 
Following the above general procedure, cis diastereoisomer 254-
cis was obtained as a white solid in 38% yield after purification 
(nHexane/EtOAc=7/3). IR (CHCl3): ˜ n = 3414, 3210, 3006, 1742, 
1730, 1621, 1444, 1316, 1234 cm1. 1H-NMR (CDCl3, 300 MHz, 
25°C):    1.35 (t, 3H, J = 6.9 Hz, CH3CH2O); 4.16 (s, 1H, 
OCH); 4.36 (q, 2H, J = 6.9 Hz, CH3CH2O ); 6.97-7.07 (m, 2H, CHarom); 7.49 (d, 1H, J = 
7.8 Hz, CHarom); 7.66 (s, 1H, NH)  ppm. 13CNMR (CDCl3, 75 MHz, 25°C):   14.2 
(CH3), 60.7 (CH2), 60.9 (CO), 62.4 (CH), 104.2 (Carom), 121.7 (Carom), 123.2 (Carom), 
124.4 (Carom), 134.0 (Carom), 141.6 (Carom), 164.2 (OC=O), 169.5 (C=O) ppm. HRMS: 
exact mass calculated for (C12H10BrNNaO4) requires m/z 333.9691, found m/z 
333.9693. Chiral-phase HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 nm, 
nHexane/EtOH=8/2, flow rate 1.0mL/min]: τmajor = 13.98 min, τminor = 12.80 min ee = 
29%. [α] D = -32.92 (c = 0.0120 g/cm3 in CHCl3) 
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(2'R,3'R)-ethyl 5,7-dichloro-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 255-
trans 
Following the above general procedure, trans diastereoisomer 255-
trans was obtained as a white solid in 27% yield after purification 
(nHexane/EtOAc=7/3). IR (CHCl3): ˜ n = 3423, 3031, 3009, 1757, 
1743, 1463, 1323, 1290 cm1. 1H-NMR (CDCl3, 300 MHz, 
25°C):    1.32 (t, J = 7.0 Hz, 3H, CH3CH2O); 4.18-4.36 (m, 3H, 
CH3CH2O, OCH); 7.38 (s, 1H, CHarom); 7.42 (s, 1H, CHarom); 8.09 (s, 1H, NH) ppm. 
13CNMR (CDCl3, 75 MHz, 25°C):   14.3 (CH3), 60.1 (CH2), 60.4 (CO), 62.9 (CH), 
116.6 (Carom), 122.4 (Carom), 124.4 (Carom), 129.3 (Carom), 130.8 (Carom), 138.9 (Carom), 
165.1 (OC=O), 170.1 (C=O) ppm. HRMS: exact mass calculated for (C12H9Cl2NNaO4) 
requires m/z 323.9806, found m/z 323.9808. Chiral-phase HPLC analysis: [Daiacel 
Chiralpack IC 5μ, =254 nm, nHexane/EtOH=7/3, flow rate 1.0mL/min]: τmajor = 5.52 
min, τminor = 6.34 min ee = 65%. [α] D = +137 (c = 0.0090 g/cm3 in CHCl3) 
(2'S,3'R)-ethyl 5,7-dichloro-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate, 255-
cis 
Following the above general procedure, cis diastereoisomer 
255-cis was obtained as a white solid in 51% yield after 
purification (nHexane/EtOAc=7/3). IR (CHCl3): ˜ n = 3423, 
3031, 3003, 1765, 1740, 1706, 1633, 1469, 1315 cm1. 1H-
NMR (CDCl3, 300 MHz, 25°C):    1.35 (t, J = 7.2 Hz, 3H, 
CH3CH2O); 4.16 (s, OCH); 4.35(q, J = 6.6 Hz, 2H, CH3CH2O,); 7.01 (s, 1H, CHarom); 
7.37 (s, 1H, CHarom); 8.31 (s, 1H, NH) ppm. 13CNMR (CDCl3, 75 MHz, 25°C):    
14.2 (CH3), 60.1 (CH2), 60.6 (CO), 62.6 (CH), 116.8 (Carom), 121.8 (Carom), 124.4 
(Carom), 129.2 (Carom), 130.9 (Carom), 138.6 (Carom), 163.8 (OC=O), 169.3 (C=O) ppm. 
HRMS: exact mass calculated for (C12H9Cl2NNaO4) requires m/z 323.9806, found m/z 
323.9808. Chiral-phase HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 nm, 
nHexane/EtOH=9/1, flow rate 1.0mL/min]: τmajor = 20.84 min, τminor = 19.81 min ee = 
72%. [α] D = +10 (c = 0.0100 g/cm3 in CHCl3) 
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diethyl ((2'S,3'S)-1-methyl-2-oxospiro[indoline-3,2'-oxiran]-3'-yl)phosphonate, 
256-trans 
Following the above general procedure, trans diastereoisomer 256-
trans was obtained as a pale yellow solid in 45% yield after 
purification (nHexane/EtOAc=4/6).1 IR (CHCl3): ˜ n = 1725, 1236 
cm1. 1H-NMR (CDCl3, 300 MHz, 25°C):   1.21 [t, J = 7.0 Hz, 
3H, (CH3CH2O)2P], 1.41 [t, J = 7.1  Hz, 3H, (CH3CH2O)2P], 3.26 
(s, 3H, NCH3), 3.73 (d, JHP = 27.6  Hz, 1H, OCH), 3.95–4.14 [m, 2H, (CH3CH2O)2P], 
4.20–4.37 [m, 2H, (CH3CH2O)2P], 6.90 (d, J = 7.9 Hz, 1H, CHarom), 7.1 (dt, J = 7.7, 1.0 
Hz, 1H, CHarom), 7.39 (dt, J = 7.9, 1.3 Hz, 1H, CHarom), 7.99 (d, J = 7.7 Hz, 1H, CHarom) 
ppm. Chiral-phase HPLC analysis: [Daiacel Chiralpack IB 5μ, =254 nm, 
nHexane/iPrOH=9/1, flow rate 1.0mL/min]: Tmajor = 42.20 min, Tminor = 23.60 min ee = 
60%. [α] D = -2 (c = 0.0101 g/cm3 in CHCl3) 
diethyl ((2'S,3'R)-1-methyl-2-oxospiro[indoline-3,2'-oxiran]-3'-yl)phosphonate, 
256-cis 
Following the above general procedure, cis diastereoisomer 
256-cis was obtained as a pale yellow solid in 35% yield after 
purification (nHexane/EtOAc=4/6).1  1H-NMR (CDCl3, 300 
MHz, 25°C):    1.35–1.43 [m, 6H, (CH3CH2O)2P], 3.26 (s, 
3H, NCH3), 3.71 (d, JH,P = 27.4  Hz, 1H, OCH), 4.18–4.48 [m, 
4H, (CH3CH2O)2P], 6.89 (d, J = 7.9 Hz, 1H, CHarom), 7.04–7.08 (m, 2H, CHarom), 7.35–
7.44 (m, 1H, CHarom) ppm. Chiral-phase HPLC analysis: [Daiacel Chiralpack IB 5μ, 
=254 nm, nHexane/iPrOH=9/1, flow rate 1.0mL/min]: Tmajor = 16.50 min, Tminor = 
12.80 min ee = 21%. [α] D = -19.45 (c = 0.0098 g/cm3 in CHCl3) 
diethyl ((2'S,3'S)-1-phenyl-2-oxospiro[indoline-3,2'-oxiran]-3'-yl)phosphonate, 257-
trans 
Following the above general procedure, trans diastereoisomer 
257-trans was obtained as a pale yellow solid in 57% yield after 
purification (nHexane/EtOAc=1/1).1 IR (CHCl3): ˜ n = 1716, 1265 
cm1. 1H-NMR (CDCl3, 300 MHz, 25°C):   1.18 [t, J = 7.1  Hz, 
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3H, (CH3CH2O)2P], 1.34 [t, J =7.1 Hz, 3H, (CH3CH2O)2P], 3.76 (d, JH,P = 27.6 Hz, 1H, 
OCH), 4.00–4.08 [m, 2H, (CH3CH2O)2P], 4.18–4.33 [m, 2H, (CH3CH2-O)2P], 6.77 (d, J 
= 7.6 Hz, 1H, CHarom), 7.05 (t, J = 7.6 Hz, 1H, CHarom), 7.22 (t, J = 7.6 Hz, 1H, CHarom), 
7.35–7.46 (m, 5H, CHarom), 7.96 (d, J = 7.6 Hz, 1H, CHarom) ppm. Chiral-phase HPLC 
analysis: [Daiacel Chiralpack IB 5μ, =254 nm, nHexane/iPrOH=9/1, flow rate 
1.0mL/min]: Tmajor = 39.90 min, Tminor = 17.50 min ee = 58%. [α] D = -6.7 (c = 0.0122 
g/cm3 in CHCl3) 
diethyl ((2'S,3'R)-1-phenyl-2-oxospiro[indoline-3,2'-oxiran]-3'-yl)phosphonate, 
257-cis 
Following the above general procedure, cis diastereoisomer 
257-cis was obtained as a pale yellow solid in 36% yield after 
purification (nHexane/EtOAc=1/1).1 1H-NMR (CDCl3, 300 
MHz, 25°C):    1.33–1.42 [m, 6H, (CH3CH2O)2P], 3.79 (d, 
JH,P = 27.3 Hz, 1H, OCH), 4.18–4.45 [m, 4H, (CH3CH2O)2P], 6.86 (d, J = 7.9 Hz, 1H, 
CHarom), 7.05–7.14 (m, 2H, CHarom), 7.28–7.39 (m, 1H, CHarom), 7.40–7.57 (m, 5H, 
CHarom) ppm. Chiral-phase HPLC analysis: [Daiacel Chiralpack IB 5μ, =254 nm, 
nHexane/iPrOH=9/1, flow rate 1.0mL/min]: Tmajor = 12.40 min, Tminor = 9.29 min ee = 
24%. [α] D = -20.5 (c = 0.0047 g/cm3 in CHCl3) 
diethyl ((2'S,3'S)-1-benzyl-2-oxospiro[indoline-3,2'-oxiran]-3'-yl)phosphonate, 258-
trans 
Following the above general procedure, trans diastereoisomer 258-
trans was obtained as a yellow solid in 45% yield after purification 
(nHexane/EtOAc=1/1).1 IR (CHCl3): ˜ n = 1731, 1262 cm1. 1H-
NMR (CDCl3, 300 MHz, 25°C):   1.22 [t, J = 7.1 Hz, 3H, 
(CH3CH2O)2P], 1.43 [t, J =7.1 Hz, 3H, (CH3CH2O)2P], 3.81 (d, 
JH,P = 27.4  Hz, 1H, OCH), 4.02–4.14 [m, 2H, (CH3CH2O)2P], 
4.24–4.39 [m, 2H, (CH3CH2-O)2P], 4.96 (s, 2H, CH2N), 6.81 (d, J = 7.6 Hz, 1H, 
CHarom), 7.07 (t, J = 7.6 Hz, 1H, CHarom), 7.24–7.36 (m, 6H, CHarom), 8.00 (d, J = 7.6 
Hz, 1H, CHarom) ppm. Chiral-phase HPLC analysis: [Daiacel Chiralpack IB 5μ, =254 
nm, nHexane/iPrOH=9/1, flow rate 1.0mL/min]: Tmajor = 39.90 min, Tminor = 17.50 min 
ee = 58%. [α] D = -6.7 (c = 0.0122 g/cm3 in CHCl3) 
N
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diethyl ((2'S,3'R)-1-benzyl-2-oxospiro[indoline-3,2'-oxiran]-3'-yl)phosphonate, 
258-cis 
Following the above general procedure, cis diastereoisomer 
258-cis was obtained as a yellow solid in 35% yield after 
purification (nHexane/EtOAc=1/1).1 1H-NMR (CDCl3, 300 
MHz, 25°C):   1.33 [t, J = 7.1 Hz, 6H (CH3CH2O)2P], 3.69 
(d, JH,P = 27.6 Hz, 1H, OCH), 4.14–4.40 [m, 4H, 
(CH3CH2O)2P], 4.90 (s, 2H, CH2N), 6.71 (d, J = 7.8 Hz, 1H, CHarom), 6.92–7.02 (m, 2H, 
CHarom), 7.16–7.30 (m, 6H, CHarom) ppm. Chiral-phase HPLC analysis: [Daiacel 
Chiralpack IB 5μ, =254 nm, nHexane/iPrOH=9/1, flow rate 1.0mL/min]: Tmajor = 
10.00 min, Tminor = 12.10 min ee = 9%. [α] D = -10.7 (c = 0.0053 g/cm3 in CHCl3) 
(2'S,3'S)-1-(2,4-dichlorobenzyl)-2-oxospiro[indoline-3,2'-oxiran]-3'-
yl)phosphonate, 259-trans 
Following the above general procedure, trans 
diastereoisomer 259-trans was obtained as a pale yellow 
solid in 54% yield after purification 
(nHexane/EtOAc=1/1).1 IR (CHCl3): ˜ n = 1733, 1253 cm1. 
1H-NMR (CDCl3, 300 MHz, 25°C):    1.23 [t, J = 7.1 
Hz, 3H, (CH3CH2O)2P], 1.42 [t, J =7.1 Hz, 3H, 
(CH3CH2O)2P], 3.81 (d, JH,P = 27.4  Hz, 1H, OCH), 3.97–4.19 [m, 2H, (CH3CH2O)2P], 
4.22–4.39 [m, 2H, (CH3CH2-O)2P], 5.03 (s, 2H, CH2N), 6.73 (d, J = 7.9 Hz, 1H, 
CHarom), 7.05–7.20 (m, 3H, CHarom), 7.30–7.34 (m, 3H, CHarom), 7.43 (d, J = 1.9 Hz, 1H, 
CHarom), 8.00 (d, J = 7.6 Hz, 1H, CHarom) ppm. Chiral-phase HPLC analysis: [Daiacel 
Chiralpack IB 5μ, =254 nm, nHexane/iPrOH=9/1, flow rate 1.0mL/min]: Tmajor = 
26.20 min, Tminor = 16.80 min ee = 44%. [α] D = -20.4 (c = 0.0091 g/cm3 in CHCl3) 
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O
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(2'S,3'R)-1-(2,4-dichlorobenzyl)-2-oxospiro[indoline-3,2'-oxiran]-3'-
yl)phosphonate, 259-cis 
Following the above general procedure, cis diastereoisomer 
259-cis was obtained as a pale yellow solid in 29% yield after 
purification (nHexane/EtOAc=1/1).1 1H-NMR (CDCl3, 300 
MHz, 25°C):    1.50 [t, J = 7.1 Hz, 6H (CH3CH2O)2P], 3.87 
(d, JH,P = 27.6 Hz, 1H, OCH), 4.21–4.57 [m, 4H, 
(CH3CH2O)2P], 5.15 (s, 2H, CH2N), 6.83 (d, J = 7.2 Hz, 1H, 
CHarom), 7.14–7.52 (m, 6H, CHarom) ppm. Chiral-phase HPLC analysis: [Daiacel 
Chiralpack IB 5μ, =254 nm, nHexane/iPrOH=9/1, flow rate 1.0mL/min]: Tmajor = 
11.00 min, Tminor = 9.90 min ee = 10%. [α] D = -5.32 (c = 0.0064 g/cm3 in CHCl3) 
(2'S,3'S)-5-chloro-1-methyl-2-oxospiro[indoline-3,2'-oxiran]-3'-yl)phosphonate, 
260-trans 
Following the above general procedure, trans diastereoisomer 
260-trans was obtained as a white solid in 38% yield after 
purification (nHexane/EtOAc=1/1). IR (CHCl3): ˜ n = 1734, 1260 
cm1. 1H-NMR (CDCl3, 300 MHz, 25°C):   1.26 [t, J = 7.0 Hz, 
3H, (CH3CH2O)2P], 1.42 [t, J =7.0 Hz, 3H, (CH3CH2O)2P], 3.26 
(s, 3H, NCH3); 3.73 (d, JHP = 26.6 Hz, 1H, OCH), 4.05–4.18 [m, 2H, (CH3CH2O)2P], 
4.25–4.34 [m, 2H, (CH3CH2-O)2P], 6.83 (d, J = 8.3 Hz, 1H, CHarom), 7.38 (d, J = 8.3 
Hz, 1H, CHarom), 8.02 (s, 2H, CHarom) ppm. 13CNMR (CDCl3, 75 MHz, 25°C):   16.4 
[(CH3), d, JCP = 5.9 Hz], 16.6 (d, JCP = 5.6 Hz), 27.1 (NCH3), 58.1 (d, JCP = 203.4 Hz), 
59.9, 63.3 (d, JCP = 6.3 Hz), 63.8 (d, JCP = 6.1 Hz), 109.8 (Carom), 121.2 (Carom), 127.5 
(Carom), 128.8 (Carom), 131.0 (Carom), 144.3 (Carom), 170.4 (C=O) ppm. HRMS: exact 
mass calculated for (C14H17ClNNaO5P) requires m/z 368.0431, found m/z 368.0433. 
Chiral-phase HPLC analysis: [Daiacel Chiralpack IC 5μ, =254 nm, 
nHexane/EtOH=9/1, flow rate 1.0mL/min]: Tmajor = 18.92 min, Tminor = 17.56 min ee = 
52%. [α] D = +4 (c = 0.0170 g/cm3 in CHCl3) 
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(2'S,3'R)- 5-chloro-1-methyl-2-oxospiro[indoline-3,2'-oxiran]-3'-yl)phosphonate, 
260-cis 
Following the above general procedure, cis 
diastereoisomer 260-cis was obtained as a pale yellow 
solid in 58% yield after purification 
(nHexane/EtOAc=1/1).IR (CHCl3): ˜ n = 1752, 1258 cm1. 
1H-NMR (CDCl3, 300 MHz, 25°C):   1.59-1.65 [m, 6H (CH3CH2O)2P], 3.48 (s, 3H, 
NCH3); 3.92 (d, JH,P = 27.0 Hz, 1H, OCH), 4.44–4.68 [m, 4H, (CH3CH2O)2P], 7.05 (d, 
J = 7.9 Hz, 1H, CHarom), 7.50–7.60 (m, 2H, CHarom) ppm. 13CNMR (CDCl3, 75 MHz, 
25°C):   16.4 [(CH3),  t, JCP = 6.3 Hz), 27.0 (NCH3), 60.0 (d, JCP = 200.7 Hz), 60.6, 
62.8 (d, JCP = 6.5 Hz), 64.4 (d, JCP = 6.6 Hz), 122.5 (Carom), 125.8 [(Carom), d, JCP = 27.0 
Hz], 126.5 [(Carom), d, JCP = 9.2 Hz], 128.2 [(Carom), d, JCP = 20.0 Hz], 131.0 (Carom), 
143.7 (Carom), 168.5 (C=O) ppm. HRMS: exact mass calculated for (C14H17ClNNaO5P) 
requires m/z 368.0431, found m/z 368.0433. Chiral-phase HPLC analysis: [Daiacel 
Chiralpack IC 5μ, =254 nm, nHexane/EtOH=85/15, flow rate 1.0mL/min]: Tmajor = 
32.17 min, Tminor = 30.15 min ee = 10%. [α] D = -1 (c = 0.0060 g/cm3 in CHCl3) 
 (2'R,3'S)-1,3'-dimethylspiro[indoline-3,2'-oxiran]-2-one, 261-trans 
Following the above general procedure, trans diastereoisomer 261-
trans was obtained as a pale yellow oil in 57% yield after purification 
(nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 1725, 1617, 1469, 1374, 
1258 cm1. 1H-NMR (CDCl3, 300 MHz, 25°C):   1.60 (d, J = 5.0 Hz, 
3H, CH3CH); 3.27 (s, 3H, NCH3); 3.77 (q, J = 5.0 Hz, 1H, OCH), 6.94 
(d, J = 7.9 Hz, 1H, CHarom), 7.10 (d, J = 7.7 Hz, 1H, CHarom), 7.40 (t, J = 7.5 Hz, 1H, 
CHarom)  ppm. 13CNMR (CDCl3, 75 MHz, 25°C):   13.8 (CH3), 26.7 (NCH3), 60.6, 
61.5, 108.9 (Carom), 121.6 (Carom), 122.6 (Carom), 124.1 (Carom), 130.1 (Carom), 145.5 
(Carom), 172.7 (C=O) ppm. HRMS: exact mass calculated for (C11H11NNaO2) requires 
m/z 212.0687, found m/z 212.0689. Chiral-phase HPLC analysis: [Daiacel Chiralpack 
IC 5μ, =254 nm, nHexane/EtOH=70/30, flow rate 1.0mL/min]: Tmajor = 10.61 min, 
Tminor = 9.90 min ee = 72%. [α] D = -1 (c = 0.0133 g/cm3 in CHCl3) 
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(2'S,3'S)-1,3'-dimethylspiro[indoline-3,2'-oxiran]-2-one, 261-cis 
Following the above general procedure, cis diastereoisomer 261-
cis was obtained as a pale yellow oil in 42% yield after 
purification (nHexane/EtOAc=8/2). IR (CHCl3): ˜ n = 1725, 1618, 
1465, 1377, 1224 cm1. 1H-NMR (CDCl3, 300 MHz, 25°C):   
1.73 (d, J = 5.1 Hz, 3H, CH3CH); 3.27 (s, 3H, NCH3); 3.75 (q, J = 
4.8 Hz, 1H, OCH), 6.90 (d, J = 7.7 Hz, 1H, CHarom), 7.07-7.08 (m, 2H, CHarom), 7.34-
7.39 (m, 1H, CHarom) ppm. 13CNMR (CDCl3, 75 MHz, 25°C): 12.4 (CH3), 26.8 (NCH3), 
59.9, 63.4, 108.7 (Carom), 121.8 (Carom), 122.9 (Carom), 124.3 (Carom), 130.1 (Carom), 144.6 
(Carom), 171.8 (C=O) ppm. HRMS: exact mass calculated for (C11H11NNaO2) requires 
m/z 212.0687, found m/z 212.0689. Chiral-phase HPLC analysis: [Daiacel Chiralpack 
IB 5μ, =254 nm, nHexane/EtOH=90/10, flow rate 1.0mL/min]: Tmajor = 7.86 min, 
Tminor = 7.23 min ee = 48%. [α] D = +1 (c = 0.0054 g/cm3 in CHCl3) 
General procedure for the synthesis of 1,2-diols 277, 284-290 (procedure 1) 
 
 
1) Preparation of the Grignard reagent 
A solution of 4-Bromoanisole (3.74 g, 20.0 mmol) in dry THF (2 ml) was added to 
activated magnesium turnings a (0.48 g, 20 mmol) under dry atmosphere. The 
exothermic reaction mixture was kept at room temperature.b After heat development 
ceased, the mixture was diluted with dry THF (8 ml) and the resulting solution 
(calculated ca. 2 mmol/ml) was used immediately. 
2) Addition to hydroxyketones 
A solution of Grignard reagent prepared above (2 mL, 4 mmol) was added dropwise to 
an ice-cooled solution of hydroxyketone in THF (8 mL, 2 mmol). The reaction mixture 
was allowed to reach room temperature and after completionc was quenched at 0 °C 
with concentrated aqueous NH4Cl (2 ml). The aqueous phase was extracted with ethyl 
acetate (4 x 20 ml); the combined organic extracts were dried over MgSO4, filtered and 
concentrated under reduced pressure directly before purification. Flash chromatography 
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on silica gel yielded pure products, which were stored at -20 °C or directly used for the 
kinetic resolution. 
Notes: 
a)  Activation was performed with a few drops of 1,2‐dibromoethane. 
b) If there is no exothermic reaction at this point, initiation is performed by adding more 
1,2‐dibromoethane and fast heating (with a heat gun) and cooling to 25 °C (repeated 
until reaction becomes exothermic after cooling). 
c) completion was observed through TLC visualization: UV (254 nm) and/or PMA 
stain. 
General procedure for kinetic resolution of diols (procedure 2) 
 
Isovaleraldehyde (0.8 mmol) was added dropwise to the solution of diol (0.2 mmol), 
molecular sieves (20 mg) and catalyst (0.002 mmol) in dry toluene (2 mL) and stirred at 
20 °C. Then Et3N (28mL) was added to the reaction mixture near 50% conversion of the 
starting material (in most cases within 6-20 h).a The reaction mixture was concentrated 
under reduced pressure and purified via flash chromatography eluting with a gradient 
1% EtOAc/Hexane to 40% EtOAc/Hexane, to isolate the product and the starting 
material.  
 
Note: 
For small scale reaction, conversion was observed through TLC visualization: UV (254 
nm) and/or PMA stain and checked by measuring enantiomeric excess of the diol during 
time. For larger scale reactions, the reaction was performed in a vial with septum and 
directly quenched after a pre-determined time. 
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Characterization of diols 277, 284-290 
2-Phenylpropane-1,2-diol, 277 
Following the above general procedure (procedure 1), 277 was 
obtained as a pale yellow oil in 90% yield after purification 
(DCM/MeOH=98/2) following procedure 1.116 1H NMR (500 MHz, 
CDCl3) δ 1.52 (s, 3H, CH3), 2.01 (brs, 1H, OH), 2.70 (brs, 1H, OH), 3.70 (m, 2H, CH2), 
7.27 (t, J = 7.3 Hz, 1 H, CHarom), 7.36 (m, 2H, CHarom), 7.45 (d, J = 7.3 Hz, 2H, CHarom) 
ppm. 13C NMR (500 MHz, CDCl3):   26.1 (CH3), 71.1 (CH2), 74.8 (C), 125.1 (Carom), 
127.2 (Carom),  128.4 (Carom),  144.9 (Carom)  ppm. MS: m/z=152.1 [M+].Enantioenriched 
diol was obtained following procedure 2. Chiral-phase HPLC analysis: [Column OD3, 
5μ, =210 nm, nHeptane/iPrOH=95/5, flow rate 1.0mL/min]: Tmajor = 10.03 min, Tminor 
= 9.36 min, ee = 96%.  
2-Phenylbutane-1,2-diol, 284 
Following the above general procedure (procedure 1), 284 was 
obtained as a colourless oil in 43% yield after purification 
(haxane/EtOAc=1/1).117 1H NMR (500 MHz, C6D6) δ 0.73 (t, J = 7.43 
Hz, 3H, CH3), 0.97 (brs, 1H, OH), 2.24 (s, 1H, OH), 3.40 (m, 2H, 
(CH2), 7.08 (t, J=7.29 Hz, 1H, CHarom), 7.17 (t, J = 7.3 Hz, 2H, CHarom), 7.29 (d, J = 7.3 
Hz, 2H, CHarom); 13C NMR (500 MHz, C6D6):   17.6 (CH3), 31.44 (CH3CH2), 70.6 (C), 
77.1 (CH2), 126.0 (Carom),  126.9 (Carom),  128.4 (Carom),  144.2 (Carom) ppm. 
Enantioenriched diol was obtained following procedure 2. Chiral-phase HPLC analysis: 
[Column OD3, 5μ, =210 nm, nHeptane/iPrOH=95/5, flow rate 1.0mL/min]: Tmajor = 
8.09 min, Tminor = 7.42 min, ee = 99%. [α] D = -1.87 (c = 0.0220 g/cm3 in CHCl3) 
2-(2-methylphenyl)-propane-1,2-diol, 285 
Following the above general procedure (procedure 1), 285 was 
obtained as a colourless oil in 88% yield after purification 
(haxane/EtOAc=1/1).118 1H NMR (500 MHz, CDCl3) δ 1.61 (s, 3H, 
CH3), 1.83 (brs, 1H, OH), 2.56 (s, 3H, CH3), 3.87 (m, 2H, CH2), 7.18 
(m, 3H, CHarom), 7.45 (m, 1H, CHarom); MS: m/z=166.2 [M+]. Enantioenriched diol was 
obtained following procedure 2. Chiral-phase HPLC analysis: [Column OD3, 5μ, =210 
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nm, nHeptane/iPrOH=95/5, flow rate 1.0mL/min]: Tmajor = 9.15 min, Tminor = 8.32 min, 
ee = 96%. 
2-(3-methylphenyl)-propane-1,2-diol, 286 
Following the above general procedure (procedure 1), 286 was 
obtained as a colourless oil in 70% yield after purification 
(haxane/EtOAc=1/1).119 1H NMR (500 MHz, CDCl3) δ 1.53 (s, 3H, 
CH3), 1.70 (brs, 1H, OH), 2.38 (s, 3H, CH3), 2.51 (brs, 1H, OH), 3.72 
(m, 2H, CH2), 7.10 (d, J = 6.8 Hz, 1H, CHarom), 7.26 (m, 3H, CHarom); 
MS: m/z=166.2 [M+]. Enantioenriched diol was obtained following procedure 2. Chiral-
phase HPLC analysis: [Column OD3, 5μ, =210 nm, nHeptane/iPrOH=95/5, flow rate 
1.0mL/min]: Tmajor = 8.04 min, Tminor = 7.45 min, ee = 94% 
2-(4-methylphenyl)-propane-1,2-diol, 287 
Following the above general procedure (procedure 1), 287 was 
obtained as a colourless oil in 50% yield after purification 
(haxane/EtOAc=4/6). 1H NMR (500 MHz, CDCl3) δ 1.53 (s, 
3H, CH3), 1.74 (brs, 2H, 2xOH), 2.35 (s, 3H, CH3), 3.71 (m, 2H, 
CH2), 7.19 (d, J = 8.1 Hz, 2H, CHarom), 7.35 (d, J = 7.8 Hz, 2H, CHarom); MS: 
m/z=166.2 [M+] Enantioenriched diol was obtained following procedure 2. Chiral-phase 
HPLC analysis: [Column OD3, 5μ, =210 nm, nHeptane/iPrOH=95/5, flow rate 
1.0mL/min]: Tmajor = 9.98 min, Tminor = 9.14 min, ee = 96%. 
2-(4-chlorophenyl)-propane-1,2-diol, 288 
Following the above general procedure, 288 was obtained as a 
colourless oil in 65% yield after purification 
(DCM/MeOH=95/5).120 1H NMR (500 MHz, CDCl3) δ 1.47 (s, 
3H, CH3), 2.43 (t, 1H, OH), 2.97 (brs, 1H, OH), 3.62 (m, 2H, 
CH2); 7.26 (d, J = 8.6 Hz, 2H, CHarom), 7.44 (d, J = 8.6 Hz, 2H, CHarom); 13C NMR (500 
MHz, CDCl3)    26.2 (CH3), 70.9 (C), 74.7 (CH2), 126.7 (Carom), 128.5 (Carom), 133.2 
(Carom), 143.7 (Carom) ppm; MS: m/z=186.0 [M+]. 
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2-(4-methoxyphenyl)-propane-1,2-diol, 289 
Following the above general procedure (procedure 1), 289 was 
obtained as a colourless oil in 60% yield after purification 
(hexane/EtOAc = 1/1). 1H NMR (500 MHz, DMSO-d6) δ 1.35 
(s, 3H, CH3), 3.35 (m, 2H, CH2), 3.72 (s, 3H, CH3), 4.61 (t, J = 
4.6 Hz, 1H, OH), 4.75 (s, 1H, OH), 6.83 (m, 2H, CHarom), 7.34 (m, 2H, CHarom) ppm; 
13C NMR (500 MHz, DMSO-d6)   26.1 (CH3), 55.0 (CH3), 70.6 (CH2), 73.3 (C), 112.9 
(Carom), 126.6 (Carom), 139.5 (Carom), 157.7 (Carom) ppm; MS: m/z=182.2 [M+]. 
Enantioenriched diol was obtained following procedure 2. Chiral-phase HPLC analysis: 
[Column OD3, 5μ, =210 nm, nHeptane/iPrOH=95/5, flow rate 1.0mL/min]: Tmajor = 
17.28 min, Tminor = 13.44 min, ee = 99%. [α] D = +8.635 (c = 0.0170 g/cm3 in CHCl3) 
2-(1-naphtalenyl)-propane-1,2-diol, 290 
Following the above general procedure (procedure 1), 290 was 
obtained as a colourless solid in 80% yield after purification 
(hexane/EtOAc = 6/4).121 1H NMR (500 MHz, CDCl3) δ 1.83 (s, 3H, 
CH3), 1.86 (brs, 1H, OH), 2.82 (brs, 1H, OH), 4.11 (m, 2H, CH2), 
7.47 (m, 3H, CHarom), 7.64 (d, J = 7.3 Hz, 1H, CHarom), 7.80 (d, J = 
8.4 Hz, 1H, CHarom), 7.88 (d, J = 7.4 Hz, 1H, CHarom), 8.66 (d, J = 8.4 Hz, 1H, CHarom) 
ppm; MS: m/z=202.3 [M+]. 
Characterization of acetals 281, 291, 296 
4-isobutyl-2-methyl-2-phenyl-1,3-dioxolane, 281 
281 was obtained following the above general procedure 
(procedure 2), quenching reaction at 50% conversion after 15 h; 
purification: gradient hexane 100% to hexane/EtOAc = 1/1. 
Colourless oil, 0.022 g (from 0.2 mmol of diol), 50%. GC 
(Column: 25 m Lipodex G, G566); detector: FID; temperature: 
injector 220 °C, detector 125 °C, oven 220°C; gas: 0.5 bar H2), tmajor = 21.05 min, tminor 
= 21.42 min, minor diastereomer (tmajor = 20.04 min, tminor = 19.72 min); ee = 97%; dr = 
98:2;  1H NMR (500 MHz, C6D6) δ 0.94 (m, 6H), 1.39 (s, 3H), 1.76 (m, 2H), 1.96 (m, 
2H), 3.75 (m, 2H), 5.26 (t, J = 5.23 Hz, 1H), 7.08 (t, J = 7.35 Hz, 1H), 7.18 (t, J = 7.5 
H3C OH
OH
290
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Hz, 2H), 7.37 (d, J = 7.2 Hz, 2H);  13C NMR (500 MHz, C6D6) δ 23.1, 23.2, 25.1, 26.3, 
43.6, 77.5, 81.7, 104.5, 125.2, 127.1, 128.4, 146.7; MS: m/z=220.3 [M+]. 
4-isobutyl-2-ethyl-2-phenyl-1,3-dioxolane, 291 
291 was obtained following procedure 2, quenching the reaction 
at 52% conversion after 20 h; purification: gradient hexane 100% 
to hexane/EtOAc = 1/1. Colourless oil, 0.021 g (from 0.2 mmol of 
diol), 44%. GC (Column: 25 m Lipodex G, G566); detector: FID; 
temperature: injector 220 °C, detector 320°C, oven 110 to 220°C; 
gas: 0.5 bar H2), tmajor = 30.75 min, tminor = 31.45 min, minor diastereomer (tmajor = 29.17 
min, tminor = 28.42 min) ee = 96%; dr = 97:3; 1H NMR (500 MHz, C6D6) δ 0.94 (t, J = 
7.56 Hz, 6H), 1.39 (s, 3H), 1.63 (m, 1H), 1.75 (m, 3H), 1.95 (m, 1H), 3.82 (m, 2H), 5.25 
(t, J = 5.24 Hz, 1H), 7.08 (t, J = 6.94 Hz, 1H), 7.19 (t, J = 7.53 Hz, 2H), 7.32 (d, J = 
8.08 Hz, 2H); 13C NMR (500 MHz, C6D6) δ 8.62, 23.12, 23.20, 32.27, 40.05, 43.70, 
76.69, 104, 29, 125.68, 126.94, 145.00, 128.50; MS: m/z=234.3 [M+]. [α] D = -50.73 (c 
= 0.0110 g/cm3 in CHCl3) 
 
4-isobutyl-2-(4-methoxyphenyl)-2-methyl-1,3-dioxolane, 296 
Compound 296 was obtained following procedure 2, 
quenching the reaction at 50% conversion after 16 h; 
purification: gradient hexane 100% to hexane/EtOAc = 
1/1. Colourless oil, 0.024 g (from 0.2 mmol of diol), 48%.  
GC (Column: 25 m Lipodex G, G566); detector: FID; 
temperature: injector 220 °C, detector 320°C, oven 145 to 220°C; gas: 0.5 bar H2), tmajor 
= 45.80 min, tminor = 44.23 min, minor diastereomer (tmajor = 41.12 min, tminor = 42.19 
min). ee = 96.9%; dr = 98:2; 1H NMR (500 MHz, C6D6) δ 0.96 (m, 6H), 1.43 (s, 3H), 
1.78 (m, 2H), 1.98 (m, 1H), 3.32 (s, 3H), 3.77 (m, 2H), 5.29 (t, J = 5.2 Hz, 1H), 6.81 (d, 
J = 8.72 Hz, 2H), 7.31 (d, J = 8.75 Hz, 2H); 13C NMR (500 MHz, C6D6) δ 23.19, 23.21, 
25.07, 43.72, 54.81, 77.69, 81.51, 103.99, 113.88, 126.38, 138.73, 159.19; MS: 
m/z=250.3 [M+]. [α] D = -41.58 (c = 0.0215 g/cm3 in CHCl3) 
O
O
H3C
H3CO
296
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General procedure for preparing catalyst H 
 
Catalyst H was prepared following the above reaction scheme. 
(a) In a refrigerated flask (-5°C through ice/NaCl bath) 575 mg (5 mmol) (S)-proline 37 
were stirred for ten minutes in 2.5mL NaOH 2M. Afterwards 1mL (7mmol) di benzyl 
chloroformiate and 1.75mL of NaOH 4M are added drop by drop, in 30 minutes. The 
reaction was then stirred at 0°C for one hour and then washed with Et2O (2x1.5mL). 
Then the reaction mixture was acidified to pH 2 with HCl 6M and then saturated with 
anhydrous sodium sulphate. Solvent was evaporated in vacuo yielding 1.1g 207 (88% 
yield) as a colourless oil, which was used for next step without further purification. 
(b) To a solution of 249 mg Cbz-(S)-proline 207 in 2 mL dry DCM, stirred at 0°C, were 
added 305 μL triethylamine (2.2mmol) and 105 μL (1.1mmol) ethyl chloroformate. The 
reaction was stirred at 0°C for 30 minutes and 109 mg (1 mmol) of 208 were added. The 
mixture was stirred overnight at room temperature, then 2 mL HCl were added and the 
reaction was extracted with DCM (2x2mL). Organic layers were dryed over anhydrous 
Na2SO4 and solvent was evaporated in vacuo. Purification via flash chromatography led 
to 255 mg of clean product 209 (0.75 mmol). 
(c) 157 mg (0,46 mmol) of 209 were dissolved in 3 mL of MeOH under Ar atmosphere 
together with 8 mg of Pd/C (10% Pd/C). The reaction was heated to reflux and 286 μL 
of cyclohexene were added. After one hour the mixture was filtrated on Celite and 
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solvent was evaporated in vacuo. Purification (CHCl3/MeOH) via flash chromatography 
led to 93 mg of clean product H (98%). 
Characterization of 209 and H 
(S)-benzyl 2-((2-hydroxyphenyl)carbamoyl)pyrrolidine-1-carboxylate, 209 
Following the above procedure, compound 209 was purified via 
flash chromatography (hexane/acetate = 9/1) and isolated in 75% 
yield as a pale yellow oil. 1H-NMR (CDCl3, 300 MHz, 25°C): δ = 
10.00 (bs, 1H, NHamide), 7.43-7.35 (m, 4H, CHarom), 7.11 (t, J = 7.6 
Hz, 1H, CH), 7.01 (d, J = 8.1 Hz, 1H, CH), 6.91 (d, J = 6.8 Hz, 1H, 
CH), 6.83 (t, J = 7.4 Hz 1H, CH), 5.33 (s, 2H, CH2Ph), 4.40 (m, 1H, CH), 3.64-3.44 (m, 
2H, CH), 2.32-1.84 (m, 4H, 2xCH). 
(S)-N-(2-hydroxyphenyl)pyrrolidine-2-carboxamide, H 
Following the above procedure, compound 209 was purified via 
flash chromatography (hexane/acetate = 9/1) and isolated in 75% 
yield as a pale yellow oil. 1H-NMR (CDCl3, 300 MHz, 25°C): δ = 
9.99 (bs, 1H, NHamide), 7.11 (t, J = 7.6 Hz, 1H, H4), 7.01 (d, J= 8.1 
Hz, 1H, H6), 6.91 (d, J= 6.8 Hz, 1H, H3), 6.83 (t, J = 7.4 Hz, 1H, 
H5), 3.94 (dd, J = 9.4, 5.0 Hz, 1H, H2), 3.07 (m, J = 16.4, 10.1, 6.5 Hz, 2H, H5’), 2.75 
(bs, 1H, OH), 2.25 (m, J = 16.8, 7.5 Hz, 1H, H4), 2.06 (m, J = 19.3, 6.4 Hz, 1H, H4’), 
1.79 (m, J = 13.6, 6.6 Hz, 2H H3), 1.72–1.52 (m, 1H, NHamine) ppm. 13C-NMR (75 
MHz, CDCl3): δ = 175.5 (CON), 149.3 (C4’), 127.3 (C6’), 125.3 (C3’), 122.2 (C5’), 120.2 
(C1’), 120.2 (C2’), 60.5 (C2), 47.6 (C5), 31.1 (C3), 26.5 (C4) ppm. 
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Assignment of configurations of epoxides 
 
General Information 
NOESY experiments were recorded with a Bruker AC 300 spectrometer. All 
calculations were carried out on a simple PC endowed with a Intel(R) Xeon Quadcore 
E5420 at 2.50 GHz. Optical rotation analyses were carried out on a Jasco DIP-370 
digital polimeter using a Na-lamp. The starting geometries were generated by 
conformational analysis with the SPARTAN02 software,q using molecular mechanics 
(MMFF94s force field) and retaining all the structures differing by 4 kcal/mol by most 
stable conformer. All these geometries were fully optimized at the DFT/B3LYP/6-31G* 
and 6-31++G (2d,2p) level in the gas phase as implemented in the GAUSSIAN09 
package.r In all cases, the free energy values at T = 298K were employed to calculate 
the population of each conformer, using the Boltzmann’s statistics. The calculations of 
the Optical Rotation Dispersion (ORD) were carried out at TDDFT/B3LYP/6-31G* 
level in the gas phase. The theoretical ORD values (to be compared with the 
experimental ones) were obtained as weighted averages on the Boltzmann’s populations 
calculated in the gas phase or in the selected solvents. 
Configuration Assignment 
NOESY Spectroscopy Data 
The trans and cis configuration assignments of the obtained spiro-epoxyoxiranes 133-
trans and 133-cis were unambiguously determined by comparing the NOESY 
spectroscopic data reported below. Indeed: 
a. in the NOESY spectrum of 133-cis [Figure 1’ (a)] cross-peaks were found between 
the aromatic 4-H atom [δ 7.04-7.14 (m, 2H, CHarom) ppm] and the epoxide proton 
[δ 4.15 (s, 1H, OCH) ppm], due the spatial proximity of these nuclei, unequivocally 
proving the cis configuration of the minor diastereoisomer 133-cis. Moreover, 
further cross-peaks are generated by the spatial interaction between the H atom 
                                                             
q SPARTAN ’02; Wavefunction Inc.: Irvine, CA. http://www.wavefunction.com 
r Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Scalmani, G.; Barone, V.; Mennucci, B.; 
Petersson, G.A.; Nakatsuji, H.; Caricato, M.; Li, X.; Hratchian, H.P. ; Izmaylov, A.F.; Bloino, J.; Zheng, G.; Sonnenberg, J.L.; Hada, 
M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; 
Montgomery, Jr., J.A.;. Peralta, J.E; Ogliaro, F.; Bearpark, M.; Heyd, J.J.; Brothers, E.; Kudin, K.N.; Staroverov, V.N.; Kobayashi, R.; 
Normand, J.; Raghavachari, K.; Rendell, A.; Burant, J.C.; Iyengar, S.S.; Tomasi, J.; Cossi, M.; Rega, N.; Millam, J.M.; Klene, M.; 
Knox, J.E.; Cross, J.E.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R.E.; Yazyev, O.; Austin, A.J.; Cammi, R.; 
Pomelli, C.; Ochterski, J.W.; Martin, R.L.; Morokuma, K.; Zakrzewski, V.G.; Voth, G.A.; Salvador, P.; Dannenberg, J.J.; Dapprich, S.; 
Daniels, A.D.; Farkas, O.; Foresman, J.B.; Ortiz, J.V.; Cioslowski J.; Fox, D.J. GAUSSIAN 09, Revision A.02; Gaussian, Inc.: 
Wallingford, CT, 2009 
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belonging to the N-CH3 [δ 3.22 (s, 3H, CH3N) ppm] group and 7-H atom on the 
aromatic ring [δ 6.89 (dd, J = 7.8Hz, 0.5Hz, 1H, CHarom) ppm ]. 
b. conversely, no NOESY cross peaks for the epoxide proton were found in the major 
isomer 133-trans [Fig. 1 (b)], although the through-space connectivity between the 
N-CH3 group [δ 3.25 (s, 3H, CH3N) ppm] and the aromatic 7-H atom [δ 6.89 (ddd, 
J = 7.9Hz, 0.9Hz, 0.6Hz, 1H, CHarom) ppm] is clearly still present. 
(a) (2'S,3'R)-ethyl 1-methyl-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate 133-cis 
 
 
 
 
 
 
 
(b) (2'R,3'R)-ethyl 1-methyl-2-oxospiro[indoline-3,2'-oxirane]-3'-carboxylate 133-trans 
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Optical Rotation Dispersion Data: comparison between calculated and experimental 
values.  
ORD values of 133-trans were calculated by means of the Time-Dependent Density 
Functional Theory (TDDFT) method, using B3LYP functional,s which, with the 6-31G* 
(or higher) basis sets is wide used by the experimental organic chemists to assign the 
absolute configuration of new synthetic and natural compounds.t The (2’R,3’R) 
configuration was arbitrarily fixed at two newly formed stereogenic centers. Molecular 
mechanics provided six conformers, then fully optimized at DFT/B3LYP/6-31G* level 
of calculation. Calculated conformers free energies were used to carry out Boltzmann’s 
populations distribution. In Figure 2’ the most stable conformer (2’R,3’R)-133-trans-A 
structure is reported.  
 
Figure 2’ The most stable conformer (2’R,3’R)-2aA calculated at DFT/B3LYP/6-31G* level of theory. 
All optimized conformers differ each other by the orientation of the ester moiety (Figure 
3’).  
                                                             
s (a) Becke, A.D. J. Chem. Phys., 1993, 98, 5648. (b) Lee, C.; Yang .W.; Parr, R.G. Phys. Rev. B, 1998, 37, 785 
t Synthetic compounds: (a) Xu, D.; Wang, Y.; Luo, S.; Zhong, A.; Chen, H.; Xu, Z. Adv. Synth. Cat. 2008, 350, 2610. (b) Gioia, C.; Fini, 
F.; Mazzanti, A.; Bernardi, L., Ricci, A. J. Am. Chem. Soc., 2009, 131, 9614. Natural products: (c) Ge, H.M.; Zhu, C.H.; Da, H.S.; 
Zhang, L.D.; Xie, D.Q.; Yang, J.; Ng, S.W.; Tan, R.X. Chem. Eur. J., 2008, 14, 376. See also: (d) Bringmann, G.; Gulder, T.A.M.; 
Reichert, M.; Gulder, T. Chirality, 2008, 20, 628. (e) Bringmann, G.; Bruhn, T.; Maksimenka; K.; Hemberger, Y. Eur. J. Org. Chem., 
2009, 2717 and references cited therein. 
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Figure 3’ Structures of the most stable conformers of (2’R,3’R)-2a optimized at the DFT/B3LYP/6-31G* 
The calculated optical rotatory power at four different wavelengths (589.3, 546, 435 and 
405 nm), calculated at the TDDFT/B3LYP/6-31G*, relative free energies, conformers 
Boltzmann populations for all optimized conformers of (2’R,3’R)-2a and comparison 
with the experimental ORD (c = 0.55 g/cm3 in CH2Cl2) are shown in Table 1. Results 
strongly supports (2’R,3’R)-2a absolute configuration. 
 
 
 
 
 
 
 
 
 
 
 
! "#$ ! "%$
! "&$ ! "' $
! "( $ ! ") $
(2R,3R)-133-trans-A (2R,3R)-133-trans-B 
(2R,3R)-133-trans-C (2R,3R)-133-trans-D 
(2R,3R)-133-trans-E (2R,3R)-133-trans-F 
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Table 1’. Relative-free energies with respect to the most stable conformer, populations, ORD values (deg 
[dm g/cm3]-1) obtained at TDDFT/B3LYP/6-31G* level for each conformer and experimental ORD in 
CH2Cl2 
Conformers 
ΔG 
(kcal/mol) 
% pop [α]D [α]546 [α]435 [α]405 
133-trans-
A 
0.0 45.9 -101 -127 -294 -419 
133-trans-B 0.4 24.3 -51 -64 -153 -220 
133-trans-C 0.5 21.4 -75 -92 -193 -262 
133-transD 1.4 4.7 -15 -18 -37 -50 
133-trans-E 1.7 2.7 -7 -8 -18 -25 
133-trans-F 2.2 1.0 -2 -2 -6 -8 
Total 
Calc.ORD 
  -250 -312 -701 -984 
Experimental 
ORD 
 -101 -134 -295 -395 
 
The sign, the order of magnitude and the uniform trend in the experimental ORD have 
been correctly reproduced by the calculations, despite the fact that the Boltzmann 
averaged ORD values are about twice higher than the experimental ones. Such 
difference may result from basis set calculation errors in overestimating ORD. 
Nevertheless, it is important to notice that all calculated conformers OR are negative. In 
facts problems may arise in the case of flexible molecule having many conformers with 
opposite-signed OR in order to get a more accurate geometries, populations and OR 
computational analysis achieving a reliable absolute configuration assignment.u In any 
case we also performed a geometry conformers optimization at DFT/B3LYP/6-
31++G(2d,2p), and a ORD calculation at TDDFT/B3LYP/6-31G* level of theory, in 
                                                             
u Mazzeo, G.; Giorgio, E.; Zanasi, R.; Berova, N.; Rosini, C. J. Org. Chem., 2010, 75, 4600. 
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order to check if significantly changes may occur in the theoretical predictions of 
respective conformers and/or in the conformational distribution, which could become 
more significant as in the present case where several conformers are involved. Then no 
significantly differences were reported (Table 2).  
Table 2. Relative-free energies with respect to the most stable conformer, populations, 
ORD values (deg [dm g/cm3]-1) obtained at TDDFT/B3LYP/6-31++G(2d,2p) level for 
each conformer and experimental ORD in CH2Cl2 
Conformers 
ΔG 
(kcal/mol) 
% pop [α]D [α]546 [α]435 [α]405 
133-trans-A 0.0 53.9 -115 -145 -337 -478 
133-trans-B 0.6 18.6 -39 -49 -116 -167 
133-trans-C 0.7 17.2 -57 -71 -149 -202 
133-transD 1.3 6.4 -20 -25 -51 -68 
133-trans-E 1.8 2.7 -6 -8 -17 -24 
133-trans-F 2.3 1.1 -2 -3 -6 -9 
Total 
Calc.ORD   -240 -301 -677 -948 
Experimental ORD 
(CH2Cl2) 
 -101 -134 -295 -395 
In conclusion we got a satisfactory agreement between experimental and calculated 
ORD avoiding large basis set such as aug-cc-pVDZ or 6-311++G** calculations and 
saving more computational efforts. 
Likewise, the (2’S,3’R) configuration to the major enantiomer of cis-3a has been 
assigned by exploiting the same quantum mechanics protocol. In particular, the 
experimental optical rotation value at  = 589.3 nm for the (2’S,3’R)- 3a is []D = -105 
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(c = 0.035 g/cm3 in CHCl3) which has to be compared with the ab initio calculated one 
[]D = -258 [deg (dm g/cm3)-1. 
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